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Background
Pneumococcal meningitis (PM) is a life-threatening disease. Recurrent
PM is relatively rare and associated with predisposing conditions.
This study analyzed the outcome of patients with recurrent versus
non-recurrent PM.
Methods
We conducted a retrospective study, analyzing the records of all the
patients hospitalized between 2005 and 2015 for PM in our institution.
We included patients with the diagnostic of PM based on appearance
on Gram stain, a positive latex agglutination reaction of cerebral spinal
fluid (CSF) samples and/or a positive culture for Streptococcus pneumo-
niae (CSF culture or blood culture and concomitant meningitis). We de-
fined “recurrent meningitis” as at least two episodes of meningitis,
separated by a period of at least 4 weeks.
Results
We identified a total of 194 PM episodes in 182 patients. Thirty eight
(20 %) patients were diagnosed with recurrent meningitis, and they
had 93 prior episodes recorded. The majority of patients with recurrent
meningitis experienced two meningitis episodes, but we found 3
patients with 7, 11 and 40 recurrent episodes. Nineteen (50 %) pa-
tients in recurrent meningitis group and 90 (58 %) in non-recurrent
group were men. Median age of patients with recurrent versus
non-recurrent meningitis was 29 versus 57 years (p < 0.001). Nine
(24 %) patients with recurrent meningitis versus 64 (41 %) patients
with non-recurrent meningitis had an underlying immunosuppressive
condition (p = 0.02, OR:0.41, 95 % CI:0.18–0.92). The immunosuppres-
sion was: diabetes mellitus in 32 (44 %), alcoholism in 19 (26 %), end-
stage liver disease in 7 (9.5 %) and malignancy, malnutrition, preg-
nancy, splenectomy and immunosuppressive therapy in 15 (20.5 %).
We found dissemination of infection from a contiguous site in 74
(38 %) cases, bone defects and/or CSF leakage in 36 (18.5 %) cases
and hematogenous spread in 14 (7.2 %) cases. A cranial bone discon-
tinuity and/or CSF leakage were identified in recurrent versus non-© 2016 The Author(s). Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zerecurrent meningitis in 21 (55 %) versus 15 (10 %) episodes (p < 0.001,
OR:14.41, 95 % CI:6.21–33.4). Hematogenous spread was observed only
in the non-recurrent meningitis group. In recurrent versus non-
recurrent meningitis, impaired consciousness on admission was noted
in 15 (40 %) versus 64 (41 %). We noted one death (2.6 %) among pa-
tients with recurrent PM group vs 42 (27 %) in the non-recurrent group
(p<0.001, OR:0.07, 95 % CI:0.01–0.5). Death was associated with non-
recurrent meningitis (p < 0.001), contiguous spread (p = 0.014), immu-
nodepression (p = 0.01) and impaired consciousness (p = 0.005).
Conclusions
Patients with recurrent meningitis were younger, with less immuno-
suppression conditions and had a better survival versus those with
non-recurrent meningitis. Mortality of PM was associated with im-
munosuppression and impaired consciousness, but the small number
of deaths in the recurrent group did not allow us to analyses the
differences between the two groups.
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Background
Bacteriophages are hypothesized to contribute to biofilm eradication
through multiple actions, such as: 1) amplification in host cells; 2)
production of depolymerizing enzymes that degrade the matrix of
extracellular polymeric substances; 3) induction of depolymerizing
enzymes in host cells; 4) infection of persistent bacterial cells and
lysis upon reactivation [1].
Methods
We have performed an in vitro experiment in the National Institute
for Infectious Diseases „Prof. Dr. Matei Balș”, assessing the influence on
biofilm formation and biofilm eradication of commercially-available
bacteriophage cocktails Intesti and Pyo (Eliava BioPreparations, Tbilisi,
Georgia) in different binary dilutions (1/2 through 1/64) as presented in
Neguț et al., GERMS 2014. We have used two bacterial models:le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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negative model (44 strains of Pseudomonas aeruginosa) [2].
Results
Intesti and Pyo bacteriophages inhibited biofilm formation of both
Gram-positive (p = 0.004, p = 0.001) and Gram-negative (p = 0.001, p =
0.001) models for all the dilutions used, respectively. The median op-
tical density (OD) of staphylococcal culture decreased with 8.114 %
(−9.386 %, 16.533 %) for the dilution 1/64 of Intesti, and 8.108 %
(0.684 %, 20.143 %) for Pyo, respectively. The median OD decreased
with 29.191 % (4.607 %, 48.448 %) for the dilution 1/2 of Intesti, and
35.555 % (6.122 %, 47.852 %) for Pyo, respectively. For the Gram-
negative model, the OD decreased with 20.554 % (6.542 %, 44.814 %)
for 1/64 Intesti and with 15.817 % (2.711 %, 38.082 %) for 1/64 Pyo dilu-
tion. The OD decreased with 40.806 % (10.582 %, 64.275 %) for 1/2
Intesti and 35.101 % (5.445 %, 48.742 %) for 1/2 Pyo dilution, respect-
ively. The decrease in biofilm density as measured by the rate of
change (ROC) was higher for the Gram-negative model compared with
the Gram-positive model, but statistical significance was ascertained
only for Intesti (p < 0.001, Z = −3.712 at 1/64 dilution, and borderline
significance at 1/2 dilution: p = 0.050, Z = −1.959). Eradication of pre-
formed biofilm was achieved in both models through the addition of
phages: Intesti and Pyo for Staphylococcus spp. (p < 0.001, p = 0.009)
and Intesti for Pseudomonas aeruginosa (p = 0.011).
Conclusions
By extrapolating our findings we hypothesize that phages may even-
tually represent an option for primary prophylaxis through coating of
orthopedic prostheses and for secondary prophylaxis, by preventing
osteomyelitis relapses through biofilm reduction when administered
via local instillations.
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Background
Sepsis is a severe, life-threatening syndrome with high incidence and
mortality rate, which needs a rapid diagnosis and severity evaluation
in order to avoid fatal complications. If the diagnosis has preset criteria
(SOFA score more than 2), the prognosis remains an important problem
in septic patients management. Over the years, several markers of in-
flammation were evaluated such as fibrinogen, C reactive protein or
procalcitonin (PCT). Objectives: to appreciate the efficacy of neutrophil/
lymphocyte ratio (NLR), mean platelet volume (MPV), red cell distribu-
tion width (RDW) and PCT in sepsis prognosis and to correlate their
values with the severity and with the estimated mortality rate.
Methods
Prospective study realized in the Matei Balș Institute between October
2015 – July 2016, including 55 patients diagnosed with sepsis. There
were evaluated: number of SIRS criteria, primary sites of infection, in-
criminated germs, organ failures, septic metastases and there werecalculated two scores of severity - APACHE (Acute Physiology and
Chronic Health Evaluation), APS (Admission Point Score) and the esti-
mated mortality rate. The statistical analysis was realized using SPSS.
Results
The study included 55 patients with a mean age of 57.9 years old
and a sex ratio M:F = 1:1.75. The primary septic focus was found in
92.7 % of cases: respiratory (43.1 %), digestive (31.4 %), urinary
(21.6 %), others (3.9 %). The most frequent isolated germs were E.
coli (46.7 %), Streptococcus pneumoniae (20 %), Clostridium difficile
(13.3 %), others including Klebsiella, Legionella, Neisseria meningitidis
(20 %). 3.6 % of patients had septic metastases (cerebral or cutane-
ous) and 67.3 % presented at least one organ failure: hematological
(57.3 %), renal (21.8 %), respiratory (5.5 %). The mean value of initial
NLR was 17.7 and it was statistically significant correlated with the
number of organ failures, with APACHE (p = 0.01) and APS (p = 0.01)
scores and with the mortality rate (p = 0.01). This last correlation was
stronger than the one between PCT with the mortality. VPM (mean
value of 8.1 fl) and RDW (14.5) did not correlate with the two scores.
PCT with a median of 14.58 ng/mL was correlated with APACHE (p =
0.02), APS (p = 0.05) and mortality rate (p = 0.05).
Conclusions
Septic patients’ outcome can be easily appreciated using NLR, which
proved an important prognostic role in sepsis through the statistically
correlations with the severity scores and the estimated mortality rate.
PCT also remains a good test to appreciate the severity. Although some
studies showed the importance of VPM and RDW in sepsis, these
markers weren’t associated with the prognosis.
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Background
Neonatal bacterial meningitis is a rare disease, but characterized by
particularly high severity. Group B Streptococcus is the leading cause
of neonatal meningitis and is responsible for infections followed by
serious neurological sequelae. Although Neisseria meningitidis is not a
common causative agent of meningitis in this age group, in our clinic
cases we diagnosed a few cases in newborns and infants up to
3 months. Objectives: Study of bacterial meningitis diagnosed in
newborns and infants up to 3 months. Setting peculiarities determined
by the etiologic agent and the age of the children on the evolution
and development of sequelae.
Methods
Retrospective study of cases of bacterial meningitis in children aged
0–3 months, admitted to our clinic between 2014 and 2016.
Results
In the time period studied in our clinic 6 cases of bacterial meningitis
were diagnosed in infants younger than 3 months: 2 cases of neonatal
meningitis produced by group B Streptococcus developed serious
neurological sequelae (encephalomalacia, cortical atrophy, ventricu-
lomegaly). Neisseria meningitidis was isolated from 2 newborns and
2 infants aged two months and caused purulent meningitis that
evolved favorably, without sequelae.
Conclusions
Group B Streptococcus is a major cause of neonatal sepsis and
bacterial meningitis respectively and is responsible for particularly
severe neurological sequelae. That's why additional measures are
required for surveillance of pregnant women, for early detection
and intra-partum prophylactic treatment to reduce morbidity newborn
by this infection. Neisseria meningitidis, although not considered a
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 33 of 76common etiologic agent of meningitis in infants, was responsible
for four of the cases detected. This demonstrates the presence of
N. meningitidis in the population and the effects of exposing chil-
dren to highly pathogenic agents in the first days of life. Although
cases treated in our clinic have evolved favorably, their presence is
an alarm signal for epidemiological measures and an argument for
completing the diagnostic guidelines of bacterial meningitis in
infants.
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Background
The rapid diagnosis in sepsis, especially in cases without the evi-
dence of a septic focus, represents an important challenge in clin-
ical practice. The neutrophil/lymphocyte count ratio (NLCR) is an
easily measurable parameter which can have a role in diagnosis of
sepsis and also in assessing the severity of septic patients. NLCR
was evaluated especially in patients with severe sepsis admitted in
ICU and the data about its importance in so called community
acquired sepsis are lacunar. Objective: To analyze the diagnostic
and prognostic value of NLCR in patients with community acquired
sepsis.
Methods
We performed a prospective single center study that included con-
secutive cases of sepsis admitted in Matei Balș Institute. For each pa-
tient we determined NLCR at admission. Two groups of patients
were created: group 1 with NLCR < 10 and group 2 with NLCR > 10.
Clinical and biological parameters and also the severity calculated
with APACHE IV and APS scores were comparatively analyzed be-
tween the two groups.
Results
Fifty-five consecutive patients with sepsis were analyzed, with
mean age of 57.92 years old and sex ratio F:M = 1.75:1. Group 1 in-
cluded 21 patients with NLRC <10 (38.18 %) and group 2–34 pa-
tients with NLRC >10 (61.82 %). The comparative analysis between
the two groups showed: more patients with 3 or 4 criteria for sys-
temic inflammatory response syndrome (SIRS) in the second group
(55.88 % vs. 42.85 %), more patients with identified etiology in the
second group (32.32 % vs. 14.28 %) but without statistical signifi-
cance (p = 0.2543), more patients with at least one organ dysfunc-
tion (76.47 % vs. 52.38 %, p = 0.032) and with procalcitonin at
baseline > 2 ng/mL (medium PCT in the first group = 2.88 ng/mL vs.
medium PCT in the second group = 16.88 ng/mL) in the second
group. The correlations of initial value of NLRC with the severity
scores (APACHE IV and APS) and with the estimated mortality rate
were statistically significant (p = 0.01). The last correlation was
stronger than the one between procalcitonin and the mortality rate
(p = 0.05).
Conclusions
NLRC more than 10 was associated with severity expressed through
the number of SIRS criteria and the presence of organ dysfunction at
baseline. The value of NLRC was correlated with severity appreciated
with APACHE IV and APS scores and with the estimated rate of mor-
tality. NLRC is an easy to obtain biomarker which can be very helpful
in order to assess the severity of sepsis.A6
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Background
Whooping cough is a highly contagious acute infectious disease caused
by bacilli of the genus Bordetella pertussis, parapertussis and extremely
rare in humans B. bronchiseptica with paroxysmal cough and variable
impaired general condition, hematological changes and high risk of
complications.
Case report
We present a 28 years patient diagnosed with HIV stage C3 in 1996, for
which antiretroviral treatment (Abacavir + Lamivudine, Darunavir, Ritonavir
scheme initiated in 2009). The patient came in the Clinic Infectious Dis-
eases because of fever, cough initially dry, thereafter productive in bouts
fallowed by episodes of faintness, sweating, exertional dyspnea, weight
loss (~15 kg in the last 3 weeks). At the moment of hospitalization, the pa-
tient shows influenced general condition orthopnea , oxygen saturation
92 % without O2 mask, discreet congestive pharynx, tongue with chalky
deposits, right basal crepitation rales, tachycardia HR= 125 b/min, liver
with lower edge at 2 cm under the right costal margin, without meningeal
irritation signs. Biological leukocytosis with lymphocytosis, inflammatory
syndrome, lymphocyte CD4= 243 cells/L, viremia = 5087 copies/mL. The
chest-ray revealed interstitial drawing that looks like frosted glass designed
predominantly perihilar right, dilated bronchi, alveolointerstitial type opaci-
ties suprahilar and infrahilar right side. We suspected pneumocystosis pul-
monary tuberculosis (which was denied) and whooping cough, Bordetella
pertussis IgM which was positive. We initiated treatment with oxygen on
mask, rebalancing electrolyte solutions antibiotics, antifungical and expec-
torant, with a slowly favorable evolution.
Conclusions
The disease is very contagious and was considered a childhood infec-
tion but now it has been identified also in adults.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Primo-infection with varicella zoster virus causes varicella, one of the
most frequent pathologies in the first stage of childhood and not
only. The complications of this disease may vary from pyogenic infec-
tions to pneumonia and neurological (cerebellar) lesions.
Case report
We present the clinical case of a 8-months old male baby with no signifi-
cant pathological antecedents, admitted into the clinic of the “Victor
Babeș” Timișoara Hospital of Infectious Diseases between 29.05-08.06.2016
with the diagnosis of varicella and Cronobacter sakazakii sepsis. The
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 34 of 76present disease started 5 days prior to admission into our clinic with poly-
morphous eruption in crust stage. Afterwards fever is associated
(T = 39 °C). We mention the fact that all along the disease the baby was
following ibuprofen treatment. Due to the fact that the baby’s condi-
tion remains strongly influenced, the non-steroidal anti-inflammatory
treatment is associated with cefuroxime and acyclovir. In the 6th day of
disease the tumefaction of the right inferior limb is associated. At
admission, the baby had strongly influenced condition, tumefaction of
the inferior right limb, was dyspneic, sleepy with polymorphous
eruption in crust stage, therefore the baby is admitted directly into the
Intensive Care Unit. Hemoculture was positive for Cronobacter sakazakii.
Thrombocytes = 55.000/μL, VSH = 45 mm/h, CRP = 272.79 mg/dL, serum
urea = 43.8 mg/dL, creatinine = 0.33 mg/dL. Evolution was favorable
with symptomatology remission under established treatment.
Conclusions
Within the last years in medical practice other complications of extreme
gravity of varicella emerged: cellulitis, compartment syndrome, sepsis
of various etiologies (Streptococcus, Staphylococcus, Gram negative
germs, etc.) Performant modern apparel certainly contributes to estab-
lishing the bacteriologic diagnosis and implicitly the antibiogram which
led to an optimal therapeutical behavior. From experience, we consider
that the varicella zoster virus is more virulent, being able to cause
severe forms or complication in certain patients categories.
Consent
Written informed consent was obtained from the parents for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Anaerobic bacteria are not a common cause of prosthesis joint infec-
tion (PJI) but their implication may be greater than expected because
of many false negative results due to the difficulties in isolating and
identifying this type of bacteria. Sonication is a very important tool
for the microbiological diagnosis giving the clinician a higher chance
to find the microorganism involved in PJI. The aim of this study was
to evaluate the prevalence of anaerobic bacteria in PJI and the main
epidemiological characteristics of infections produced by anaerobes.
Methods
We performed a prospective 4-year study conducted in National In-
stitute for Infectious Diseases Prof. Dr. Matei Balș, Bucharest between
2012 and 2016, in which we included all orthopedic sonicated implants
sent from the regional centers. The implants were sonicated at 40 kHz
on BactoSonic® ultrasonic bath (Bandelin, Germany) and the sonication
fluid was cultured on both aerobe and anaerobe media. The period of
incubation was 7 days for aerobe culture and 14 days for anaerobe cul-
tures, respectively. Vitek®2 Compact automated system (Healthcare,
BioMérieux, USA) was used for bacteria identification and antibiotic
susceptibility. The interpretation of the results was made according
to the latest EUCAST breakpoints.
Results
Among 94 sonicated orthopedic implants we isolated 5 anaerobic
bacteria (5.3 % prevalence). Propionibacterium acnes was isolated in 3
cases, on one clavicle plate and on one hip and one shoulder re-
placement. Parvimonas micra and Finegoldia magna were the other
two anaerobes isolated from a hip and knee prosthesis. Patients fromwhom anaerobe bacteria were isolated were 3 males and 2 females
with a median age of 48 years (45; 67). All the anaerobic infections
were monobacterial. The median time between surgery and the on-
set of the symptoms was 12 months (5;30). All the isolated strains
were sensitive to all the antibiotics tested except for metronidazole
to which Propionibacterium acnes is resistant.
Conclusions
In our study the prevalence of anaerobic PJI was 5.3 %, a prevalence
similar to the one cited in the literature but this prevalence may be
higher. Anaerobic bacteria are slow growing organisms and they re-
quire special conditions to grow, thus the number of false negative
results can be significant.
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Background
Streptococcus pneumoniae, along with Neisseria meningitidis, represent
two of the most frequent causes of bacterial meningitis in adoles-
cents and young adults. Delayed diagnosis or inadequate treatment
of this condition may result in serious complications such as brain
damage, hearing loss or even death.
Case report
We present the case of a 37 year old female, without any known
medical condition, under no current medication, who was admitted
in our clinic for fever, chills, fronto-occipital headache, nausea, vomit-
ing, photophobia, symptoms which had been present for the last
36 hours with progressive enhancement. Upon physical examination
she was febrile (38.3 °C), sweating, no pulmonary crackles or cardiac
murmurs, her blood pressure was 100/60 mmHg and pulse rate was
74 bpm, without hepatosplenomegaly, oriented to time and place
but with signs of meningeal irritation (Kernig's sign, Brudzinski's sign,
and nuchal rigidity). Laboratory tests revealed leukocytosis with neu-
trophilia, biological inflammatory syndrome, electrolyte imbalance,
positive procalcitonin, negative HIV, HTLV serology, negative markers
of viral hepatitis B or C, normal urinalysis, negative hemocultures, and
sinus X-ray showed bilateral maxillary sinusitis. Lumbar puncture at the
moment showed no cerebrospinal fluid (CSF) modification: normal
pressure, clear appearance, negative Pandy’s reaction, 1 cell/μL,
protein – 31 mg/dL, glucose – 57 mg/dL, chloride – 700 mg/dL,
negative CSF cultures. PCR using mass spectrometry (PLEX – ID)
performed from CSF identified Streptococcus pneumoniae. Cranial
magnetic resonance imaging (MRI) with contrast showed minimal
meningeal enhancement, with no other modifications. Given all this
data (clinical appearance and identification of Streptococcus pneu-
moniae in CSF using PLEX-ID), we considered the case as bacterial
meningitis at an early stage, with normal CSF. She received treatment
with meropenem 2 g q8h, vancomycin 1 g q12h and dexamethasone
for 14 days with very good clinical response. The lumbar puncture re-
peated after 10 days showed no change from the previous examin-
ation. The patient fully recovered with no sequelae.
Conclusions
Bacterial meningitis exhibiting apparently normal CSF parameters,
even if uncommon, is a very well-recognized phenomenon. A lumbar
puncture which shows no abnormalities in CSF cannot exclude bac-
terial meningitis in the early stage of the disease. Empiric antibiotic
should be used when the diagnosis of bacterial meningitis is strongly
suspected even in the cases with normal CSF results. PCR technique
represents a great tool in establishing the causative pathogen of
meningitis, making possible the diagnosis of this condition even in
the early stages when no changes in the CSF are noticeable.
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Written informed consent was obtained from the patient for publication
of this Case report and any accompanying images. A copy of the written
consent is available for review by the Editor of this journal.
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Background
Important etiologic agent of atypical pneumonia, Mycoplasma pneumo-
niae can cause frequent extrapulmonary manifestations (MEP – neuro-
logical, cardiac, skin, joints, gastrointestinal), which sometimes evolve
isolated, thus making diagnosis and proper treatment difficult.
Methods
The study was retrospective and included 24 diagnosed cases of in-
fection with Mycoplasma pneumoniae, hospitalized in the Department
of Clinical Infectious Diseases, University of Medicine and Pharmacy
“Gr.T.Popa” Iaşi, in the period 2013–2016.
Results
The annual evolution of morbidity revealed a relatively constant num-
ber of cases in the period 2013–2015, with a significant increase in
cases in 2016 (45.83 %). The study included 14 children and 10 adults,
sex ratio (F/M) 1.18 and a predominant urban origin of cases (15 urban/
9 rural). Of the 24 patients, 21 showed signs of single respiratory mani-
festations (25 %) or in combination with skin manifestations (20.83 %),
joints (12.5 %), liver (12.5 %) or neurological manifestations
(45.83 %). Respiratory impairment was more common in adults (p =
0.007) and neurological impairment in children (p = 0.008) and in
women (p = 0.05), with no difference by gender or age, referred to
other extra pulmonary manifestations. MEP patients were admitted
to hospital early (8 days versus 16 days). The average duration between
the occurrence of respiratory and extrapulmonary events was a day for
the joint, 4.6 days for neurological, 7 days for liver manifestations and
12.5 days for skin manifestations. MEP appearance was not favored by
the patient’s immune suppressed status (p = 0.807), previously adminis-
tered antibiotic therapy before hospitalization (p = 0.632). Those with
only pulmonary manifestations frequently received macrolides prior to
hospitalization (p = 0.011) with no difference between the 2 groups with
the administration of beta-lactams (p = 0.102). Leukocytosis was de-
tected in a high proportion of those with MEP (p = 0.05), and we identi-
fied no statistically significant difference between the two groups in
terms of the values of other inflammation tests, of liver cytolysis tests,
pulmonary radiographic changes (p = 0.795) or the frequency of compli-
cations (p = 0.345). The average length of hospitalization was higher in
patients with MEP (10.83 days versus nine days those without MEP).
Conclusions
Mycoplasma pneumoniae should be considered in all cases with fever
and respiratory symptoms evolving unfavorably treated with betalac-
tamine and associates MEP.
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Background
In children, bacterial sepsis is a not a very common condition but it is
often accompanied by severe complications that can leave sequelae.Sometimes it can be life-threatening and requires a complex and
quickly set treatment. Sepsis is more common in immunosuppressed
patients.
Methods
We conducted a 5 years study from Jan 2011 to Dec 2015 on 2851
children admitted in our pediatric intensive care unit of the National
Institute for Infectious Diseases for severe forms of SIRS and bacterial
sepsis. Some of them were immunosuppressed. We watched the cor-
relation of data obtained by hemocultures, CSF cultures versus PCR
and the clinical evolution of the patients.
Results
In the 60 months of study, 265 children met the clinical and biological
criteria for severe bacterial sepsis; 68 % of the patients came from other
hospitals, reason for which we consider that the etiology is most likely
nosocomial pathogens. Sex distribution was approximately equal.
Considering age distribution, children in the group 3–5 years of age
prevailed; 49 of them were immunosuppressed; 10 patients had
acquired immunosuppression, 20 congenital and 19 mixed. We ob-
tained 163 hemoculture positive results (61 %) and 112 obtained
by molecular methods. The data were correlated with conventional
methods of diagnosis.
Conclusions
Bacterial sepsis in children is a serious condition resulting in 24
deaths (14 %) in our study. It requires quick etiologic diagnosis and
establishment of appropriate emergency treatment. PCR is an effective
and rapid diagnosis method, identifying the causal agent in 42 % of
cases.
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Background
Staphylococcus aureus is a common colonizing and infecting agent in
humans [1], with increased mortality in case of bacteremia.
Case report
A 60 year old man with a history of diabetes and hypertension was
referred to our clinic with the suspicion of infective encephalitis. The
onset of symptoms was 10 days prior to presentation with high fever,
malaise, lower limb muscular weakness which progressed to paresthesia,
rigidity and intense headache with bradypsychia and bradylalia. The pa-
tient denied using any recreational drugs, recent head trauma or any
other open skin lesions. At admission he was febrile, bedridden, with
generalized muscular atrophy, Janeway lesions, petechiae, 5th right toe
necrosis, left endophthalmitis, holosystolic murmur in the apex with
radiation to the axilla, hepatomegaly, with no signs of meningeal ir-
ritation. The lab reports showed leukocytosis with neutrophilia,
anemia, thrombocytopenia, acute inflammatory syndrome, positive
procalcitonin, hyperglycemia with high glycated hemoglobin level,
hyponatremia, hypokalemia, hypoalbuminemia. Transthoracic echocar-
diography showed mobile mitral valve vegetation on the anterior
leaflet, 10 mm in diameter, with normal ejection fraction. Two sets
of blood cultures grew methicillin-susceptible Staphylococcus aureus
(MSSA). Chest X-ray showed peripheral, bilateral, lower lobe infiltrative
densities. Head magnetic resonance imaging (MRI) showed suggestive
images for small abscesses in the supratentorial region. Given this data,
the diagnosis of infective endocarditis with multiple septic emboli
(pulmonary, ocular, cerebral) was established. Antibiotic therapy with li-
nezolid and rifampin was initiated, due to a very good multiple organ
penetration. As musculoskeletal secondary determination (septic
arthritis, thigh abscess) and linezolid hematological side effects
(anemia) occurred, we switched therapy to oxacillin, amikacin and
levofloxacin. The patient had a good clinical response, with a total
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 36 of 76course of antibiotic therapy of 6 weeks. He was referred to a car-
diovascular surgeon for further monitoring.
Conclusions
Patients suffering from uncontrolled diabetes have a higher risk of infec-
tions with endogenous microbes, with more severe outcomes. In our
case, even if the MSSA strain isolated in hemocultures didn’t represent a
therapeutic challenge in terms of antibiotics options, it did develop into
a severe and life threatening illness. This strain of MSSA possibly
used all its energy in the synthesis of multiple virulence genes (adhesion,
penetration, invasion) which determined numerous extra-cardiac compli-
cations of endocarditis.
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Consent
Written informed consent was obtained from the patient for publication of
this Case report and any accompanying images. A copy of the written
consent is available for review by the Editor of this journal.
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Background
Streptococcus suis is a commensal pathogen of swine, a neglected patho-
gen that can be transmitted to humans by close contact with sick or carrier
pigs. Meningitis and sepsis are the most frequent clinical manifestations in
humans. A recently published systematic review identified 24 studies in-
cluding 913 patients with meningitis due to Streptococcus suis [1]. Most
cases have been reported in Asia. Objective: to draw attention to a poten-
tial under-diagnosed cause of meningitis and sepsis in our country.
Methods
We performed a retrospective analysis of patients diagnosed with
Streptococcus suis infection between January 2005-December 2015 in
one tertiary care hospital in Bucharest, Romania. We also reviewed
the Steptococcus pneumoniae meningitis, according to the microbio-
logical method confirming the etiology.
Results
We identified five patients hospitalized for Streptococcus suis infec-
tion – four patients had meningitis and one patient had endocarditis.
Two patients reported contact with pork meat.
In patients with meningitis the median age was 43 years (IQR 40–45),
with a male: female ratio of 3:1. Three patients presented with altered
level of consciousness and two with severe hearing impairment. Cerebral
spinal fluid (CSF) examination showed changes characteristic for bacter-
ial meningitis. Latex agglutination test for Streptococcus pneumoniae was
positive in two patients, nonetheless, Streptococcus suis was isolated in
CSF in all patients. They were all treated with a third generation cephalo-
sporin for 14 days and all of them improved. Two patients developed se-
quelae, consisting in permanent sensorineural deafness and ataxia.
In the studied period we identified a total of 194 cases of pneumo-
coccal meningitis, in which the diagnosis was based on appearance
on Gram stain and/or positive latex agglutination reaction of CSF
samples in 82 (42 %) and positive culture in 112 (58 %) patients.
The patient with endocarditis was a 40 year old male, who was admit-
ted for fever and malaise. Echocardiography showed aortic valve endo-
carditis. The patient underwent treatment with a beta-lactam/beta-
lactamase inhibitor and an aminoglycoside for 4 weeks, and after valve
replacement with a glycopeptide for 4 weeks.
Conclusions
Streptococcus suis could be miss-identified as other species of strepto-
cocci, thus in the settings that lack resources to routinely speciateα-hemolytic streptococci and where (undercooked) pork is a basic
diet, underdiagnosis of Streptococcus suis infection is likely. Hearing
loss, although is not a complication related to Streptococcus suis
meningitis, is frequently reported.
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Background
Romania reports an increasing number of resistant Klebsiella pneumoniae
(KP) strains isolated from invasive infections every year. The most recent
report of the European Antimicrobial Resistance Surveillance Network
(EARS-Net) has placed us among the first countries regarding KP resistance
to fluoroquinolones, third generation cephalosporins, aminoglycosides, car-
bapenems, and multidrug resistance. We analyzed the antimicrobial resist-
ance of bloodstream KP isolates in 2010 and 2015 in the National Institute
for Infectious Diseases “Prof. Dr. Matei Balș”, Bucharest, Romania.
Methods
The antimicrobial susceptibility tests of KP strains isolated from blood
between January 1st 2010 - December 31st 2010 and between January
1st 2015 - December 31st 2015 were analyzed. We compared the re-
sistance trend between these two periods. Statistical analysis was per-
formed using Fisher exact test. p < 0.05 was considered significant.
Results
We identified 18 strains of KP in 2010: 46.15 % resistant to
aminopenicillin-betalactamase inhibitors association, 37.7 % resistant to
piperacillin-tazobactam, 38.46 % resistant to third generation cephalo-
sporins, 47.07 % resistant to fluoroquinolones, 41.17 % resistant to
aminoglycosides. We didn’t find any strains resistant to carbapen-
ems. 38.88 % of the strains had combined resistance to fluoroqui-
nolones, third generation cephalosporins and aminoglycosides and
22.22 % were extended-spectrum betalactamases (ESBL) producing
strains. In 2015, 37 strains of KP were isolated. The resistance rates
to aminopenicillin-betalactamase inhibitors association, piperacillin-
tazobactam, third generation cephalosporins, fluoroquinolones, amino-
glycosides were 36.11 %, 24.32 %, 29.72 %, 27.02 % and 21.62 %,
respectively. One strain was resistant to carbapenems. 21.62 % of
the strains had combined resistance and 29.73 % were ESBL. The
overall resistance to aminopenicillin-betalactamase inhibitors association,
piperacillin-tazobactam, third generation cephalosporins, fluoroquinolones,
gentamycin, amikacin, trimethoprim-sulfamethoxazole and the combined
resistance decreased statistically non-significant. The same thing
was noticed for the increasing rate of ESBL producing strains.
Conclusions
The percentage of KP strains isolated from blood increased between
2010 and 2015. We didn’t find statistically significant changes of the re-
sistance rates of KP to all the classes of tested antimicrobials. The pres-
ence of carbapenem resistance among the isolates from 2015 could be
a major problem for the public health and hospital-acquired infections
control. Our data regarding the proportion of resistant bloodstream KP
strains are different from those reported by EARS-Net. We found lower
and decreasing resistance rates to fluoroquinolones, aminoglycosides,
third generation cephalosporins, carbapenems and combined resist-
ance. Still, with Romania occupying one of the first places in Europe re-
garding KP isolated from invasive infections resistance to antibiotics,
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 37 of 76further monitoring is mandatory and efforts should be made in order
to control this problem.
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Background
Staphylococcus aureus has a high incidence in human infectious pathology,
registering severe infections caused by antibiotic-resistant strains. In
Romania, methicillin-resistant S. aureus (MRSA) accounts to up to 53.8 % of
S. aureus strains isolated from blood cultures (EARS-Net report 2012). In
many European countries, the percentage of MRSA invasive infections
caused by S. aureus decreased below 25 % through the implementation
of programs designed to limit bacterial resistance. Objectives: to determine
the antibiotics resistance of S. aureus strains isolated from blood cultures.
Methods
We performed a retrospective study (01.01.2011 - 06.01.2016) analyzing
blood cultures results collected from patients hospitalised in the Infec-
tions Disease and Pneumology Clinics of “Victor Babeş” Hospital from
Craiova. The antibiotics resistance of 180 S. aureus strains isolated from
blood cultures was analyzed based on the results of disc diffusion sen-
sitivity testing. The methicillin-resistant strains presented an inhibition
zone around the disk of cefoxitin (30 mcg) under 22 mm. The results’
evaluation was carried out by comparing percentage differences and
by performing the Chi2 test.
Results
During the study period, 1806 blood cultures were performed, and only
233 (12.9 %) were positive. Blood cultures were positive for S. aureus in
77 % of cases, Klebsiella pneumoniae in 8.1 % of cases and Escherichia
coli in 4.5 % of cases. Distribution by age of blood culture positive for
S. aureus were: under 1 year old - 14.8 % of cases, 1–16 years old -
17.3 % and over 16 years old - 67.8 %. The blood cultures MRSA per-
centage was 45.5 % (82 out of 180 tested strains) with a peak in 2013
(28 strains) compared to 2015 (8 strains). The antibiotics resistance in
S. aureus isolated strains was: to penicillin 83.9 %, to oxacillin 45.5 %, to
clarithromycin 45.4 %, to amoxicillin/clavulanic acid 31.6 %, to trimetho-
prim/sulfamethoxazole 30.8 %, to ceftriaxone 24.5 %, to meropenem
19.3 %, to levofloxacin 18 %, to gentamicin 17.7 %, to chloramphenicol
11.9 %, to clindamycin 10.4 %, to vancomycin 7.78 %, to linezolid
4.9 %. The MRSA percentage was higher in infants (53.3 %) compared
to adults (44.8 %), without statistically significant difference.
Conclusions
S. aureus was the most common etiologic agent isolated in blood cul-
tures, with a high prevalence of methicillin-resistant strains (45.5 %). From
the tested antibiotics, the lowest resistance was observed at linezolid and
vancomycin. Clindamycin, aminoglycosides and fluoroquinolones were
active against strains of MRSA without antibiotics multiresistance.
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β-lactamases production remains the most important mechanism of
β-lactam resistance. The most prevalent extended-spectrum β-lactamases
(ESBL) in hospital and community settings that preferentially hydrolyze
cefotaxime, belong to plasmid-mediated ESBL, is CTX-M. Our objective
was to study bacterial resistance to improve the diagnosis and treatment
of infections with these pathogens.
Methods
Fifty-nine strains (isolated from urine and several from blood) were
collected between June 23rd and September 23rd 2011 from two hospi-
tals of Quebec City in Canada. Strains were sent to the Research Center
of Infectious Diseases of Laval University in Quebec City. Identification
and antibiotic resistance were determined using the Vitek® 2 System
(bioMérieux). ESBL production was tested according to CLSI recommen-
dations. Crude DNA extracts were prepared from each strain by a rapid
DNA extraction method. DNA was used for PCR amplification using dif-
ferent primers specific to blaTEM, blaSHV, and blaCTX-M genes. All ampli-
cons produced were sequenced, to identify the genes of resistance.
Results
From 59 strains tested, 32 (54.2 %) were ESBL+, and 28 (45.8 %) were
ESBL-. Escherichia coli was the most prevalent species with a percentage
of 88.1 % of the strains tested. The 32 ESBL producing-strains were posi-
tive for at least one of the resistance genes tested. The predominant re-
sistance gene was blaCTX-M either alone or in combination with the blaTEM
gene, all present in E. coli. Sequence analysis of the 28 blaCTX-M genes
found revealed that 18 strains were members of CTX-M group 1, and 10
were members of CTX-M group 9. Two different resistance genes were
identified in 15 strains: blaCTX-M + blaTEM (13) and blaSHV + blaTEM (2). How-
ever, sequence data revealed that all blaTEM genes identified in both
ESBL+ and ESBL strains did not encode ESBL. This suggests that the re-
sistance phenotype in ESBL-producing strains with two resistance genes
should be conferred by blaCTX-M or blaSHV genes. Another resistance gene,
not tested in this study, is most likely responsible for the ESBL resistance
phenotype in the strain containing only the blaTEM-non-ESBL gene.
Conclusions
This study showed that blaCTX-M are the most prevalent resistance
genes in ESBL-producing Enterobacteriaceae in Quebec City and are
part of groups 1 and 9. This is consistent with global data showing
the predominance of the CTX-M ESBL worldwide and with recent
epidemiological data, in other regions in Canada, showing that CTX-
M-15 as well as CTX-M-14 and CTX-M-9, being respectively part of
groups 1 and 9, are most commonly found.
A17
Postoperative meningoencephalitis with Acinetobacter baumannii
XDR – a therapeutic challenge - Case report
Cleo Nicoleta Roșculeț, Dalila-Ana Toma, Catrinel Ciuca, Daniela Tălăpan,
Cătălin Apostolescu, Andrei Rogoz, Andrei Stangaciu, Viorica Mitescu,
Tudor Vladoiu, Doina Iovănescu
National Institute for Infectious Diseases “Prof. Dr. Matei Balș”, Bucharest,
Romania
Correspondence: Cleo Nicoleta Roșculeț (cleo_n_rosculet@yahoo.com)
BMC Infectious Diseases 2016, 16(Suppl 4):A17
Background
Acinetobacter baumannii is an aerobic Gram negative bacterium which,
depending on the profile of resistance (MDR- multidrug resistance,
XDR- extensive drug resistance, PDR- pandrug resistance), may be ex-
ceptionally the source of severe infection, more or less therapeutically
controllable.
Case report
We have chosen to bring forward the peculiar case of a 62 year old
man, who was transferred to our department for agitation, confusion
(GCS = 7–8) and fever occurring 12 days in the postoperatory period
(left otomastoidectomy) under the suspicion of bacterial meningo-
encephalitis. The patient’s medical records emphasize a history of
chronic suppurative otomastoiditis surgically treated twenty years
before. From that moment forward, the patient presented numerous
relapses (left ear pain, purulent otorrhea) accompanied by neuro-
logical involvement (left facial nerve peripheral palsy), for which
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 38 of 76local treatment and outpatient antibiotic therapy were conducted.
Two years before admission, a tympanic-mastoid cavity with purulent
discharge was clinically perceived. MRI confirmed the presence of an
abscess in the left petrous part of the temporal bone. Successive evalu-
ations were conducted through multidisciplinary approach, but the sur-
gical intervention was delayed. On the current admission, blood and
multiple samples were taken and a lumbar puncture was performed.
The CSF aspect was highly suggestive of bacterial meningoencephalitis.
The patient was immediately started on broad-spectrum antibiotics
aimed at covering highly resistant bacteria. CSF cultures came back
positive for Acinetobacter baumannii XDR (colistin sensitivity present).
Following complex therapy, the clinical and biological profile improved.
The neurological status became stable (GCS = 12–13), thus permitting
surgical reintervention.
Conclusions
All minimal ear infectious involvement must be promptly addressed
in order to prevent local complications that may lead to destructive
irreversible lesions. Once these lesions appear, a multidisciplinary ap-
proach becomes compulsory and high financial and human costs are
implied.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
A18
Septic arthritis with Burkholderia cepacia
Michaela Oana, Simona Costin
“Dr. Constantin Papilian” Military and Emergency Hospital, Cluj-Napoca,
Romania
Correspondence: Michaela Oana (sincostin@yahoo.com)
BMC Infectious Diseases 2016, 16(Suppl 4):A18
Case report
We present the case of a 39 years urban female, which shortly after an
arthroscopic procedure develops fever, chill, partial functional impo-
tence, local swelling. In joint puncture we isolated Burkholderia cepacia,
susceptible only to meropenem, minocycline and trimethoprim. After
2 weeks of meropenem and 4 weeks of minocycline the evolution
was favorable, but soon subfebrility, swelling, pain and functional
impotence reappeared. After 8 months Burkholderia cepacia (with
similar susceptibility) is isolated again. She took meropenem (6 g/day)
in combination with doxycycline 14 days, followed by meropenem and
trimethoprim. The intra-articular devices were removed. The patient be-
came afebrile, local evolution was favorable and the culture negative in
day 18. On day 21 she develops agranulocytosis and we discontinued
trimethoprim, decreased the dose of meropenem and supplemented
with granulocyte growth factor. Then the evolution was favorable: local,
hematological and bacteriological. We continued the therapy another
5 weeks with meropenem and up to 6 weeks with minocycline.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
The emergence and spread of antibiotic resistance has become a
worldwide top priority health problem. Besides genetic resistance, bac-
teria have developed a multitude of mechanisms leading to toleranceto antimicrobials. It is estimated by the Centers for Disease Control and
Prevention that in the USA 23,000 people die every year due to infec-
tions with multidrug resistant bacteria.
Methods
We have performed a pilot experimental study in the National Insti-
tute for Infectious Diseases „Prof. Dr. Matei Balș”, treating six patients
with combined therapy: antibiotics and bacteriophages. The study re-
ceived Ethics Committee approvals: Matei Balș c/5101/02.10.2014 and
Carol Davila 47/26.01.2015. The pathogenic agents were evaluated for
phage susceptibility to commercial Georgian phage cocktails, namely
Pyo and Intesti (Eliava BioPreparations, Tbilisi, Georgia). We included in
the study patients failing antibiotic therapy, with hard-to-treat infections
due to antibiotic resistant bacteria, biofilm formation or hard to sterilize
infection sites. Phages were administered orally or/and topically.
Results
This pilot study included the following types of infections: recurrent
endocarditis with Staphylococcus aureus, chronic osteomyelitis with S.
aureus and P. aeruginosa, periprosthetic dorsolumbar soft-tissue in-
fection with S. aureus, chronic cutaneous infection with S. simulans, E.
coli and P. aeruginosa, axillary hidradenitis with Proteus mirabilis and
S. epidermidis and chronic osteomyelitis with S. aureus. For all six cases
the combined therapy proved to be safe, with no adverse reactions
and no adverse changes in laboratory parameters. A total of 5 patients
had negative cultures during therapy, but 7 days after the end of
therapy the cultures became positive again for 3 of the cases. For
one patient (recurrent endocarditis with S. aureus) we concluded
that the timespan between relapses was longer after receiving the
combined therapy compared with antimicrobial treatment alone. In
one case (periprosthetic dorsolumbar soft-tissue infection with S.
aureus) we achieved sustained bacteriological response, although
the patient was considered hard-to-treat due to a history of multiple
drug allergy syndrome, presence of multiple foreign bodies (metallic
rods and screws), with biofilm formation and a history of unsuccessful
long term antibiotic therapy.
Conclusions
To our knowledge, this is the first experimental trial conducted in
Romania with combined therapy antibiotics and bacteriophages since
1975, which proved the safety of bacteriophages in clinical settings.
We consider this study the cornerstone for future research regard-
ing in vivo phage therapy in Romania.
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Background
Healthcare-associated infections (HAI) surveillance programs may focus,
amongst others, on specific microorganisms like multidrug resistant or-
ganisms (MDROs). Methicillin-resistant Staphylococcus aureus (MRSA) and
other MDROs of public health concern may pose problems in acute and
non-acute healthcare settings, so detecting and monitoring these is im-
portant in hospital-based prevention, surveillance and control efforts.
The program of HAI surveillance and control in the National Institute for
Infectious Diseases “Prof. Dr. Matei Balș” includes actively screening for
MDROs of all patients admitted in the ICU and regardless of the ward,
for those transferred from other healthcare settings into our hospital.
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The study was conducted between January 1st 2015 – July 31st 2016
by collecting swabs from criteria based selected patients: pharyngeal
(908), nasal (880) and rectal (823). A total of 2,611 swabs were processed
in 19 months’ interval. The targeted microorganisms were MRSA, vanco-
mycin resistant enterococci (VRE) and other multidrug resistant Gram-
negative bacteria. Swabs were inoculated on appropriate chromogenic
culture media from Oxoid, UK (Brilliance MRSA agar, Brilliance VRE agar,
Brilliance ESBL agar) and were interpreted at 24–48 hours of incubation
at 37 °C, aerobic atmosphere. All microorganisms were identified and
tested for susceptibility to antimicrobials by MicroScan Walk Away 96
Plus (Siemens, USA). EUCAST guidelines were used for interpretation.
The KPC, MBL and OXA-48 Confirm kits (Rosco Diagnostica, Denmark)
were used to determine the carbapenemase-producing strains.
Results
MRSA was detected in 4.84 % of the pharyngeal and 5.79 % of the
nasal swabs. The positive rectal swabs, counted one per patient, were
28.06 % (231/823). A percentage of 68.83 % of rectal swabs were
positive for one microorganism, 25.97 % positive for 2 microorganisms
and 5.20 % for 3 microorganisms. The total number of microorganisms
isolated from rectal swabs was 315 (Escherichia coli 32.69 %, VRE
26.34 %, Klebsiella pneumoniae 23.17 %, Pseudomonas aeruginosa 5.39 %,
Acinetobacter baumannii 4.12 % and other MDROs less than 3 % each).
VRE carriage varied between 21.89 % in 2015 and 30.13 % in 2016. The
proportion of Klebsiella pneumoniae carbapenemase-producer strains
has increased from 5/38 (13.1 %) in all year 2015 to 10/35 (28.5 %) in first
7 months of 2016. Only one other microorganism (Enterobacter cloacae)
was carbapenemase producer.
Conclusions
MRSA colonization varied between 4.84 % (pharyngeal) and 5.79 %
(nasal). VRE carriage increased with 10 % in 2016 and carbapenemase-
producing Klebsiella pneumoniae doubled in the first 7 months of 2016,
compared with 2015.
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Background
Bacterial infections remain one of the important causes of disease
worldwide and the options for treating are limited due to the emer-
gence of antimicrobial resistance (AMR). The aim of this study is to
evaluate the AMR of Gram-positive cocci isolated in National Institute
of Infectious Diseases “Prof. Dr. Matei Balș” between 2009–2015.
Methods
A total of 7808 non-duplicated strains: 2067 Staphylococcus aureus, 651
coagulase-negative staphylococci, 292 Streptococcus pneumoniae, 922
Enterococcus faecalis, 251 Enterococcus faecium and 3621 Streptococcus
pyogenes were tested for their antimicrobial resistance. Susceptibility
tests were performed in automated systems Vitek 2C (BioMerieux) and
MicroScan Walkaway (Siemens), and also with Sensititre (Thermo Scien-
tific) MIC plates and Etest (BioMerieux); for Streptococcus pneumoniae
disk diffusion method was used. Results were interpreted using CLSI and
EUCAST criteria.
Results
Staphylococcus aureus resistance to oxacillin varied from 34.4 % in
2009 to 55.7 % in 2011 and has decreased to 44.8 % in 2015. Erythro-
mycin and clindamycin resistant strains of Staphylococcus aureus haveincreased between 2009–2014 from 45.2 % to 58.1 %, and from 13.8 %
to 58.3 %, respectively. Staphylococcus aureus strains resistant to quino-
lones have varied annually to ciprofloxacin (13.4–21.9 %) and moxiflox-
acin (8.4–16.8 %) without a clear increasing or decreasing tendency.
Trimethoprim-sulfamethoxazole resistance has remained at low levels
(0.5–1.5 %) and no strains have been resistant to linezolid and vanco-
mycin. The incidence of resistance was higher for coagulase-negative
staphylococci, most isolated from blood, 60.5–81.7 % for oxacillin, 21.2–
42.1 % for trimethoprim-sulfamethoxazole. The incidence of penicillin-
resistant Streptococcus pneumoniae strains isolated from invasive infec-
tions decreased from 37.5 % in 2010 to 12.0 % in 2015. Enterococcus
faecium was more resistant compared with Enterococcus faecalis to all
tested antimicrobials, for gentamicin with 45.7–75.5 % compared
with 38.7–61.5 % and for ciprofloxacin 35.7–64.5 % compared to
85.7–100 %. The first vancomycin-resistant Enterococcus faecium
strains were isolated in 2012 with an incidence of 4.3 % which
reached 35.0 % in 2014. Only two Enterococcus faecalis vancomycin-
resistant strain were isolated, one in 2013 and one in 2014. Strepto-
coccus pyogenes resistance to erythromycin increased significantly
over time from 7.6 % in 2010 to 16.9 % in 2015.
Conclusions
Oxacillin resistance incidence in Staphylococcus aureus has registered
a slight decrease, since 2011, from 55.7 % to 44.8 % in 2015.
Coagulase-negative staphylococci are significantly more resistant
than Staphylococcus aureus. In 2012 the firsts strains of Enterococcus
faecium resistant to vancomycin were isolated and in 2014 their
proportion reached 35.0 %. Continuous monitoring of antimicrobial
resistance is highly needed, in particular to guide an efficient
empirical therapy.
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Background
Carbapenems are probably the most important last-line antibiotics for
treatment of infections involving multidrug-resistant gram-negative
bacteria. In the last years, the emergence of carbapenem-resistance of
Gram-negative bacilli is considered one of the worldwide most import-
ant challenges of public health.
Methods
The analysis is based on antimicrobial resistance data collected by NIPH
for 2012–2015 and national antibiotics sales for 2011–2015, provided
by IMSHealth Romania. The European level data were obtained from
EARS Net and ESAC Net newest reports.
Results
The percentage of carbapenem-resistance in Escherichia coli was low in
the past four years, 0 (2012) - 2.1 % (2015) in the past four years, but sev-
eral resistant isolates represent an alert for the risk of community ac-
quired infections due to XDR strains. For other Gram-negative bacteria
the carbapenem-resistance is already high or rapidly emerging: Klebsiella
pneumoniae, from 15 % (2012) to 35.1 % (2015), third highest resistance
level in EARS Net; Pseudomonas aeruginosa 60 % (2012) - 66.4 % (2015),
first resistance percentage in EARS Net and Acinetobacter baumannii
81.5 % (2012) to 82.1 % (2015) fourth resistance level in EARS Net; similar
high percentages were obtained when the results only from Infectious
Diseases Hospitals were analyzed. The risk factors for carbapenem-
resistance are carbapenem usage and carbapenem-resistant bacteria
transmission. The carbapenems usage in Romania increased with 113 %
after 2013 (R2 = 0.746) and germ transmission is probably at a high level
in our hospitals, as several very recent examples had proven.
Conclusions
The high percentage of carbapenem-resistance in Romania is related
to misuse of carbapenems (generated by some pseudo-science myths)
and to germ transmission in Romanian hospitals. Both problems need
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 40 of 76to be addressed and Infectious Diseases specialists could play a pivotal
role in the control of this public health severe emergency
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Background
Healthcare-associated meningitis or ventriculitis is a serious and
life-threatening complication of invasive neurosurgical procedures
or penetrating head trauma.
Methods
The current study reviewed 78 cases of health care-associated men-
ingitis or ventriculitis which were treated in “Sf Parascheva” Infectious
Diseases Hospital Iași from January 2011 to December 2015.
Results
The reviewed cases involved 78 adult patients. The age of the patients
was between 18 and 89, with a higher frequency in the age group 60–
80. Healthcare-associated bacterial meningitis may occur after neurosur-
gical procedures, head trauma, placement of internal or external ventricu-
lar catheters, ENT and maxillofacial surgery. From 78 cases, in 42 there
was a positive cerebrospinal fluid culture. The most frequent agents are
Gram negative bacilli (Pseudomonas spp, Acinetobacter spp, Escherichia
coli and Klebsiella pneumoniae) and Gram positive cocci (Staphylococcus
aureus – with a particular focus on MRSA, coagulase-negative
Staphylococcus and Streptococcus pneumoniae). At the admission in the
clinic the signs and symptoms were: fever, headache, changes in mental
status (Glasgow Coma scale 3–12), nausea/vomiting, focal neurologic def-
icit, neck stiffness, seizures and photophobia. The diagnostic evaluation
involved neuroimaging investigation (CT/MRI) and cerebrospinal fluid
analysis. Empiric antimicrobial therapy should be directed towards the
likely infecting pathogen. The complications involved were brain abscess,
ventriculitis, cranial nerve damage, deafness and blindness. The outcome
was negative in 38 % of cases and positive in 62 % (with disability in 30
patients and without disability in 32 patients).
Conclusions
Healthcare-associated meningitis or ventriculitis remains challenging
in terms of diagnosis, treatment and prevention.
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Background
In a medical world in which infections are caused by bacteria with
increased virulence, nosocomial infection is a serious threat for allmedical departments. Epidemiological data must be thoroughly col-
lected and interpreted in the setting of clinical facts, thus guiding
the complex process of therapeutic intervention.
Methods
We analyzed the clinical data obtained in our ICU department over a
period of 6 months in 2016 and outlined the main patterns involved
in the occurrence and evolution of nosocomial infections. The main
sources of nosocomial infections were venous and arterial catheters
responsible for bloodstream infections (4 cases), orotracheal intubation
(5 cases) causing severe ventilator-associated pneumonia and bladder
catheterization responsible for most cases of urinary tract infections
(4 cases). Every nosocomial infection’s ethology was analyzed and
correlated to its clinical impact. Suggestive signs developed when
peripheral catheters were implanted and fever was the first sign of
catheter-associated bloodstream infection. The purulent aspect of
pulmonary secretions in intubated patients was the first omen of VAP.
The turbid aspect of urine indicated a potentially hospital-acquired in-
fection in patients with bladder catheterization.
Results
In our Institute – specialized in diagnosis and treatment of infectious
diseases – nosocomial infections in different stages of evolution are
part of our current pathology. Based on this argument, in our ICU from
January to July 2016, there were 13 cases considered “imported” noso-
comial infections – failure of previous treatments – and 1 case was de-
clared “novel” nosocomial infection – ventilator associated pneumonia
(VAP) with A. baumannii in an immunocompromised patient with end
stage AIDS/HIV infection. Unfortunately, his evolution was continually
unfavorable with subsequent death.
Ten patients with “imported” nosocomial infections had favorable evo-
lutions, and were discharged in good conditions. The 2 others died as a
result of VAP with MRSA and VAP with P. aeruginosa respectively.
Conclusions
Most of the patients admitted to our clinic over a period of 6 months
were infected with multi-resistant bacteria at the time of admission
thus emphasizing the spread of germs with high antibiotic resistance
in the community and the necessity of a thorough bacteriological
survey at the time of inter-hospital transfer. Nosocomial infections re-
main a constant threat whose dynamics must be closely monitored
in the future.
Viral hepatitis - epidemiology,
treatment and monitoring
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Background
The use of directly acting antiviral agents in chronic HCV hepatitis
has proved to be efficient and safe in clinical trials.
Methods
Transaminases, bilirubin, blood cell count at initiation, 2, 4, 8, 12 weeks
of treatment were evaluated in 124 patients with HCV associated
cirrhosis, undergoing treatment with dasabuvir (Exviera™), ombitasvir,
paritaprevir, ritonavir (Viekirax™) and ribavirin. HVC-RNA was determined
at initiation and at end of therapy (EOT).
Results
We included 124 patients of which 56 were males. The mean age
was 51.7 ± 23.4 years. Two patients with liver transplant and a patient
with HCV genotype 1a received 24 weeks of treatment. Two patients
did not receive ribavirin: one with minor thalassemia, one with poly-
arthritis. We included 2 patients with diabetic nephropathy with end
stage renal disease (ESRD), one undergoing hemodialysis. 58 patients
have reached the end of treatment (one patient with liver transplant);
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15 patients have been evaluated at 12 weeks after EOT; they all had un-
detectable viremia at EOT, and had sustained virologic response. Ri-
bavirin was discontinued in 7 patients - 2 due to severe cutaneous
reactions - erythroderma. Both patients with ESRD discontinued ribavi-
rin after week 2 due to severe anemia. One patient with systemic lupus
stopped ribavirin at week 2 due to hypotension. A patient with thalas-
semia presented duodenal hematoma with pancreatic reaction in the
first week, with improvement under medical therapy and discontinu-
ation of ribavirin, with undetectable viremia at EOT. Ribavirin doses
were decreased at week 4 in a patient with variceal bleeding, and
stopped at week 8 due to severe anemia. These patients also had viro-
logic response at EOT. Another patient presented with hepatocellular
carcinoma in week 2; he underwent transarterial chemoembolization in
week 8, with decompensation by ascites, ultimately with good evo-
lution, undetectable viremia at EOT and complete response of the
nodule. The mean initial levels of transaminases were double the
normal values; they decreased dramatically after the first two weeks
of treatment and low levels were maintained throughout therapy.
The mean initial bilirubin level was normal, with values increasing dur-
ing the first month: 1.4 mg/dL at week 2 and 2.84 mg/dL at week 4.
Afterwards there was a small constant decrease and normalization
after EOT.
Conclusions
Therapy with Exviera™/Viekirax™/ribavirin is well tolerated, safe and
efficient in patients with chronic HCV hepatitis and cirrhosis. Ribavirin
dose reductions should not be a milestone in therapy.
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Background
At the Clinical Hospital for Infectious Diseases, a study has been
performed to evaluate antiviral and hepatoprotective effects of the
medicinal product Viusid in treatment of viral hepatitis B and C.
Methods
The study involved 20 patients with chronic viral hepatitis: B - 10
patients (Group I), and C – 10 patients (Group II), among them in
Group I – 7 men and 3 women, and in Group II – 4 and 6, respect-
ively. The patient examination included physical exam, biochemis-
try tests (ALT, AST, GGT), complete blood count, molecular biology
assays (HBV DNA and HCV RNA quantification by PCR). Viusid was
prescribed as follows: 1 sachet 3 times daily (every 8 hours) for
3 months. The patient physical examinations were performed
monthly, and the laboratory tests – at the beginning and at the
end of treatment.
Results
Clinical manifestations were scanty in both groups: right hypochon-
driac pain in 44.4 % of cases in Group I, and 36.4 % – in Group II,
weakness or fatigue – 22.2 % in Group I, 9.1 % – in Group II. At the
end of treatment no clinical manifestations were present. Complete
blood count, leukocyte count remained in the normal range with
nonsignificant evolution. Lymphocyte count trended to increase
within the normal range. Platelet count did not change signifi-
cantly. Biochemistry tests: positive evolution of both total and dir-
ect bilirubin levels with their normalization in both groups was
observed. ALT, AST and GGT were increased in all patients of both
groups. In Group II, the average values of these parameters tended
to reduce. In patients of Group I, the reduction was more significant
than in those of Group II. Molecular biology assays. The HCV RNA
level decreased from 442,843,736 IU/mL to 288,801,564 IU/mL, but
did not become negative. The HBV DNA level reduced on averageby 50 % (at the beginning of treatment – 4,729,167 IU/mL, and
1,833,933 IU/mL – at the end of treatment), and in 4 patients HBV
DNA was not detected.
Conclusions
The treatment of both patient groups with Viusid showed that the
clinical and biochemical improvement that was more apparent in
Group I, which indicates the protective effect of the medicinal prod-
uct Viusid; the reduction of HBV DNA level by 50 % and HCV RNA
level by 40 %, denotes an antiviral effect of the drug.
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Background
The FDA warned that the direct acting antiviral (DAA) can cause se-
vere liver injury in patients with advanced liver disease. However,
liver decompensation was not reported in patients with HCV Child-
Pugh A cirrhosis. In July 2016 a case of HCV Child-Pugh A patient
treated with ombitasvir-paritaprevir/ritionavir-dasabuvir (OPrD) with
severe liver decompensation was reported. The jaundice during OPrD
therapy was reported especially in HIV-HCV co-infected patients. A
guideline regarding the management of these patients has not been
published yet. Objective: to analyze the predictive factors for hyper-
bilirubinemia during DAA therapy for HCV Child-Pugh A cirrhosis and
also to establish the management of these patients.
Methods
This is a prospective study of patients with HCV genotype 1 Child-
Pugh A cirrhosis, treated with OPrD-ribavirin regimen, in the Third
Department of Matei Balș Institute. We analyzed the patients who
developed hyperbilirubinemia during antiviral therapy in order to
identify the risk factors for this side effect. The management of these
patients was also analyzed. The statistical analysis was made with
open-epi 3.0 program.
Results
Eighty-seven patients with HCV compensated cirrhosis are treated in
our department with OPrD-ribavirin regimen. Three patients discon-
tinued the antiviral therapy, two of them because of liver decompen-
sation. After one month of therapy, 20 patients had total bilirubin
more than 2 mg/dL and 7 of them had total bilirubin more than
4 mg/dL (the maxim value was 21 mg/dL). In the same time, these
patients developed anemia and 16 of them permanently discontinued
ribavirin. Five patients had high value of bilirubin (more than 10 mg/
dL): one patient with predominance of unconjugated bilirubin and se-
vere anemia (with hemolytic mechanism with recovery after ribavirin
discontinuation and 2 patients with liver decompensation (with discon-
tinuation of DAA regimen). Three of these patients did not develop
liver decompensation and a slow recovery after discontinuation of
ribavirin was observed. The risk factors for hyperbilirubinemia were
analyzed and two of them were highly correlated with this side effect:
Child-Pugh score at baseline 6 (RR 8 (4.48; 14.28) with p < 0.0000001)
and baseline level of platelet count less than 100000/cmm (RR 5.36
(1.973; 14.56) with p < 0.0001).
Conclusions
Hyperbilirubinemia in patients with compensated cirrhosis treated
with OPrD-ribavirin regimen represents a severe side effect. Ribavirin
must be discontinued in this situation and sometimes all DAA regi-
men has to be withdrawn. The most important risk factors for this
side effect are: Child-Pugh score at baseline 6 and platelet count at
baseline below 100000/cmm.
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Background
The Romanian National Health System has approved the use of direct
acting antivirals (DAA) for treatment of HCV compensated cirrhosis. The
approved regimen contains a protease inhibitor, paritaprevir (boosted
with ritonavir), a NS5A inhibitor - ombitasvir and a non-nucleoside
NS5A inhibitor – dasabuvir (OPrD), recommended for 12 weeks in
genotype 1b and for 24 weeks in genotype 1a. This DAA regimen is
associated with ribavirin. Objective: to evaluate the real life data re-
garding the efficacy of this regimen in genotype 1 HCV infected pa-
tients with compensated cirrhosis.
Methods
We performed a prospective analysis of all patients with HCV compen-
sated cirrhosis treated in Third Department of Matei Balș Institute since
November 2015 until July 2016. We included all patients who under-
went at least four weeks of antiviral therapy. We analyzed the evolution
of clinical and biological parameters and also the trend of HCV viral
load.
Results
Until now 88 of our patients received approval for OPrD therapy, 87
for compensated cirrhosis and one with F3 fibrosis and severe depres-
sion. A patient experienced liver decompensation during the third
month of therapy, when cholangiocarcinoma was diagnosed, and
died 2 weeks later. Our patients are in different stages of therapy:
37 patients at the end of follow-up (EF) – 42.52 %, 30 patients at
the end of therapy (EOT) – 34.48 %, 5 patients during the third
month of therapy – 5.74 %, 10 patients during the second month
of therapy – 11.49 % and 5 patients during the first month. From
the 27 patients whose viral load has been analysed after 4 weeks of
therapy, 24 registered undetectability (88.88 %) and 2 patients had
a viral load under the low limit of quantification. 66 patients finished
the therapy and all had undetectable viral load. 38 patients finished the
12 weeks monitoring period and all of them registered sustained viro-
logic response. Two patients prematurely discontinued antiviral therapy
due to liver decompensation and cardiac disorders. From 53 patients
with abnormal ALT at baseline, 32 (60.37 %) had normal ALT after
2 weeks of therapy and 50 (94.33 %) patients had normal ALT after
4 weeks of therapy.
Conclusions
The OPrD–Riba regimen was highly efficient in difficult to treat patients
with compensated cirrhosis. All the patients that have completed the
therapy achieved undetectable viral load and furthermore, in the case
of those who completed the 12 weeks period of follow-up, SVR 12 was
achieved.
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The regimen approved for the therapy of HCV Child Pugh A cirrhosis,
contained at the beginning different combinations of direct acting
antivirals and ribavirin. Some recent studies have shown that the asso-
ciation of ribavirin did not increase the efficacy of the regimen. Re-
cently, in some countries the local protocols for therapy of HCV
compensated cirrhosis recommend only DAA without ribavirin. Most of
the available data about the importance of ribavirin in the therapy of
patients with compensated cirrhosis came for clinical studies and data
from real life will be very useful. Objective: to analyze the efficacy of
ombitasvir-paritaprevir/ritonavir –dasabuvir (OPrD) without ribavirin in
patients with HCV Child Pugh A cirrhosis.
Methods
This is a prospective analysis of the OPrD regimen efficacy without
ribavirin in patients with compensated HCV cirrhosis, monitored in
Third Department of Matei Balș Institute.
Results
Between November 2015 and July 2016, 87 patients received approval
for OPrD and ribavirin therapy for HCV compensated cirrhosis, 86 for
genotype 1b and one patient with genotype 1 with undetermined sub-
type. Some of our patients had contraindications for ribavirin usage
(chronic anemia – 2 patients) and we also have patients with prema-
turely discontinuation of ribavirin. 85 patients started ribavirin, but after
one month of antiviral therapy, the ribavirin was discontinued for 16
patients (18.82 %) and for 23 (27.05 %) patients the dose was reduced.
The most important reason for ribavirin discontinuation and dose re-
duction was severe anemia but we also have patients with moderate
or mild anemia but with severe jaundice (7 patients with total bilirubin
more than 4 mg/dL – among them, 5 patients had bilirubin more than
10 mg/dL). After two more months of therapy, other 7 patients discon-
tinued ribavirin. Out of 81 patients who received at least 2 months of
therapy, 23 patients discontinued ribavirin (28.39 %) and for 20 patients
the ribavirin dose was reduced (24.69 %). Only 38 patients received full
dosage of ribavirin for at least two months. Despite the ribavirin dose
reduction or discontinuation all the patients who completed 12 weeks
of therapy achieved undetectable viral load and all patients who com-
pleted the follow-up period achieved sustained virologic response.
Conclusions
The efficacy of OPrD regimen in patients with HCV compensated
cirrhosis is similar with or without ribavirin. Because sometimes the
ribavirin side effects can conduct to a prematurely discontinuation
of all antiviral regimen, we thought that in difficult to treat patients,
the regimen without ribavirin could be a better option.
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Background
Patients with HCV cirrhosis need urgent antiviral therapy. However,
the patients with liver cirrhosis represent difficult to treat cases and
appropriate monitoring is necessary. The most important data regard-
ing the safety of ombitasvir-paritaprevir/ritonavir-dasabuvir (OPrD) and
ribavirin regimen in HCV cirrhotic patients came from Turquoise II clin-
ical trial, real life data being lacunar. According to Romanian guideline
and also with summary of product characteristics, this regimen is rec-
ommended only in Child A cirrhosis. Objective: To analyze the risk of
liver decompensation during OPrD-ribavirin regimen in HCV Child-Pugh
A cirrhotic patients.
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We performed a prospective study of HCV Child A cirrhotic patients
monitoring in Third Department of Matei Balș Institute who devel-
oped liver decompensation during OPrD therapy. We correlated the
liver decompensation with some clinical and biological characteristics
at baseline.
Results
Eighty seven Child A cirrhotic patients were treated in our Depart-
ment: 70 patients had 5 points at Child score (80.45 %) and 17 pa-
tients 6 points (19.55 %). Five patients (5.74 %) developed liver
decompensation during antiviral therapy. Two patients permanently
discontinued antiviral therapy: one after 23 days of therapy− because
after the discontinuation of ribavirin and supportive therapy the
outcome wasn’t good and the second one was diagnosed with
cholangiocarcinoma after 9 weeks of therapy. Two patients with
liver decompensation had a good outcome after cessation of ribavi-
rin and supportive therapy. They had completed the therapy with
OPrD and achieved SVR12. One patient is still in hospital under
strict monitoring; ribavirin was stopped but OPrD regimen was not
yet discontinued. The mean age was 63 year-old, 3 male and 2 female,
3 naive patients and 2 previously treated with null response. All the pa-
tients had Child score 6. All the patients had at baseline: abnormal INR
(but less than 1.7 – the limit accepted by Child Pugh score), platelet
count under 100000/cmm, mild increase of total bilirubin (between 2
and 3 mg/dL for 4 patients and below 2 mg/dL for one patient) and al-
bumin below 3.5 g/dL in one patient. Four patients had esophageal
varices at baseline and all patients had an increased spleen diameter.
Conclusions
Liver decompensation in patients with Child Pugh score A during
OPrD-ribavirin regimen has a low rate of probability, but this situation
is possible. The diagnosis of compensated cirrhosis probably has to
take into account more clinical and biological parameters, not only the
ones used by Child Pugh score.
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Background
The regimen containing NS5A inhibitor - ombitasvir, protease inhibitor
paritaprevir boosted with ritonavir and non-nucleoside inhibitor dasa-
buvir (OPrD) associated with ribavirin was approved in Romania from
November 2015 for genotype 1 HCV infected patients with compen-
sated cirrhosis. The safety data regarding this therapeutic regimen
came from clinical studies where many patients with severe comorbidi-
ties were excluded. The data coming from real-life are more relevant in
this context. Objective: the aim of our study is to analyze and to report
the side effects that occurred during and after OPrD-riba regimen and
also the management of these side effects.
Methods
We performed a prospective study using the database of cirrhotic pa-
tients treated with OPrD-riba regimen in Third Department of Matei
Balș Institute. All the adverse events that occurred in these patients
were introduced into a database and we established the correlation
between the regimen and each side effect, the grade of each side ef-
fect and also its management.
Results
A total of 87 patients were followed, with a median age of 63 years
(IQR 54–70 years) and 47 % males. 36 patients (41.4 %) reported at
least one clinical adverse event. The most common were fatigue(26.4 %), pruritus (13.8 %), dizziness (8 %), sleeping disorders (6.9 %),
nausea and/or vomiting (6.9 %), muscle and/or bone pain (4.6 %),
headache (3.4 %), diarrhoea (3.4 %) and skin rash (2.3 %). The main
laboratory abnormalities were anemia (44.8 %) and hyperbilirubinemia
(23 %). After the first month of treatment, 20 patients (23 %) developed
mild anemia (hemoglobin level 11–12 g/dL) and 19 (21.8 %) devel-
oped moderate anemia (hemoglobin level < 11 g/dL). A total biliru-
bin level > 2 mg/dL after one month of therapy was observed in 20
patients (23 %) and for 16 (18.4 %) of them ribavirin was discontin-
ued. Three patients discontinued treatment, two of them because
of liver decompensation.
Conclusions
The most important side effect was anemia which was correlated with ri-
bavirin use and for some cases ribavirin discontinuation was necessary.
Jaundice was another side effect more difficult to control. Complete
therapy discontinuations due to adverse events were infrequent.
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Background
The Romanian patients known with genotype 1 HCV compensated
cirrhosis have access to direct acting antivirals (DAA) therapy since
November 2015 for free, through a National Program financed by
Romanian Health Insurance. The eligibility criteria for DAA regimen
were: genotype 1 of HCV, detectable viral load, cirrhosis diagnosed
by FibroMax (BioPredictive France) if fibrotest is more than 0.75
and compensated cirrhosis according to Child Pugh score (Child Pugh
score A – 5 and 6 points). Objectives: to analyze all the causes that
led to the failure of access to DAA regimen via Romanian National
Program.
Methods
We performed a prospective study in which we enrolled all the pa-
tients known with compensated cirrhosis who received vouchers for
access to the therapy (FibroMax, viral load and HCV genotyping test).
The current status of each patient was analyzed.
Results
120 patients were included in the DAA therapy program in Third
Department of Matei Balș Institute. Among them: 88 (78.33 %) re-
ceived the approval, 17 patients are awaiting the approval (14.16 %), 3
patients were ineligible despite F4 fibrosis due to the diagnosis of
hepatocellular carcinoma and 12 (10 %) had fibrosis less than F4
and were ineligible according to the local guideline. From our pa-
tients only 92 (76.66 %) had F4 fibrosis according to the FibroMax.
In 4 cases the previous fibrosis investigated by FibroMax or Fibros-
can was F3 and the patients had severe comorbidities. Despite
these data, the evaluation of FibroMax during the National Program
showed F2 fibrosis and were ineligible for DAA therapy. In one
case, the result of FibroMax was F2 but the patient had significant
clinical signs of cirrhosis and the therapy was approved. For twenty-
two patients the FibroMax showed F3 fibrosis (19.16 %). However,
they were known with compensated cirrhosis previously diagnosed
by: FibroMax, Fibroscan, liver biopsy or by clinical findings like
esophageal varices. Among them, 15 patients were considered eli-
gible for therapy (65.21 %): 11 patients have already received the
approval (78.57 %) and 4 patients are awaiting the commission’s
decision. Eight patients without clinical signs of cirrhosis were de-
clared ineligible (34.78 %), despite the previous evaluation of fibro-
sis by non-invasive methods.
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The fibrosis cannot be always correctly determined by FibroMax; it is
important to use other alternative test for an accurate diagnosis of cir-
rhosis. Moreover, even the tests manufacturer from BioPredictive rec-
ommends that a fibrotest score with a value more than 0.60 can be
interpreted as severe fibrosis and must be treated urgently.
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Background
Nucleos(t)ide analogues (NAs) realize a proper suppression of viral repli-
cation in chronic hepatitis B (HBV), but a negligible immune control, so a
lifelong therapy is necessary. The highest risk after therapy discontinu-
ation, even in patients who achieved undetectable viral load (VL), is the
viral reactivation. Reactivation flares appear in 10 % of cases after therapy
cessation and are associated with jaundice, hepatocytolysis and high VL.
Some cases can develop fulminant hepatitis with high mortality rate.
Methods
We present a series of 3 cases of viral reactivation following discon-
tinuation of Entecavir (ETV), administered for chronic HBV.
Results
In 2015–2016, three patients known with chronic HBV were admitted in
our department for jaundice and ALT increase. The first case is a young
woman, pregnant in 24 weeks, under ETV for 4 years, with negative
HBeAg and undetectable VL, who decided to stop therapy when she dis-
covered the pregnancy. Six months later she was admitted in our clinic
for important hepatocytolysis. The biological exams revealed: ALT > 20 x
upper limit of normal (ULN), positive HBeAg, HBV VL of 9 log IU/mL, nor-
mal prothrombin concentration and mild hyperbilirubinemia. The pa-
tient received off label lamivudine with slow decrease of ALT and VL of
2 log IU/mL at delivery. ETV therapy was reintroduced after delivery, with
favorable outcome. The second case is a young man who discontinued
ETV because he lost his medical insurance. During antiviral therapy he
had normal ALT and undetectable VL. Five months later, he presented
ALT 5xULN, jaundice and high VL. The patient renewed his insurance
and ETV was reinitiated, with good outcome. The last patient, a 28 year-
old man is still hospitalized. He was under ETV for 6 years with good bio-
logical outcome, after a previous therapy with peginterferon. In January
2016, he stopped ETV by himself and in August he was admitted in our
clinic for jaundice and vomiting. The tests showed ALT 60xULN, hyperbi-
lirubinemia (16 mg/dL), positive HBeAg and decrease of prothrombin
concentration and fibrinogen. The therapy with tenofovir was immedi-
ately started and after 5 days, the prothrombin concentration became
normal, but ALT and bilirubin remained increased.
Conclusions
NAs therapy must be continued until HBs seroconversion, even in pa-
tients who achieved undetectable VL. The risk of severe liver decom-
pensation especially in young people is extremely high. In women with
childbearing potential, ETV can be switched with tenofovir and the
therapy must be continued during the entire pregnancy.
Consent
Written informed consent was obtained from the patients for publica-
tion of this Case report and any accompanying images. A copy of the
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Background
The regimen approved in Romania for the patients with HCV compen-
sated cirrhosis involves Ombitasvir-Paritaprevir/Ritonavir-Dasabuvir
(OPrD) in association with ribavirin. The most important side effect, dur-
ing ribavirin based therapy, is anemia, well-known from the era of
Peginterferon-ribavirin regimen. Objective: to analyze the hematological
disorders occurred during OPrD – ribavirin therapeutic regimen for HCV
compensated cirrhosis.
Methods
Prospective study of the HCV cirrhotic patients treated with OPrD-
ribavirin regimen from November 2015 until July 2016 in Third
Department of Matei Balș Institute which analyzed the dynamic of
hemoglobin level and platelet count during 12 weeks of DAA
therapy.
Results
Eighty-seven patients with HCV compensated cirrhosis were
treated in our department. The mean age was 61.93 years old
and sex ratio F:M = 1.12:1. After one month of therapy, 19 pa-
tients (21.83 %) developed moderate anemia with hemoglobin
below 11 g/dL (between 7.8 g/dL and 10.8 g/dL, with a medium
value of 9.8 g/dL). Sixteen of these patients permanently discon-
tinued ribavirin during first month of antiviral therapy and two
patients permanently discontinued all therapeutic regimen: one
patient for severe cardiac disturbances and the other for liver de-
compensation with important jaundice. For other 3 patients the
dosage of ribavirin was reduced. For 20 patients, hemoglobin
level after first month of therapy was between 11 and 12 g/dL
(mild anemia – 22.98 %) and because of severe fatigue, the dos-
age of ribavirin was reduced. After 2 months of therapy from 81
patients who reached this endpoint, other 7 patients perman-
ently discontinued ribavirin due to moderate anemia (below
11 g/dL). 37/67 (55.22 %) of patients who completed the therapy
had anemia despite the reduction or discontinuation of ribavirin.
37 patients finished the monitoring therapy (SVR12) and all the
patients who developed anemia had normal level of hemoglobin.
Regarding thrombocytopenia, it was improved during antiviral
therapy. The analysis was performed for 67 patients who finished
the therapy. At baseline, 13 patients had severe thrombocytopenia
(19.40 %) and 38 patients had platelet count more than 150000/cmm.
At the end of treatment, 6 patients remained with severe
thrombocytopenia (8.9 %) and 53 patients had platelet count
more than 150000/cmm (79.1 %). The statistical analysis showed
significant increases of platelet count.
Conclusions
The most frequent hematological side effect during OPrD-riba
therapy for HCV hepatitis was anemia with recovery after adjusting
the ribavirin dosage. Sometimes, the discontinuation of ribavirin
was necessary, without impact in efficacy of this regimen. In terms
of platelet count a significant improvement was shown.
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Background
The prevalence of risk factors, behaviors and knowledge on HBV and
HCV infection varies in different areas of the world. We have per-
formed a study to determine whether classical risk factors for HBV or
HCV showed diversity due to different ethnic or geographic origins
in two matched young cohorts: a heterogeneous study group of
international medical students, and a control group from the general
Romanian population.
Methods
We have performed a cross sectional study based on a standardized
questionnaire and serologic tests to assess the prevalence of risk fac-
tors for transmission of viral hepatitis in two study groups. The Z-test
was used for checking the statistical significance of the proportions
of specific risk factors in the two groups.
Results
The study included 371 participants (77 in the study group and 294 in
the control group). The median age of the study group was 25 years
(interquartile range [IQR]: 24, 26.5 years), and 23 years (IQR: 22, 24 years)
in the control group. The male-to-female ratio was 0.9:1 in the study
group vs. 1:1 in the control group. The following risk factors for HBV or
HCV transmission were significantly more prevalent in the study group:
blood transfusion or organ transplantation after 1992 (p = 0.029), history
of coagulopathy (p = 0.048), injected drug use (p = 0.048), having lived
with someone with hepatitis B (p = 0.005), history of travel to countries
with high HBV risk (p < 0.001), never having undergone screening for
hepatitis (p < 0.001) or HIV (p < 0.001), history of unprotected oral (p =
0.004) or vaginal (p = 0.004) intercourse with more than one partner in
the last year, occupational exposure to HIV/hepatitis (p < 0.001 each), tat-
toos or piercing (p < 0.001). However, the study group also presented
positive health-related behaviors, such as: history of vaccination against
hepatitis A (p < 0/001) or hepatitis B (p = 0.001), a previous negative re-
sult upon screening for hepatitis (p < 0.001) or HIV (p < 0.001).
Conclusions
The worldwide prevalence of certain risk factors for HBV and HCV in-
fection is a serious issue that transcends nationality, gender, ethnic
origin or educational level. Our results suggest that a global strategy
for prevention and control of hepatitis infection is needed, along
with effective vaccination programs.
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Data on hepatitis C virus reactivation (HCV-R) in patients with hema-
tological malignancies (HM) under immunosuppressive therapy are lim-
ited. The prevalence of HCV infection is higher in Romania than in other
EU countries. We aimed to evaluate clinical characteristics and outcome
of HCV–R in patients with HM undergoing immunosuppressive therapy.
Methods
We performed a prospective study that include patients with HM treated
with rituximab containing chemotherapy and anti HCV positive. The pa-
tients were monitored in the 3rd department of the Prof. Dr. Matei Balș
National Institute for Infectious Diseases, Bucharest, Romania, between
2008–2014. Anti HCV, HCV-RNA (by PCR) and biochemical tests were
measured at baseline and every three months. Viral reactivation was de-
fined as ≥1log 10 IU/mL increase of HCV-RNA following chemotherapy.
Results
We enrolled 30 HCV-infected patients: 8 (26.7 %) males and 22
(73.3 %) females, with mean age 66 ± 9.44 years. Most cases (83.3 %)
had non-Hodgkin lymphomas (NHLs), 10 % chronic lymphocytic
leukemia (CLL), 3.3 % Hodgkin lymphoma (HL) and 3.3 % Waldenström
macroglobulinemia (WM). Based on histologic features the HM indolent
subtype was predominant (53.3 %) versus aggressive subtype (46.7 %).
Advanced fibrosis (stage F3-F4) was present in 68.2 % of patients and
31.8 % had moderate or severe necroinflammatory activity. Nine
patients (30 %) had high HCV-RNA viral loads (>600 000 IU/mL) at
baseline. HCV-R was present in 30 % of cases, after a mean of
4 months (range: 3–12 months) from enrolling. A hepatic flare was
associated only in 3 of these cases. Three (10 %) patients died, one due
to HCV associated fulminant hepatitis and two due to HM complica-
tions.The median HCV viral load at baseline was 507525.00 IU/mL
(IQR = 3074957 IU/mL) in HCV-R patients versus 471129.00 IU/mL
(IQR = 1562720 IU/mL) in patients without HCV-R. Neither sex (p = 0.23),
age (p = 0.13), HCV-RNA levels at baseline (p = 1), presence of fibrosis
(p = 1), necroinflammatory activity or HM type significantly influenced
the risk of HCV-R.
Conclusions
One third of our patients had HCV-R. HCV can cause fulminant hepatic
failure in patients with HM. Close monitoring of HCV-RNA every 3 months
should be performed.
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Background
Interferon gamma (IFN γ) plays a key role in the elimination of hepatitis
C virus during the first 8–12 weeks following infection. Once the in-
fection becomes chronic the role of IFN γ becomes unclear and the
increased levels of this cytokine are not associated with a favorable
evolution. The current study aims to analyze the level of IFN γ in
sustained responders on standard peginterferon-α 2a/ribavirin therapy.
Methods
The study employed 40 assessments of the serum IFN γ level in 5 pa-
tients between 25–36 years hospitalized in the National Institute for
Infectious Diseases, Bucharest, Romania with chronic HCV infection,
genotype 1 and F2 hepatic fibrosis who received treatment with
peginterferon-α 2a 180 mcg weekly and ribavirin 1000–1200 mg/day.
All patients showed undetectable HCV RNA viral loads after the first
3 months of treatment and remained undetectable over the next
2 years of follow-up. The study performed a comparative analysis
(before/after treatment) on the serum levels of IFN γ (ELISA, Bio Sci-
entific) in the first 6 months of interferon α treatment.
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All patients showed a constant evolution of IFN ɣ levels with a moderate
increase of IFN γ from 59 to 200 pg/mL during the first 6 months of treat-
ment. Interestingly, all patients with a recent infection (<1 year) showed
much higher pre-therapy serum levels of IFN γ (984–1282 pg/mL) than
those with a more distant infection (IFN ɣ serum levels 120–171 pg/mL).
Conclusions
HCV patients with a sustained response to peg interferonα/ribavirin
therapy display constant levels of IFN γ during the first 6 months of
treatment. The level of IFN γ in recent HCV infections was much
higher compared with more distant infections. The pre-therapy level
of serum IFN ɣ did not influence the virologic outcome to the stand-
ard interferon α therapy.
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Background
Risk-reduction campaigns are essential parts of national health pro-
grams. To better select the population groups to target, we have
undergone an assessment of specific risk factors for transmission of
HBV, HCV and HIV infection in Romania.
Methods
We implemented a nationwide screening program for chronic viral
infections, which also included a standardized questionnaire for
assessing the prevalence of risk factors for HBV, HCV or HIV transmis-
sion in the general population in Romania. The statistical analysis
was performed with IBM SPSS Statistics version 22 (Armonk, USA).
Results
We analyzed a significant sample from the general population in
Romania, with a median (interquartile range) age of 46 (36, 57) years
and a male to female ratio of 0.6:1. We identified a higher prevalence
of risk factors in the male population, namely a history of sexually-
transmitted infections (STIs – OR: 3.4, CI 95 %: 1.3, 10.0), piercing/tattoos
(OR: 1.9 CI95 %: 1.4, 2.6), unprotected anal (OR: 2,6, CI95 %: 1.1,
6.0), vaginal (OR: 2.2, CI95 %: 1.5, 3.3) and oral (OR: 5.5, CI95 %: 2.9,
10.2) intercourse but not homosexual intercourse (p = 0.524), mul-
tiple sex partners (p = 0.403), injecting drug use (IDU – p = 0.205), or
needle sharing (p = 0.613). The prevalence of IDU was significantly
higher in patients who also had a history of STIs (OR: 372, CI95 %:
64, 2180), and the same was true for needle sharing (OR: 124, CI95 %:
26, 598). Similarly, piercings/tattoos were significantly associated with
IDU (OR: 69, CI95 %: 14, 346), needle sharing (OR: 16, CI95 %: 4.5, 56.8),
all types of unprotected intercourse: homosexual (OR: 10, CI95 %: 4.7,
21.2), oral (OR: 34, CI95 %: 19, 61), vaginal (OR:13, CI95 %: 8, 23), or anal
(OR: 25, CI95 %: 10, 64), and multiple sex partners during the past
6 months (OR: 10, CI95 %: 7, 14).
Conclusions
Although the overall prevalence of risk factors in the general popula-
tion in Romania appears to be low or under-declared, we have identi-
fied certain high-risk groups, which cumulate a large number of risk
factors and have high likelihood of acquiring HBV, HCV or HIV infection.
We propose priority targeting of these special population groups
though information campaigns and risk reduction interventions.
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Case report
A 42 yo patient recently hospitalized in the Râmnicu Vâlcea Hospital
for jaundice with immunoglobulin M antibodies against hepatitis A
detected in blood is hospitalized in our institute for supervision and
the continuation of the treatment. Recent medical history shows the
onset of the symptoms 11 days before with fever, jaundice and the
patient recognizes contact with a person with confirmed infection
with hepatitis A. As a development of the disease, the patient be-
came comatose (GCS 3), with severe respiratory acidosis, depending
on advanced respiratory support. After 24 hours, he becomes conscious,
but shows limp quadriplegia, facial asymmetry, thenar and hypothenar
eminence atrophy, abolished tendinous reflexes and preserved sensitiv-
ity. The MRI reveals no alterations that could explain the neurological
deficit, the lumbar puncture is within normal limits. The patient had a fa-
vorable biological trend with the correction of coagulation disorders and
improvement of sepsis markers. The second lumbar puncture showed
albuminocytologic dissociation. The findings of motor nerve conduction
studies showed markedly reduced amplitudes of compound muscle ac-
tion potentials and suggested demyelinating polyneuropathy. Based on
Guillain-Barré syndrome diagnosis, there were conducted five sessions
of plasma exchange and after each of them we noticed progressive im-
provement of the motor deficit, including of the respiratory muscles,
therefore the respiratory support was ceased after 8 days.
Conclusions
Acute hepatitis with HAV can also trigger an immune response,
therefore clinicians should consider this rare but serious possibility of
Guillain-Barré syndrome following acute hepatitis A infection.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Liver fibrosis was historically considered an irreversible and progressive
process. However, recent data have shown that after obtaining
sustained virological response (SVR) to anti-infectious treatment,
liver stiffness starts to decrease, potentially returning back to normal
post-infection values.
Methods
We have analyzed the evolution of liver fibrosis as assessed by shear-
waves elastography on Aixplorer (SuperSonic Imagine, France) in pa-
tients with chronic HCV infection and cirrhosis, treated with the 3D
regimen ombitasvir/paritaprevir/ritonavir plus dasabuvir (AbbVie, USA).
Liver stiffness was determined at baseline, at the end of 12 weeks of
treatment and at a follow-up visit at 12 weeks post-treatment. Data
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order correlation in SPSS Statistics for Windows (v22.0, IBM Corp, USA).
Results
We present the results for 87 patients, with a male-to-female ratio of
0.9:1, a median (interquartile range – IQR) age of 58 (49.5, 64.5) years
and a mean ± standard deviation duration of HCV evolution of 9.2 ±
4.9 years. Follow-up data is currently available for 60/87 patients (69 %)
and all achieved sustained virological response. The median (IQR) liver
stiffness at baseline was 13.9 (12.6, 19.2) kPa and it decreased signifi-
cantly to 10.7 (7.8, 15.1) kPa at 12 weeks post-treatment (p = 0.002,
Z = −3.146). The median decrease in liver stiffness was −1.8 (−3.1, −0.2)
kPa over an interval of 24 weeks, and it was correlated with shorter evo-
lution of HCV infection prior to starting treatment (rs = 0.346, p = 0.023).
Conclusions
Based on our results, we would recommend earlier therapy for chronic
HCV infection, to ensure faster decrease of liver stiffness after treat-
ment. Further long-term studies are needed to determine the exact
pace at which liver fibrosis decreases past the point of SVR.
Acknowledgement
1) “Romanian Center for Applied Bio-Molecular Research in Infectious
Diseases”, project financed through the Sectoral Operational Programme
Increasing of Economic Competitiveness (POS CCE).
2) RO 19.02. Project “Strengthening the prevention and control of HIV/AIDS,
HBV, HCV in Romania”, financed by the Norway Financial Mechanism 2009–2014,
“Public Health Initiatives”.
A41
Preliminary results for treatment with sofosbuvir and daclatasvir of
patients with chronic hepatitis C
Irina Russu1, Tiberiu Holban1, Tatiana Pantilimonov2, Galina Chiriacov2,
Arcadie Macvovei2, Elena Scorohodico2, Oleg Dmitriev2
1Department of Infectious Diseases, Parasitology and Tropical Medicine,
Nicolae Testemițanu State Medical and Pharmacy University, Chișinău,
Republic of Moldova; 2Toma Ciorbă Clinical Hospital for Infectious
Diseases, Chișinău, Republic of Moldova
Correspondence: Irina Russu (irina.rusu@usmf.md)
BMC Infectious Diseases 2016, 16(Suppl 4):A41
Background
It is estimated that about 103 million people around the world are in-
fected with hepatitis C virus (HCV). Due to population screening for
HCV and initiation of antiviral treatment, HCV prevalence decreased in
some countries. The purpose of antiviral treatment is to eradicate HCV
completely and obtain sustained virologic response (SVR). The biblio-
graphical data confirms that over 99% of patients with SVR remain HCV
RNA negative 4-5 years after stopping treatment [1].
Methods
We assessed 21 patients diagnosed with chronic HCV genotype 1b who
received combination therapy with sofosbuvir plus daclatasvir (SOF/DCV)
for 12 weeks. Patients with cirrhosis were not included in our study. The
degree of fibrosis was established by Fibroscan and Fibromax.
Results
Out of 21 patients with chronic HCV, 18 were naive and 3 pre-treated
with peg-IFN and ribavirin. 13 (62%) were men and 8 (38%) women
with ages between 21 and 58 years. Most patients had a poor clinical
picture like fatigue, right upper quadrant pain. 14 (66.6%) patients had
moderate level of hepatic cytolysis (ALT average 188 U/L), bilirubin was
within normal limits. HCV RNA detected prior to treatment ranged from
290.000 to 24 million copies/mL (average 3.8 million copies/mL). De-
gree of fibrosis - F0 was established in 2 patients, F1 - in 3, F2 - in 12
and F3 - in 4 patients. No adverse events occurred in any patient during
treatment with SOF/DCV. At 4 weeks of antiviral therapy 20 (95.2%)
showed undetectable viremia HCV-RNA, only one patient decreased
from 8 million to 500.000 copies/mL. All 21 (100%) patients achieved
ALT normal limits. At 12 weeks of treatment all 21 patients experienced
virologic response (HCV RNA - undetectable). At 24 weeks after starting
of treatment 13 (62%) patients had SVR (HCV RNA - undetectable). 8
patients are on the point of completing treatment with dynamic super-
vision to 24 weeks.Conclusions
Our study shows a high rate of SVR after treatment with sofosbuvir
and daclatasvir in naive as well as pre-treated patients with chronic
HCV, and no significant side effects from taking these drugs.
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Background
HIV and syphilis can be found in similar patient groups and the associ-
ation of these two infections is becoming more frequent. The two
diseases can influence each other’s evolution and the presence of
one can facilitate infection with the other. In addition, the presenta-
tion, diagnosis, and management of syphilis differ in subtle ways
between HIV-infected and HIV-uninfected patients. Objectives: Deter-
mining the prevalence of syphilis in newly diagnosed HIV patients and
identifying epidemiological, clinical and laboratory aspects in those
coinfected.
Methods
We performed a retrospective study in patients newly diagnosed
with HIV infection in the National Institute for Infectious Diseases
“Prof. Dr. Matei Balș” between the 1st of January 2015 and 30th of
June 2016. Patients were tested for syphilis and we collected data re-
garding demographics, epidemiology, clinical and laboratory aspects
in these patients, at baseline and in dynamics.
Results
We included in our study 403 adults newly diagnosed with HIV in-
fection in the National Institute for Infectious Diseases “Prof. Dr.
Matei Balș” between the 1st of January 2015 and 30th of June
2016. 295 (73.21 %) of those diagnosed with HIV were men and
108 (26.79 %) were women. A syphilis diagnostic test was per-
formed in 301 (74.68 %) of these patients and 64 (16 %) had HIV-
syphilis coinfection. A concomitant HIV-syphilis diagnosis was
established for 57 (90 %) out of 64 patients. Out of 9 % of patients
in whom a treponemal test was performed from the CSF, 6 % had
a negative result and 3 % (2 patients) were diagnosed with neuro-
syphilis. Most of our patients with HIV syphilis coinfection were of
reproductive age: most patients were aged between 30 and
39 years old (21 men and 7 women) while the second age group
was that of 20–29 years old (13 men and 6 women). 20 (31.25 %)
of the patients diagnosed with HIV and syphilis were diagnosed
also with at least one type of hepatitis virus. Most of them, 18
(28.12 %) were infected with hepatitis C virus and 2 (3 %) had
hepatitis B virus. Out of 64 patients with coinfection, 23 had AIDS
at the time of diagnosis. The medium viral load at baseline was
594.251 copies/cmm and 18 patients had a viral load above
100000 copies/cmm. 192 (47.62 %) patients diagnosed with HIV re-
ceived antiretroviral therapy.
Conclusions
Testing for other sexually transmitted diseases (especially syphilis)
remains an important objective in HIV infected patients in order to
prevent transmission and improve the outcome.
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Background
Thrombophilias are a group of hereditary or acquired hematological con-
ditions which predispose to thrombotic phenomena and are triggered
by molecular dysfunctions of the hemostasis proteins. The thrombophilia
comorbidity in HIV-positive pregnant women has been little studied.
Methods
The study carried out in 2015 at the Clinical Hospital of Obstetrics and
Gynecology „Prof. Dr. Panait Sârbu” from Bucharest refers to a number
of 9 HIV positive patients diagnosed with thrombophilia.
Results
The study was carried out on a number of 51 HIV positive patients, out
of which 45 pregnant women eventually gave birth and 6 had second
trimester spontaneous abortion (patients with deliberate pregnancy).
Out of the patients who delivered (42 by Caesarian section and 3 by va-
ginal birth) 6 cases were diagnosed with thrombophilia (2 cases with
antiphospholipid syndrome and 4 cases with congenital thrombophi-
lia). The thrombophilia diagnosis was established in 5 of the cases with
spontaneous abortion with repetition in the second pregnancy trimes-
ter. In all cases the treatment with low molecular weight heparine was
initiated.
Conclusions
No correlation between the incidence of thrombophilia and HIV in-
fection stage or the duration of ARV therapy has been found.
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Background
Relapsed or difficult to treat oropharyngeal candidiasis is in some cases
revealing for HIV infection, being the most common fungal infection in
these patients. The objective of this study is to determine the preva-
lence of oropharyngeal candidiasis in HIV infected patients.
Methods
We presented a retrospective study on patients born between 1988–1989,
in which we included 216 patients diagnosed with AIDS, staged as
A3, B3 and C AIDS, monitored in the Infectious Diseases Hospital of Iași
and admitted between 1st of January and 31st of December 2015.
Results
In the 216 group of patients evaluated in the study, the percentage
of female patients was 52.31 %, while in men it was 47.68 %. The
prevalence of urban area was (64.56 %), versus only (35.44 %) for
rural environment. AIDS C3 stage of disease represented 56.94 %,
followed by B3 stage (27.7 %), C2 (8.33 %), and C1 stage (3.25 %).
The therapy was established with local antifungal treatment in 32 %
of the cases, 68 % receiving systemic treatment with Diflucan, instituted
during hospitalization.
Conclusions
The degree of immunosuppression correlates with oropharyngeal
manifestations of infection, oropharyngeal candidiasis having a very
high prevalence in C3 staged patients. Early detection and treatmentof these lesions is provided if there is a permanent collaboration
between the infectious disease specialist and the dentist.
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Background
Tuberculosis is the most common opportunistic infection and a major
cause of death in HIV infected patients. The annual risk for active tuber-
culosis in these patients is 5–10 % per year, compared to 5–10 % for
lifetime in uninfected individuals. Objectives: To determine the preva-
lence of TB infection in HIV infected patients.
Methods
We studied retrospectively the observation charts of patients with
generalized tuberculosis, lung, lymph node and HIV infected hospital-
ized in the Regional HIV/AIDS Center Iași, between the 1st of January
and 31st of December 2015.
Results
During the year of 2015, in Iași Infectious Diseases Hospital 15 cases
of TB were registered among the total of 1060 HIV infected patients,
that means a prevalence of 1.4 %. Of all patients, a number of 3
(20 %) were non-adherent, non-compliant to ARV therapy; 2 cases of
TB (13.3 %) belonged to pediatric cohort with known and treated
HIV infection, since childhood. In 4 cases (26.6 %) TB infection was
revelatory for AIDS, and we registered 2 deaths (13.3 % of all patients
hospitalized for TB). Note that in both cases the patients were ARV
non-adherent, and non-compliant. At the moment of detection of TB
infection, CD4 levels varied between 80 and 436 cells/cmm, and the
values of viremia oscillated between 20 and 364000 copies/mL. The
average duration of hospitalization was 9 days, requiring therapeutic
approach in infectious diseases specialists team-intensive care specialist-
psychologist.
Conclusions
Although there is a low prevalence of Mycobacterium tuberculosis infec-
tion, this condition is a challenge for infectious diseases specialists, psy-
chologists and ATI specialists, regarding the therapeutic adherence and
compliance and long-term care and follow-up of HIV positive patients
that have also tuberculosis.
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Background
By recording data obtained from analysis of HIV/AIDS deaths which
were necropsied the last 2½ years in our hospital we propose updating
the HIV/AIDS database belonging to the Clinical Hospital of Infectious
Diseases, Constanța, focusing on parameters that express the epidemio-
logical tendency of the evolution of HIV/AIDS in the region. Objective:
Analysis of the data referring to the HIV/AIDS deaths recorded in
the Clinical Infectious Diseases Hospital, Constanța, in the period
01.01.2014 - 30.06.2016. Formulation of general epidemiological
considerations.
Methods
We conducted a retrospective epidemiological study on data from the
Register of deaths and from the Register of pathological examinations
(necropsy) of the Clinical Infectious Diseases Hospital, Constanta, in the
period 01.01.2014 - 30.06.2016.
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From a total of 47 deaths (19 F, 28 M) appearing in the records of
the Pathology Department, there are 40 deaths (100 %) HIV AIDS
(18 F - 45 %, 22 M - 55 %), of which were autopsied 26 - 65 %
(11 F - 27.5 %, 15 M - 37.5 %). Distribution of HIV/AIDS deaths according
to resident backgrounds - 21 urban (52.5 %), rural 19 (47.5 %). The
residence towns mentioned are: Constanța (12 - 30 %), Năvodari (4
- 10 %), Medgidia (2 - 5 %), Cernavodă (2 - 5 %), Mangalia (1–
2.5 %). From rural provenance there are the residence localities:
Râmnicu de Sus, Târguşor, Poarta Albă, Văleni, Făurei, Cobadin,
Drăgăşani, Pecineaga (2014), Lumina, Dobromir, Oituz, Valu Traian
(2015), Mihail Kogălniceanu, Ciocârlia, Canlia, Lipniţa, Ostrov, Tech-
irghiol (2016). Of the 40 HIV/AIDS patients who died, 25 (62.5 %)
have birth years from 1984 to 1990, of which 21–52.5 % (9 F, 12 M -
male predominance) belong to cohort 1987–1989 (1987–6 deaths -
15 %, 1988–9 deaths - 22.5 %, 1989–6 deaths - 15 %). The number of
registered HIV/AIDS deaths fell from year to year: 2014–19 deaths
(47.5 %), 2015–11 deaths (27.5 %), 2016 (first 6 months) - 10 (25 %).
During designated period, the age group 25–29 years had the highest
mortality (25 deaths - 62.5 %), followed by the age group 45–49 years
(5 deaths - 12.5 %). The common pathological diagnoses are type: liver
damage (liver B cirrhosis, chronic hepatitis C), lymphoma (Burkitt) - on
growing trend, lung disease (pulmonary TB on decreasing trend,
pneumocystosis), sepsis.
Conclusions
HIV AIDS patients continue to experience difficulties in specific assess-
ment and monitoring. The role of the epidemiology specialist (the
clinician of the community), of the specialist in palliative cares (before
death, the HIV/AIDS patients had required palliative care), pathologist
(diagnostic certainty) were revised.
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Background
Patients with HIV/AIDS represent a risk group for viral hepatitis which
may progress to severe liver failure or other complications. We present
the case of a patient with acute liver failure with chronic B hepatitis
known with HIV infection late presenter.
Case report
The patient, diagnosed with chronic B hepatitis and HIV infection in
August 2015 is admitted in the Clinic of Infectious Diseases Timișoara
for: scleral and skin jaundice, hyperchrome urine, hepatalgia, nausea,
anorexia, asthenia, etc. The physical examination at admission revealed:
influenced general state, afebrile, scleral and skin jaundice, generalized
lymphadenopathy, the inferior edge of the liver palpable at 2.5-3-3.5 cm
below the costal margin, the lower pole of the spleen was palpable, with
no signs of meningeal irritation. Biological samples were collected: cell
blood count, biochemistry, coagulation, electrophoresis, CD4, HIV viral
load (VL), HBV VL, AcVHD, AcHCV, bilirubin, γ-GT, alkaline phosphatase,
α-fetoprotein, cholinesterase, urinalysis, etc. The patient is unemployed,
with a low intellectual level (4 elementary grades) and low adher-
ence to ARV therapy (Combivir 2x1 tablet/day, 400 mg Prezista 2x1
tablet/day, 100 mg Norvir 1 tablet/day). The results of blood tests
were: RBC 3.27x106/μL, Hb 12.4 g/dL, Ht 33.1 %, PLT 118x103/μL,
prothrombin time 19.4 sec (42.6 %), total bilirubin 29.18 mg/dL, direct
bilirubin 23.98 mg/dL, TGP 429.9 U/L, TGO 293.8 U/L, total protein
5.44 g/dL, cholinesterase 2147 U/L, γ -GT 63.4 U/L, alkaline phosphatase
141 U/L, α-FP 257.3 IU/mL, Electrophoresis: 44.7 % albumin, α-1 globu-
lin 3 %, α-2 globulin 7.4 %, β-globulins 8.3 %, γ-globulins 36.6 %, CD4
83 cells/μL, HIV VL <20 copies/mL, HBV DNA 461634 IU/mL, negative
HDV Ab, negative HCV Ab. The treatment was complex: Ampicillin,Cefort, Arginine-Sorbitol, Aspatofort, Hepa-Merz, Ursofalk, Bilichol,
phenobarbital, hydrocortisone hemisuccinate, Omeprazole, KCl, Vitamin
B6, calcium gluconate, plasma, glucose 10 %, sodium chloride 0.9 %,
etc. After 20 days of hospitalization, the clinical and biological evolution
was favorable (TB 16.04 mg/dL, TGP 120 U/L, PT 14.5 sec (55.5 %), total
protein 6.6 g/dL, K 4.1 mmol/L), the patient is cooperative, he is fed
orally, without nausea or vomiting, without bleeding, and the jaundice
is in remission. We note that we made a switch of the antiretroviral
therapy using emtricitabine (200 mg/day), Tenofovir (245 mg/day)
Raltegravir (400 mg, 2x1 tablets/day).
Conclusions
An early diagnosis, associated with specific therapy and rigorous moni-
toring of clinical and biological data, can contribute to a favorable evo-
lution in patients with HIV-HBV coinfection and acute liver failure.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
A48
Lifestyle impact on HIV management
Nurcan Baydaroglu1, Alina Cristina Neguț1,2, Oana Săndulescu1,2, Daniela
Manolache2, Gabriela Ceapraga2, Monica Andreea Stoica2, Anca Streinu-
Cercel1,2, Adrian Streinu-Cercel1,2
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
2National Institute for Infectious Diseases “Prof. Dr. Matei Balș”, Bucharest,
Romania
Correspondence: Nurcan Baydaroglu (nurcanbb@hotmail.de)
BMC Infectious Diseases 2016, 16(Suppl 4):A48
Background
Introduction of highly active antiretroviral therapy moved the step for-
ward in HIV infection, reducing the mortality caused by opportunistic
infections and making the disease a manageable chronic condition.
Methods
We have performed a cross-sectional study on 119 consenting HIV-
infected patients from the National Institute for Infectious Diseases
“Prof. Dr. Matei Balș”, Bucharest, in the time span 2014–2015, to assess
their medical history, lipid profile, CD4 cell count, viral load, and lifestyle
habits.
Results
In our study group, the male:female ratio was almost 2:1. The median
(interquartile range) age was 35 (26, 44) years and the mean ± stand-
ard deviation body mass index (BMI) was 23.65 ± 3.97 kg/sqm. A total
of 42 (37 %) patients were overweight/obese. Almost all our patients
were on antiretroviral therapy (115/119) and 69 (73 %) patients had
comorbidities. The median recent CD4 cell count was 518.00 (305.50,
745.50) cells/mL. Regarding risk factors: most of our patients (70 %)
were not consuming alcohol; almost half of our patients (45 %) were
smokers. Most of the patients were performing moderate (39 %) or
intense (36 %) physical activity. The BMI was influenced by lipid pro-
file, a higher proportion of overweight/obese patients were identified
in the group of patients with high triglycerides levels or high LDL
level compared with the group with normal values (p = 0.0002, p =
0.013). We also observed that triglycerides and cholesterol were not in-
fluenced by alcohol consumption (p = 0.617, p = 0.802) or by smoking
(p = 0.317, p = 0.275). Heavy drinking may have a negative impact on
glycemia levels, becoming a risk factor for diabetes – in our study there
was a higher percentage of alcohol users in the group of patients with
high glycemia (p = 0.041). Smoking was not associated with hydroxy-
vitamin D concentration (p = 0.568) or parathyroid hormone value (p =
0.944), but smoking was identified as a risk factor for femoral osteope-
nia (p = 0.013). Physical activity was not associated with HIV status; the
proportion of patients performing intense physical activity was similar
in the group of patients with recent CD4 cell count less than 200 cells/
cmm compared with the group of patients with recent CD4 cell count
higher than 500 cells/cmm (p = 0.802).
Conclusions
Considering the duration of HIV infection a risk factor for complications
due to chronic inflammation, the modifiable risk factor (smoking,
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 50 of 76alcohol consumption, sedentariness) should be avoided for a better
quality of life.
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Background
Women at childbearing age with HIV infection want to procreate,
their management represents a challenge for the infectious disease
doctor.
Methods
We studied retrospectively the observation charts of HIV positive pa-
tients, who were under observation in the Regional HIV/AIDS Center
Iași, in the period January 2012-June 2016.
Results
Iași Regional Center follows 1475 patients that are HIV infected, of
which 676 women, that represents a percentage of 45.83 % of the
total. A number of 623 represents women at childbearing age (13–49
years), which represents 92.16 % of all HIV positive women. In the
mentioned period, 133 women gave birth, representing 21.35 %
of all women with HIV infection at childbearing age. Counties dis-
tribution showed a higher incidence in Bacău, namely 21.81 %
(39 newborn) and the year with most births occurred in 2013
with 33 newborn (24.81 %). 79.7 % of patients received treatment
with KLT + CVB, 10 women were detected with HIV infection at
birth. 94 % of children were born by Caesarian section. During
these years, there have been two deaths in children, one of
whom died 10 days after birth and another was stillborn. All
newborns received prophylaxis for 6 weeks, in one case prophy-
laxis was interrupted for a month. Three of the children were de-
clared HIV positive at 18 months.
Conclusions
The correct tracking and teamwork (infection disease doctor, social
worker, psychologist) made the number of HIV positive patients who
gave birth to HIV negative children to be significantly high, due to a
good adherence and compliance to ARV therapy.
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Two of the foremost neurological impairments developed by HIV late
presenters consist of progressive multifocal leukoencephalopathy
(PML) and HIV encephalopathy (HIVE). PML is a viral opportunistic
pathology, associated almost exclusively with the HIV infection. HIVE
is a not-opportunistic disease, directly mediated by HIV.
Diagnosing PML and HIVE represents a challenge for physicians, taking
into consideration the myriad of variables, the associated conditions
that could be brought about by the HIV infection and the advent of
new tools that could be successfully used in order to provide a
diagnosis.
Methods
Observational and cross-sectional study consisting of 15 HIV-infected
patients treated at the National Institute for Infectious Diseases “Prof.
Matei Balș”, with exitus due HIV-associated complications, which
were subject to brain necropsies. Brain tissue samples were analyzed
by pathologists from the Colentina Clinical Hospital in Bucharest.
We have compared the pathological diagnoses with their correspond-
ing clinical ones, enforced by clinical presentation, laboratory and
medical imaging data, collected from archived medical records. The
end-point was identifying the superposition of clinical and patho-
logical diagnoses.
Results
Four PML pathologic diagnoses were issued, three of them as con-
firmation to their respective three clinical suppositions and one with-
out a corresponding clinical diagnosis. PML was also suspected in a
patient that lacked relevant pathologic evidence for its confirmation.
However, the patient proved to be suffering from cerebral cryptococ-
cosis. In the case of two patients, PML was the sole pathologic diag-
nosis, whereas the rest of them exhibited PML accompanied by HIV
encephalopathy. There were also three clinical diagnoses that were
speculated, alongside PML, all of them being refuted by the post-
mortem examination: cerebral hemorrhage, cerebral toxoplasmosis
and lymphoma.
Four HIVE pathologic diagnoses were issued, with no correlation with
the clinical suppositions inferred in regard to the concerned patients.
These pathological diagnoses were associated with ischemic stroke,
PML, cerebral hemorrhage, lymphoma or toxoplasmosis. HIVE was
clinically suspected in six patients, but all of them were proved to be
affected by other disorders, such as meningoencephalithis, hyperemia
and cerebral edema, PML or pons/cerebellar decrepitude. In all, there
were no confirmed cases of HIV encephalopathy.
Conclusions
The superposition of PML clinical and pathological diagnoses was 3/5
(60 %) and there were no pathologically confirmed cases of HIVE,
with elevated levels of over- and under- diagnosis. Thus, the observed
lack of correlation calls into better understanding of both illnesses. In
the extended presentation we provided an up to date diagnosis
algorithm for both.
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Background
Released in 2014, UNAIDS’s Fast Track-Ending the AIDS Epidemic by
2030 sets certain targets, which in Romania can be achieved through
close monitoring of perinatal HIV. Hence, the national antenatal HIV
screening process has revealed an increase in the number of HIV in-
fected women – intravenous drug users (IDUs) since 2011, due to con-
sumption of synthetic cannabinoids and cathinones (the so called “legal
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 51 of 76highs”). Moreover, the percentage of new IDU/HIV cases increased from
2.8 % in 2010 to 20 % in 2015, the highest number of consumers living
in or around Bucharest.
Methods
Between January 2012 and June 2016, the Pediatric Immunosuppression
Unit of the National Institute for Infectious Diseases “Prof. Dr. Matei Balș”
surveyed 421 HIV-exposed newborns. 14.7 % (62/421) were perinatally
exposed to “new drugs” consumed by their mothers. However, at the
end of 2015 the rate of HIV mother-to-child transmission in Romania
remained stable-below 2.3 %. The following parameters were evaluated
for mothers: time of HIV screening, time of HIV diagnosis, age, prenatal
care, time when taken into the active surveillance program, treatment/
prophylaxis, type of birth, drugs taken and screening for co-infections
(HBV, HCV, STIs). The parameters of interest for children were: sex, age,
time of diagnosis, ART prophylaxis, type of birth, type of feeding, neuro-
logical assessment, CD4 count, HIV-RNA, ultrasound evaluation.
Results
During the 4 year monitoring period, the following results of HIV time
of detection in IDU/HIV mothers were obtained: 40 % (25/62 mothers
tested) were found with HIV before pregnancy, 11.2 % (7/62) during
pregnancy, 41 % (26/62) during delivery and 6.4 % (4/62) in the first
24 hours after birth. Although all newborns perinatally exposed to
HIV/IDU benefitted from post-partum prophylaxis and received arti-
ficial nutrition, 14.5 % (9/62) exposed to drug use were HIV infected. All
children had poor neonatal adaption, mainly a severe withdrawal syn-
drome - 57 % (40/62) of newborns monitored and more than 50 % had
neurological lesions.
Conclusions
The majority of pregnant women with HIV-consumers of drugs (espe-
cially “new drugs”) have little access to antenatal care, which leads to
late discovery of HIV. The use of synthetic cannabinoids and cathinones
by HIV pregnant women has important effects on newborns and their
subsequent development which poses a challenge for the post-partum
surveillance system. These women come from poor families who don’t
ensure them a proper support. Furthermore, due to issues associated to
risky behavior it is difficult to include them in HIV screening or preven-
tion programmes, which need to be adapted to their needs.
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Background
In our country, the prevalence of HIV with hepatitis B virus (HBV) co-
infection in young HIV positive patients was high, about 40 %. Meas-
urement of liver fibrosis using (as a noninvasive method) transient
elastography (TE) in HIV patients can be used as a tool to determine
and monitor hepatic diseases. We evaluated the ability of APRI and
FIB-4 score to differentiate between the different stages of fibrosis
(no fibrosis/minimal fibrosis = F0-1 and F2-4 =moderate-severe fibrosis/
cirrhosis), taking as a reference, in the absence of liver biopsy, hepatic
fibrosis stratification by Fibroscan.
Methods
We studied a group of patients infected with HIV (110) and 64.5 % of
these are co-infected HIV/HBV. We determined the cut-off values for
APRI and FIB-4 that identify significant fibrosis with maximum specifi-
city by AUROC for each group. Kappa score was then calculated for
the concordance between methods.
Results
For HIV/HBV co-infected patients, to identify significant fibrosis com-
paring APRI versus Fibroscan the Kappa score = 0.494, 95 % CI (0.245,0.742) on the identification of fibrosis (F0-1 to F ≥ 2); for FIB-4 versus
Fibroscan the Kappa score = 0.481, 95 % CI (0.238, 0.725) for both the
moderate concordance. Regarding the comparison of the two methods
APRI and FIB-4, Kappa score = 0.698, 95 % CI (0.485, 0.910), concord-
ance significant. For patients with HIV, to identify significant fibrosis by
APRI versus Fibroscan Kappa = 0.217, 95 % CI (−0.424, 0.858) on the
identification of fibrosis (F0-1 to F ≥ 2), for the FIB-4 Kappa = 0.164,
95 % CI (−0.451, 0.779) for both the correlation is reduced. Regarding
the comparison of the two methods APRI and FIB-4 Kappa = 0.217,
95 % CI (−0.424, 0.858), which confirms the low correlation.
Conclusions
There is some evidence that the tests used: APRI and FIB-4 have the
ability to distinguish for both groups of patients (HIV and HIV/HBV) be-
tween the two classes of fibrosis (F0-1 to F ≥ 2), patients with and
without advanced liver disease. Although in patients with HIV infection
a low concordance was seen between non-invasive methods for the
diagnosis of fibrosis, in co-infected patients it was moderate and these
tests could be used as evaluation methods in their monitoring of liver
injury especially when the results of these tests are concordant.
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Background
Highly active antiretroviral therapy (HAART) represents the corner-
stone in the management of HIV-infected patients, its main goal –
immune restoration, rapidly achieved and maintained undetectable
HIV-RNA viral load.
Methods
We performed a retrospective descriptive study including the HIV-
infected patients in care in Mureș county. We selected all patients
who achieved rapid and long-lasting undetectable HIV-RNA plasma
viral load (36 months). We collected data regarding demographic fea-
tures, route of transmission and duration of HIV infection, nadir CD4+
T-cells count, maximum HIV-RNA plasma viral load.
Results
Out of all 200 HIV-infected patients from Mureș county in care in the
Clinic of Infectious Diseases I, County Clinical Hospital Mureș, under
HAART at present time, 78 (39 %) have had undetectable viral loads
for the past 36 months. 57.69 % are male patients, 42.31 % female.
Most of them (72 %) are part of the Romanian cohort, while 28 %
have acquired the infection via sexual route. The average length of
HIV-infection history was 12 years, with a maximum of 26 years. Nadir
CD4+ T-lymphocytes count registered an average of 248 cells/μL, while
the highest HIV-RNA plasma viral load had an average level of 295094
copies/mL. The most recent CD4+ T-cells count average is 661 cells/μL.
All patients had good adherence to HAART regimen.
Conclusions
Combined antiretroviral therapy leads to good results, with im-
munologic and virologic success and provided a good compliance
and correct administration.
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Lipopolysaccharide (LPS), a heteropolymer synthesized by Gram
negative bacilli is considered a marker of microbial translocation and
immune activation in HIV infected patients. Nevertheless, low LPS
serum levels were not always correlated with a favorable clinical out-
come. Our study explores the serum LPS level correlation with viro-
logical and immunological markers, treatment adherence and clinical
evolution in HIV-infected patients.
Methods
We performed a prospective study between 2011–2016 on 44 patients
admitted to “Matei Balș” National Institute for Infectious Diseases, of
which 34 HIV infected patients (14 women, 20 males aged between
16–64 years) and 10 controls. Thirty-two of the HIV-infected patients
had been following antiretroviral treatment for at least 6 months
and 23 were considered adherent to treatment; two patients re-
fused the treatment. The serum LPS level (Endoblock ELISA test kit),
CD4 T lymphocyte count (flowcytometry) and the patients’ HIV RNA
(Real Time PCR) viral load were assessed. The patients were classified
depending on their HIV RNA viral load (responder/nondetectable RNA
HIV versus nonresponder/detectable RNA HIV), the CD4 T cell count
(CD4-T cell below or above 200 cell/cmm), clinical outcome (favorable
or unfavorable due to opportunistic infections and malignancies over
the next 2 years) and length of previous antiretroviral treatment
(<5 years or > 5 years). We compare the serum level of LPS between
the different groups of HIV infected patients and between the HIV-
infected patients and healthy controls. Statistical analysis was per-
formed using Student’s T test, Mann–Whitney analysis and Pearson’s
correlation.
Results
The level of LPS was not correlated with the CD4 T lymphocyte count
(p = 0.814), virologic response (p = 0.744), clinical outcome (p = 0.210)
or therapeutic adherence (p = 0.692). Nevertheless the serum level of
LPS was significantly higher in HIV-infected patients (71.34 ± 67.48 pg/mL
compared with 13.52 ± 16.87 pg/mL, p value <0.001).
Conclusions
HIV infected patients display significantly higher values of LPS irrespect-
ive of the length of treatment or clinical outcome. Although LPS levels
were not correlated with immunologic or virologic parameters it is pos-
sible that dynamic measurements could help ascertain the role of LPS
in the clinical evolution of these patients.
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Background
Cathelicidin LL37 is a human immunomodulatory peptide synthe-
sized in monocytes/macrophages through T-cell secreted IFN ɣ in-
duction, following the activation of vitamin D receptors. LL37 was
also detected in the biliary and liver endothelium and recent studies
indicate a direct antiviral effect against HCV in cell cultures but its
role in liver inflammation remains unknown.
Methods
We performed a prospective study on 27 patients (17 women, 10 men,
aged 22–71 years) with HCV infection and 6 controls hospitalized in the
National Institute for Infectious Diseases “Prof. Dr. Matei Balș” Bucharest,
Romania. Of the 27 patients, 15 had recently received treatment with
peginterferon and ribarivin and showed negative RNA HCV viral loads,
2 patients were cured following acute HCV infection and 10 were un-
treated (positive RNA HCV viral loads). The study recorded the serum
level of LL37 (Elisa Hycult Biotech) and IFN ɣ (Elisa, Bioo Scientific)
along with liver injury markers: alanine aminotransferase (ALT), as-
partate aminotransferase (AST), alkaline phosphatase (ALP), gamma-
glutamyl transferase (GGT), bilirubin (Bil) and CD4 and CD8 T cell
lymphocyte count (flowcytometry).Results
The mean level of serum LL37 in all HCV patients was lower than
controls 48.75 (±19.02) ng/mL versus 80.98 (±82.78) ng/mL but the
difference was not statistically significant (p = 0.435). The mean value
of IFNɣ was also only numerically higher in HCV infected patients
604.94 (±1532.17) pg/mL than controls 235 (±131.77) pg/mL, p = 0.6.
The level of LL37 exhibited a moderate positive correlation with IFN ɣ
(r = 0.571) as well as a mild positive correlation between LL37 and ALT
(r = 0.404). No statistically significant correlations of LL37 serum concen-
trations were found when compared with other biological parameters
and virologic response.
Conclusions
The positive correlation between the serum level of LL37 and IFN ɣ
or LL37 and ALT suggests a possible implication of this peptide in
liver injury in HCV patients. Further studies are needed to translate
the results from in vitro studies on LL37 into the clinical practice.A56
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Background
Pulmonary tuberculosis is one of the most important opportunistic
infections in patients with HIV/AIDS, which frequently associates with
difficulties regarding the clinical and therapeutic supervision of pa-
tients. The purpose of this paper is to present a clinical case of a patient
with C3 stage HIV/AIDS infection, non-complaint with antiretroviral
therapy, precociously diagnosed with pulmonary tuberculosis, pneumo-
nia with Pseudomonas spp., candidiasis of the digestive system and
toxoplasmosis.
Case report
The authors present the case of a 29 year old patient diagnosed with
HIV infection 5 years ago, for which he refused antiretroviral medica-
tion. The patient is admitted into our clinic presenting fever, chills,
dysphagia, dysphonia, cough with mucopurulent sputum, vomiting,
epigastralgia, cephalalgia, cachexia, the onset and duration of the
symptomatology being of approximately two weeks. The physical
examination upon admission revealed paleness of the skin and
mucous membranes, dry lips, white coating of the tongue, stoma-
titis, asthenic thorax, bilaterally harsh vesicular murmur, BP 125/
79 mmHg, pulse 106, oxygen saturation 99 % on room air, awake,
alert and fully oriented, no clinical signs of meningeal irritation.
Biological samples were collected for the confirmation of the diag-
nosis (RBC and WBC count, GOT, GPT, alkaline phosphatase, serum
urea and creatinine, C-reactive protein, blood cultures, CD4, viral
load, Toxoplasma IgM antibodies, GeneExpert specimen BK, copro-
culture, sputum culture, etc). A pulmonary X-ray and a CT scan of
the thorax were also performed. Results of the lab tests included:
WBC 3380/μL, RBC 3500000/μL, Hemoglobin 10.4 g/dL, HCT 29.6 %,
ESR 90 mm/1 h, GOT 60.8 U/L, GPT 67.8 U/L, GGT 153.4 U/L, ALP
112.7 U/L, CRP 205.33 mg/L, CD4 25 cells/μL, VL 871475 copies/mL,
positive IgM Ab for Toxoplasma, sputum culture Pseudomonas spp.
80 %, Candida yeasts 20 %, coproculture Candida 30 CFUs/mL, urine
culture candida 40.000 CFUs/mL, GeneExpert positive BK, negative
BK culture, thorax CT scan condensation process in the right inferior
lobe. The following therapeutic regimen was established: Sumetro-
lim 2x2 tablets/day, Levofloxacin 500 mg/day and Gentamicin 3x80
mg/day according to the antibiogram, Fluconazole 400 mg/day,
Dexamethasone 3x8 mg/day, tuberculostatics (Isoniazid 300 mg/day, Ri-
fampicin 600 mg/day, Pyrazinamide 1.5 g/day, Ethambutol 1.6 g/day),
ARVs (Combivir, Invirase, Norvir), antipyretics, mucolytics, hydroelectro-
lytic rebalancing fluids, with slow favorable evolution. After a period of
one year, the patient discontinues the ARV medication and dies.
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Modern molecular biology techniques (GeneExpert) offer the possibility
of early pulmonary tuberculosis diagnosis and subsequent treatment in
patients with HIV/AIDS. However, the advanced immunosuppression,
together with non-compliance to treatment may associate an unfavor-
able evolution.
Consent
Written informed consent was obtained from the next of kin for publi-
cation of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
The introduction of new antiretroviral drugs in therapeutic practice has
led to changing antiretroviral regimens recommended for naϊve pa-
tients with HIV infection. We aimed to identify the main therapeutic
changes in naϊve patients diagnosed with HIV infection in 2016 at the
National Institute for Infectious Diseases “Prof. Dr. Matei Balș”.
Methods
Retrospective analysis of demographic and therapeutic character-
istics in patients diagnosed with HIV infection in the period 1
January to 30 June 2016. The data obtained were compared with
data of patients diagnosed with HIV infection in 2012–2013. It
aimed to identify statistically significant changes (p<0.05) using
Epi Info version 7.2.
Results
In the analyzed period, 111 adults were confirmed with HIV infection
compared to 499 patients in 2012–2013. Antiretroviral treatment was
administered to 84 patients (75.68 %) vs 243 (48.69 %) in the control
group; p<0.05 (CI 95: 1.353–1.785). The mean age of patients was
36.38 years (18–78) vs 33.39 years (16–72) in the control group. Males
accounted for 79.28 % (69/84 patients) vs 62.26 % (161/243 patients)
in the control group. Treatment was initiated with the following
scheme:
– 2 NRTIs + NNRTI: 12/84 patients (10.81 %) vs 85/243 (34.98 %);
p<0.05 (CI 95: 0.2354 – 0.7087),
– 2 NRTIs + PIs/r: 47/84 patients (42.34 %) vs 139/243 (57.20 %),
– 2 NRTIs + integrase inhibitors: 20/84 patients (18.02 %) vs 18/243
(7.41 %); p<0.05 (CI 95: 1.788 – 5.778)
– other schemes: 5/84 patients (4.50 %) vs 1/243 (0.41 %).
At initiation of the treatment the mean value of CD4 was similar
(260 cells/cmm) and the proportion of patients with CD4 counts
below 200 cells/cmm was 48.15 % (13/84) vs 45.27 % (110/243). Mean
viral load was much smaller (152 391 c/mL vs 543 518 c/mL) in the
group analyzed.
Conclusions
The main changes identified in patients newly diagnosed with HIV
infection in the first 6 months of 2016 were: significantly higher
percentage of those receiving antiretroviral treatment [75.68 % vs
48.69 %; p<0.05 (CI 95: 1.353 – 1.785)], a significant decrease in
the weight of schemes with NNRTIs (10.81 % vs 7.41 %) and a sig-
nificantly increase of the weight of schemes with integrase inhibi-
tors (18.02 % vs 7.41 %). The percentage of schemes with PIs/r
remained constant, these schemes being preferred in our Insti-
tute. Detection of new cases in the early stages of HIV infection is
still delayed; 48.15 % of our patients had a CD4 count below 200
cells/cmm.A58
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Background
Systemic infections are commonly encountered disorders in HIV-infected
patients and they influence their risk of death. We aimed to analyze the
risk factors associated with unfavorable evolution in these patients.
Methods
Retrospective analysis of demographic, clinical course and treatment
characteristics in patients with HIV infection hospitalized at “Prof. Dr.
Matei Balș” Institute in the period 1 January to 31 December 2015
which had positive blood cultures during hospitalization. We watched
accurate risk factors associated with death by identifying statistically
significant difference (p<0.05) using Epi Info version 7.2.
Results
In the analyzed period 62 patients were identified with HIV infection
hospitalized who had positive blood cultures during hospitalization;
11 of them have died and 51 have evolved favorably. The average age
of the deceased patients was 36.7 years vs. 33.8 years (p<0.05) and the
percentage of males was higher in both groups (90.9 % vs. 74.5 %). The
acute episode appeared on average after 4.2 years after the detection
of HIV infection in those who died vs. 2.8 years (p<0.05). Only 3/11 pa-
tients (27.3 %) received antiretroviral (ARV) treatment in history vs. 23/
51 (45.1 %). The following entry gates were identified: respiratory
(63.6 % vs. 15.7 %), skin (18.2 % vs. 37.3 %), digestive (9.1 % vs. 15.7 %),
urinary (0 vs. 3.9 %), catheter IV (0 vs. 3.9 %), unspecified (9.1 % vs.
23.5 %). Only respiratory entry gate was significantly associated with
risk of death (p<0.05; CI 95: 1.86–8.82). No significant differences were
identified in terms of weight isolated microorganisms (AFB: 38.5 % vs.
16.9 %; GPC: 38.5 % vs. 47.5 %; GPB: 0 vs. 3.4 %; GNB: 7.7 % vs. 28.8 %
and fungi: 15.4 % vs. 3.4 %. 6/13 microorganisms had resistance mech-
anisms to classical antibiotics and antifungals (46.2 %) vs. 19/59
(32.2 %). The average level of CD4 count was significantly lower in the
group of HIV deceased (16 cells/cmm vs. 134 cells/cmm; p<0.05), the
mean HIV-RNA was significantly lower (299 038 c/mL vs. 844 871 c/mL;
p<0.05) and average value of procalcitonin was higher (69.81 pg/mL vs.
19.93 pg/mL). The average length of hospitalization was significantly
lower in those who died (11 vs. 20.5 days).
Conclusions
Risk factors associated with death in HIV-infected patients with posi-
tive blood cultures were: older age of the patient, longer duration of
evolution of HIV uncontrolled infection, respiratory entry gate of sys-
temic infection, severe immunosuppression (CD4 count below 50
cells/cmm) and short duration of hospitalization.
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Objectives: Analysis of epidemiological aspects of HIV infection.
Methods
A retrospective study, between 01/01/2007-31/12/2015, in the Craiova
Regional Center (CRC), Romania, on two lots of HIV infected persons
(HIP): group A-153 HIP, new cases, diagnosed in 01/01/2010-31/12/
2015 period and group B-113 HIP, new cases, diagnosed in 01/01/2007-
31/12/2009 period.
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Demographics: group A-F/M = 46 (30.06 %)/107 (69.94 %) vs group B-
F/M = 61/52(53.99 %/46.01 %); p = 0.0001. Chronological distribution
of new cases show a top of incidence in 2008 (46 cases-40.71 %) and
in 2015 (46 cases-30.07 %). The main mode of transmission was
sexual-group A vs group B (89.55 % vs 50.44 %); p = 0.0001. Children
born from HIV infected mothers were: group A vs group B-5 (3.26 %)
vs 2 (1.76 %). Viral-immune status, at the time of HIV diagnosis, was:
group A vs group B-average of lymphocytes CD4 = 311.147 ± 97.52
cells/cmm vs 209.22 ± 63.58 (p < 0.0001) and an average of viremia
HIV = 5.29 log copies/mL vs 5.12 log copies/mL (p < 0.0001). The most
frequent opportunistic infection was tuberculosis-34 HIP (22.22 %) in
group A vs 31 HIP (27.43 %) in group B. Cases of HIP late presenters,
were: group A vs group B-78 HIP (50.98 %) vs 67 HIP (52.92 %); p = 0.29.
In the first 6 months from HIV diagnosis, 15 HIP (9.81 %) from group A
vs 14 HIP (12.38 %) from group B, died; p = 0.55.
Conclusions
In Oltenia region, new cases of HIV infection were most frequently in
men and the predominant mode of transmission was heterosexual;
HIP late presenters were present in two groups of patients. Tuberculosis
is a major cause of morbi-mortality.
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Background
The HIV epidemic in Romania is increasingly driven in the last years
by intravenous drug users (IDUs) and men having sex with men (MSM).
This study compared sex and injection risk behaviors among male and
female IDUs admitted in MMT in our center.
Methods
From July 2015 through June 2016, all new patients admitted in MMT
(136) were asked to complete a questionnaire regarding HIV risk
behaviors and were then tested for HIV, HCV and HBV.
Results
24 % of the sample were female and were more likely to be in a stable
relationship 49 %, than men 34 %. There were no significant differences
between the ages of females vs. males, with the average age being
about 34.5 years old. Males reported more daily median injecting than
females in the 30 days prior to entering treatment (5 vs. 3) and also re-
port having more STD (38 % vs. 31 %). Females had higher HIV-positive
serology results than males (36 % vs. 31 %). On HIV risk, females re-
ported using a common container (55 % vs. 46 %) more frequently.
Although male participants reported more sex with multiple partners
(23 % vs. 17 %), females reported significantly more sex without a con-
dom (63 % vs. 47 %) and more sex with an IDU partner (65 % vs. 42 %).
Conclusions
There is a high risk behavior and HIV prevalence among IDUs. Thus
there is a need for rapid introduction of interventions to address this
problem.
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Psoriasis represents a chronic, immune-mediated skin condition with
genetic backgrounds characterized by sharply defined erythematous,
scaly plaques with limited or extensive involvement. However, there
is a challenge when the patient presents with other diseases and
treatment must be adapted carefully, especially when dealing with a
patient that has both HIV infection and hepatitis C virus.
Case report
Herein we describe a case of a 35-year-old Caucasian male, with a
personal history of psoriasis vulgaris with the onset at the age of 20.
The patient received treatment with fumaric acid esters for 4 weeks
in Germany, with a favorable clinical response, but due to financial is-
sues the treatment was discontinued.
He was admitted to our dermatology department for the assessment
of a generalized skin eruption involving the trunk, buttocks, arms, feet
and the scalp, characterized by pruritic, sharply demarcated erythema-
tous plaques, covered by silvery scale with a tendency to develop
erythoderma and inverse psoriasis. The fingernails were affected and
also the distal interphalangeal joints.
The patient was also tested for HIV, viral hepatitis and syphilis. The
results showed the presence of HIV infection and hepatitis C. As far
as treatment was concerned during the hospitalization, topical therapy
was applied including emollients, keratolytics and potent corticoids
with a good clinical outcome.
Due to the laboratory findings, the patient was referred to the infec-
tious disease specialist in order to continue the investigations and start
treating the HIV infection and viral hepatitis C. Moderate to severe
cases can be treated with topical therapy, phototherapy as a first line
and as a second line oral retinoids can be an option with careful moni-
toring for potential adverse events. More refractory and severe disease
can be treated with TNF-alpha inhibitors. The positive role of the highly
active antiretroviral therapy was observed because it led to the im-
provement of the psoriasis in our patient too.
Conclusions
HIV associated psoriasis is often refractory to traditional therapies, but
when the patient has also hepatitis C virus, treatment is even more
challenging as it requires careful consideration. The particularity of this
case is represented by the fact that the patient was not tested for HIV
infection before being treated with fumaric acid esters. The generalized
psoriasis eruption in a young patient should lead to more investiga-
tions including HIV testing.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
HIV infection - immune activation,
aging with HIV
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Background
The authors focused on the characterization of the humoral immune
profile developed against gangliosides in asymptomatic HIV-infected
patients. Host immune response to the viral infection might be influ-
enced by these antibodies.
Methods
We investigated 32 asymptomatic HIV-infected patients (with no treat-
ment, without neurologic manifestations) and 32 non-HIV-infected
volunteers. The determination of antiganglioside antibodies of IgM
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was performed by immunoblot technique, using EUROLine kits. The
evaluation of the results was realized using EUROLine scan software.
After reading the signal intensity on the strips marked with ganglioside
antigens, the interpretation of the results was made. A cut-off value
equal to 10 was established (according to manufacturer’s instructions).
The results were considered positive at values of the signal intensity
greater than 10, and negative at values lower than 10.
Results
Antiganglioside autoantibodies identified in asymptomatic HIV-infected
patients and in the control group exhibit different serologic profiles. In
HIV infected patients the prevalence of autoantibodies of IgM type
against gangliosides was as follows: 28.12 % anti-GM1, 6.25 %
anti-GM2, 9.37 % anti-GM3, 6.25 % anti-GD1a, 3.12 % anti-GD1b,
0 % anti-GT1b, 3.12 % anti-GQ1b. In the control group antiganglioside
antibodies of IgM type were absent.
Conclusions
The authors consider that gangliosides expressed on the membrane
of the HIV-infected cells might induce the synthesis of antiganglioside
antibodies. The presence of anti-ganglioside antibodies seems to be a
primary immunological event in HIV infection and might play a physio-
pathological role in the studied viral infection. The ability of the host to
produce an early antigangliosidic response might be seen as a defense
mechanism directed to the elimination of a danger signal.
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Background
Since its discovery in 1983, HIV-1 has become the most extensively
studied pathogen in history. Antiretroviral therapy has markedly im-
proved the quality and the lifespan of people living with HIV. Despite
achieving viral suppression many of the HIV infected patients may
still harbor persistent low levels of inflammation that may contribute
to premature aging and cardiovascular comorbidities. Our objective
was to evaluate subclinical chronic inflammation in a cohort of per-
sons living with HIV who were undergoing ART, based on persistent
viral replication.
Methods
We performed a cross-sectional study in a cohort of Caucasian HIV-1
patients attending the National Institute for Infectious Diseases
“Prof. Dr. Matei Balș”, Bucharest, Romania. All included patients
were under ART for at least 6 months. Blood samples were tested
for: HIV viral load, CD4 cells count, C-reactive protein (CRP), tumor
necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) levels in all
patients. We evaluated inflammatory markers comparatively between
two groups: undetectable patients (with HIV viral loads below the level
of detection – group 1) and HIV patients with persistent replication
(group 2). Independent samples T-test and Mann–Whitney–Wilcoxon
test were used for assessing statistical differences between groups.
Results
Sixty patients with a mean age of 33.2 (±13.7 years) were included
in the study – 60 % were males. The mean time on ART was 80
(±47.8 months). Most patients (71.7 %) had serum HIV loads below
the limit of detection (group 1). Mean CD4 counts were 522 (±272.9
cells/cmm) for the entire cohort and 565.4 (±268.3 cells/cmm) in
group 1 and 414.2 (±261.2 cells/cmm) in group 2. Median CRP values
were 1.79 (IQR = 4.6) mg/L in group 1, compared to 2.57 (IQR = 7.6)
mg/L in patients with detectable viremia (without statistical significance,
p = 0.92). Mean IL-6 values were 37.2 (±60.7) pg/mL for group 1 vs 66(±15.5) pg/mL in group 2 (with the level of statistical significance close
to the cut-off value, p = 0.06). TNF-alpha mean values were 20 (±14.4)
pg/mL in detectable patients (group 2) compared to 16.6 (±17.5) pg/mL
in group 2 (p = 0.48).
Conclusions
In our cohort undergoing ART we noted similar levels of CRP and
TNF-alpha for patients with persistent viral replication and undetect-
able viremia. The levels of IL-6 seemed to be higher in the group
with detectable viremia.Pathogenesis of viral infections
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Background
Guillain-Barré syndrome, is an acute inflammatory demyelinating poly-
neuropathy triggered by an acute infectious process. Etiopathogeneti-
cally, the condition usually follows a viral infection (cytomegalovirus,
Epstein-Barr virus, Varicella-Zoster, herpes). We present a case of acute
polyradiculoneuritis, manifested by a pathological picture installed in
the evolution of acute varicella (Guillain-Barré syndrome) to an im-
munocompetent patient.
Case report
The authors present the case of a patient aged 37 years with chickenpox,
hospitalized in the Clinic of Infectious Diseases “Victor Babeș” Hospital Ti-
mișoara, who developed acute tetraparesis and polyradiculoneuritis.
Symptoms started two days before admission featuring high fever,
malaise and the appearance on the trunk, limbs and face of itchy
small blisters “in the drop of dew”, cardio-pulmonary balanced, con-
scious, with no signs of meningeal irritation. At about 3 weeks of
hospitalization the patient presents tetraparetic motor deficit type
accompanied by tingling in the limbs, progressive, and is transferred to
the Neurology Clinic in the Emergency County Hospital Timișoara. On
the day of admission in Neurology, the patient's condition worsens,
becomes dyspneic, which is why they decide to transfer her at the
Intensive Care Unit where she underwent oro-tracheal intubation
with mechanical ventilation. In the intensive care unit, the patient
received treatment with immunoglobulin (Octagam 5 fl/day for 5 days),
with no significant improvement, then they have done seven sessions
of plasmapheresis. Treatment was established with antibiotics, gastric
antisecretory, anticoagulants, analgesics, opioids, antipyretics, cortico-
steroids, vitamins, blood products, solutions and calorie electrolytic
rebalancing.
On admission in Neurology biological investigations were carried out,
which did not show anything pathological and lumbar puncture was
performed (WBC 0/mL, RBC 0/mL, protein 0.54 g/L). Skull and cervical
spine MRI did not show anything pathological. Chest radiography
highlighted a discrete decrease in transparency in the basal right
lung. The result of catheter tip culture showed Proteus mirabilis and
bronchial aspirate culture was positive for Klebsiella pneumoniae.
Antibiotic sensitivity was determined and the patient had a favorable
evolution.
Conclusions
Biological rigorous clinical monitoring, along with an effective inter-
disciplinary collaboration in chickenpox cases with neurological com-
plications may favorably influence the evolution of the patients.
Consent
Written informed consent was obtained from the patient for publi-
cation of this Case report and any accompanying images. A copy of
the written consent is available for review by the Editor of this
journal.
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Background
Almost 80 % of the individuals present asymptomatic enterovirus infec-
tion with one of the 71 known serotypes. A small percentage of the pa-
tients may experience a self-limited non-specific rash along with flu-like
symptoms, clinically indistinguishable from other viral infections. Rarely,
enteroviruses can be held responsible for severe manifestations such as
acute aseptic meningitis, encephalitis, hepatic, pulmonary or cardiac
complications.
Case report
A 39 year-old man, smoker, with no relevant medical history presented
to the hospital for fever (39 °C), chills, dry cough and intense myalgia
that persisted after 7-day amoxicillin self-medication. The clinical exam
revealed high fever, dyspnea on mild exertion and tachycardia. The lab
tests showed intense acute inflammatory syndrome, leukocytosis with
lymphocytosis, normochromic-normocytic anemia, moderate cytolysis,
high value of N-terminal pro-brain natriuretic peptide (NT-proBNP)
(3161 pg/mL) and high antibody titer for Echovirus 30. A chest X-ray
showed lesions suggestive for right medial lobe pneumonia, while the
cardiology consult with echocardiography diagnosed myocarditis and
pericarditis, with an ejection fraction of 40 %. Given the critical state of
the patient a bronchoscopy could not be performed at that time point.
Before receiving the positive serology for Echovirus 30, his clinical state
continued to deteriorate despite adequate cardiologic and antibiotic
therapy (levofloxacin and ertapenem), so high-dose corticotherapy (24
milligrams of dexamethasone per day for 3 weeks) was added, with
slow improvement of both clinical and biological parameters. After two
months of apparently good health, he presented to the hospital for the
same clinical and biological findings, but having stable cardiac function.
The CT-scan revealed alveolar condensation in the right medial lobe
and bronchoalveolar lavage fluid was suggestive for lymphocytic alve-
olitis. The repeated high dose corticotherapy lead to a slow but steady
improvement. All autoimmune markers were negative, and cultures
from both sputum and bronchoalveolar fluid were negative for bacteria
and fungi.
Conclusions
After ruling out bacterial and immunological etiologies two times in
a row, echovirus 30 remained the incriminated infectious agent of
both lymphocytic alveolitis and cardiac complications. While literature
data shows that severe enterovirus infections are mostly illustrated by
aseptic meningitis, our case reveals how an echovirus 30 infection can
be responsible for severe cardiac complications (myocarditis and peri-
carditis), but also for recurrent lymphocytic alveolitis, both in the same
patient.
Consent
Written informed consent was obtained from the patient for publication
of this Case report and any accompanying images. A copy of the written
consent is available for review by the Editor of this journal.
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Although remarkable progress was made on brain imagistic investiga-
tions along with the diversification of antiviral therapy, herpetic enceph-
alitis remains a brain disease with poor prognosis and high mortality
risk. The purpose is to present a clinical case of herpetic encephalitis oc-
curred in an adult immunocompetent female patient, with favorable
evolution
Case report
The authors present the case of an adult patient, presenting six days
prior to admission: headache, confusional syndrome, nausea, diarrhea,
severe fatigue. The patient presented to the County Hospital, Timișoara
where she is admitted to the Neurology Clinic. In order to put the
correct diagnosis, biological investigations (blood cell identification,
ESR, fibrinogen, blood glucose, C-reactive protein, urine analysis, blood
cultures, serum urea and creatinine, urine culture, exudate lingual for
yeast, etc.) and paraclinical investigations (cerebral computed tomog-
raphy (CT), cerebral MRI, lumbar puncture) have been made. Based on
clinical data in conjunction with the results of biological samples and
laboratory investigations, the diagnosis of herpetic encephalitis is estab-
lished and the patient is transferred to the Clinic of Infectious Diseases
for therapeutic and clinical monitoring. Physical examination at ad-
mission to our clinic reveals: afebrile patient with moderate influenced
general state, temporo-spatial disorientation, but without meningeal
signs, tongue with whitish deposits, cardio-pulmonary and digestive
systems with no pathological sings. Lumbar puncture was performed
and antiviral and symptomatic treatment was set. WBC, RBC, PLT =
normal values; neutrophils = 88.2 %, lymphocytes = 6.6 %; lumbar
puncture: clear normotensive liquid, glucose = 73 mg/dL, proteins =
0.5 g/L, erythrocytes = 55, leukocytes = 0; cerebral MRI: cortico-subcortical
lesion in the uncus, partial temporal lobe (anterior- internal), the left is-
land with no capture, with aspect suggesting herpetic encephalitis. The
result of the blood culture and CSF culture for bacterial flora and BK were
negative, so the bacterial etiology was excluded. Lingual exudate for
yeast Candida albicans was positive. The treatment consisted in: Acyclovir
250 mg, 3x2 fl/day, Ceftriaxone 1 g, 2x2g/day, Fluconazole 200 mg,
1tb/day, Dexamethasone, Mannitol, vitamin B6, symptomatic agents
and solutions for hydro-electrolytic rebalancing. The patient’s state
was favorable, the headache remitted after three days and the con-
fusional syndrome disappeared after six day of hospitalization.
Conclusions
Early diagnosis of herpetic encephalitis along with specific antiviral
therapy can favorably influence the evolution of the disease in immuno-
competent adults with this brain disorder known with a high potential
of severity.
Consent
Written informed consent was obtained from the patient for publi-
cation of this Case report and any accompanying images. A copy
of the written consent is available for review by the Editor of this
journal.
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Background
Measles represent a problem in current infectious pathologies through
the possibility of appearance of severe forms of measles and/or some
types of patients. The absence of vaccination due to various reasons
leads to spread of this disease in the receptive population and the evo-
lution of infections (center) or small epidemics (outbreaks). Objectives:
1. The analysis of incidence of measles in the last years in Timiș County;
2. Comparison with the situation from all our country and other
countries; 3. Complex analysis regarding conditions for developing
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 57 of 76severe forms or complications; 4. Concrete measures regarding the
evaluation of incidence of this disease.
Methods
We have performed many studies regarding cases of measles during
the last years hospitalized in Clinic II of Infectious Diseases of V.
Babeș Hospital Timișoara.
Results
Measles is highly contagious and can occur anytime, but that can be pre-
vented by vaccination. It is to be emphasized that in just three months of
2016 (May-July) 31 cases of measles were counted in our hospital. The most
affected age group in 2016 was between 1 to 3 years, which represents
48.3 % of all cases. In the latest years much more atypical forms of measles
have been recorded, some of them severe, predominantly with pulmonary
complications, even children with interstitial lung disease. In 30 countries
from Europe, measles cases didn’t occur in 2014. Likewise in Romania, Timiș
county, measles wasn’t present in 2008/2009 and 2013/2014.
Conclusions
This is a disease which can be prevented by following the vaccination
programs.
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Background
The pathogenesis of influenza includes an impairment of pulmonary de-
fenses which is said to “open the gates” for bacterial superinfection, and
Streptococcus pneumoniae is one the leading pathogens of superinfection,
particularly in children without history of anti-pneumococcal vaccination.
Methods
We have performed a retrospective study of the 2015–2016 influenza
season in one pediatrics ward of a tertiary-care hospital in Bucharest,
Romania. We collected demographic, clinical and microbiological
data regarding influenza disease characteristics and outcome, and re-
garding the incidence and outcome of pneumococcal colonization/
infection. We hereby report the preliminary results of this study.
Results
The study included 206 cases of influenza, occurring in children with
a median (interquartile range) age of 4.2 (2.5, 6.5) years. The influenza
season started late December and lasted until late May, with A viruses
being predominant (92.4 %). Complicated influenza was diagnosed in
73.9 % of the cases, and this was also the main presenting complaint.
Complications included: myositis (24 %), encephalitis (3.9 %), other
central nervous system complications (2.8 %), viral pneumonia (61 %),
bacterial superinfection pneumonia (6.7 %), acute otitis media (6.1 %).
Eight (3.9 %) patients with influenza presented positive nasal cultures
and one other case (0.5 %) presented acute pneumococcal otitis
media, identified after a median (IQR) duration of influenza illness
of 6 (4, 7) days. In patients with influenza plus pneumococcal
colonization the number of complications was significantly higher
(median 2 vs. 1, p = 0.037, U = 416). The erythrocyte sedimentation
rate was a good indicator of pneumococcal presence (median 26 vs.
16 mm/h, p = 0.038, U = 197), as opposed to fibrinogen (median 281 vs.
266 mg/dL, p = 0.466, U = 545.5) or C-reactive protein (median 4.2 vs.
3.2 mg/L, p = 0.589, U = 603). Importantly, the duration of hospital
admission was significantly longer (median 6.5 vs. 5 days, p = 0.026,
U = 424.5) in cases with concomitant pneumococcal colonization.
Conclusions
We have identified a low prevalence of pneumococcal colonization in
pediatric patients with influenza. However, when colonization was present,
it associated a significantly longer hospital stay and a significantly higher
number of complications, highlighting the need for close monitoring and
screening for pneumococcal colonization in children.Acknowledgements
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Background
Varicella is a highly contagious infectious disease, frequently encoun-
tered during childhood, with general receptivity and most often, with
self-limited evolution. There are cases when varicella can present severe
complications, such as acute encephalitis, cerebellitis, and rarely myeli-
tis. Often, the host has a previous immunosuppression, such complica-
tions being rare in patients with a normal immunological status.
Case report
We present the case of a 10 year old girl, diagnosed 7 days prior with vari-
cella, without any significant medical history, admitted in the Pediatric In-
tensive Care Unit of the National Institute for Infectious Diseases “Prof. Dr.
Matei Balș” for lower back pain, myalgias, muscle weakness, difficulty in
walking. The onset of the symptoms was 3 days prior with an evolution to-
wards exacerbation. Clinical exam upon admission confirmed varicella and
furthermore, urinary retention with enlarged bladder, diminished patellar,
right plantar clonus, decrease in muscle strength, myalgias, and paresthe-
sias, coordination impairment in the lower limbs and asymmetric parapar-
esis predominantly on the right side. Workup was within the normal
range. Myelitis was suspected and therefore a MRI of the head and spine
was performed, which showed medullar inflammatory lesions in the cervi-
cothoracic segment. Lumbar puncture was normal, except for a positive
varicella-zoster virus PCR from CSF. Positive diagnosis consisted of cervi-
cothoracic varicella-zoster virus myelitis. Treatment with acyclovir (60 mg/
kg/day), ceftriaxone 2 g/day, corticotherapy with methylprednisolone, hu-
man immunoglobulin, and iv fluids was promptly instituted for 14 days,
with a slow favorable evolution. Paresthesias, motor deficit, urinary reten-
tion and sensitivity impairment resolved under treatment.
Conclusions
Although this patient had a normal immunological status, she pre-
sented a severe complication of varicella, which required antiviral
and cortisone treatment in high doses for an extended period of
time, which eventually led to complete recovery.
Consent
Written informed consent was obtained from the parents for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Enteroviruses, a group of single-stranded RNA viruses, are commonly
encountered infectious agents, especially in infants and children.
They are responsible for a broad array of clinical manifestations, from
herpangina and hand-foot-and-mouth disease (HFMD), to myocarditis,
aseptic meningitis.
Methods
Faced with an increased number of enteroviruses associated infections,
during the summer season of 2016, the present paper analyzes the
managed cases in the pediatric department of the National Institute for
Infectious Diseases “Prof. Dr. Matei Balș” – Bucharest, referring specially
to the severe and challenging cases, particularly towards the ones with
associated meningoencephalitis.
Results
The simplest forms of enterovirus infections registered were cases of
hand-foot-and-mouth disease, that only required hospital management
secondary to dehydration or to associated gastroenteritis; the registered
number of HFMD exceeded 170 cases, representing over 80 % from
enteroviruses induced infections. There was no record of secondary
myocarditis, but an overwhelming number of acute viral meningo-
encephalitis cases (24) were reported, some of them undergoing
severe forms of the meningoencephalitis syndrome, complicated by
convulsive status, plegias and/or important motor deficits. The epi-
demic peak was reached during the mid-summer season (June-July)
when the integrated pediatric intensive care (PIC) department man-
aged 20 out of the 24 registered cases of the 2016 season. Import-
ant central nervous system involvement, with magnetic resonance
imaging documented lesions, was present in 5 patients, but no fatal
cases were registered.
Conclusions
Traditionally enterovirus infections present with benign symptoms, tak-
ing the form of uncomplicated summer illnesses; during the summer of
2016 we registered a high number of severe, life threatening, forms of
manifestation which required initial PIC management, long hospital
management and, in some particular case of meningoencephalitis with
associated motor sequelae, kinesiotherapy and physical therapy, fact
that highlighted the associated burden of these summer infections.
Comorbidities in viral infection
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Background
Combined antiretroviral therapy significantly improved the prognosis
and the life expectancy of HIV patients. Along with this, the profile of
HIV associated malignant pathologies has changed. Among them,
lymphoma, having a higher incidence and a poorer prognosis than
in general population, is an important cause of mortality and morbid-
ity in HIV infected people.
Case report
We present two cases of HIV-associated lymphoma with different
outcome. In the first case, a newly HIV diagnosed patient, with a good
immunological status (lymphocytes CD4 count 442/cmm, HIV-RNA =
193502 copies/mL), developed non-Hodgkin’s Burkitt-type lymphoma
and he had a fulminant evolution towards death. In the second case, a
patient known for over twenty years with HIV infection and who had
discordant immunological and virological response to antiretroviral
therapy (lymphocytes CD4 count 19/cmm, undetectable HIV-RNA), was
diagnosed with Hodgkin’s lymphoma and he had a favorable evolution
with chemotherapy. Both patients presented with systemic extranodal
involvement, B symptoms and were classified in stage IV lymphoma.
The extranodal involvement included central nervous system and liverin the case of the patient with non-Hodgkin’s Burkitt-type lymphoma
and liver and spleen involvement in the case of patient with Hodgkin’s
lymphoma. Both patients required exhaustive medical investigations
and a close interdisciplinary cooperation during the entire time of diag-
nostic and therapeutic procedures.
Conclusions
HIV-associated lymphoma manifests in various forms in clinical settings.
Unlike in general population, HIV-associated lymphoma is usually more
aggressive and has a poor prognostic. Therefore it must be included
into the differential diagnosis panel in patients presenting with sudden
increase in lymph nodes, neurological manifestation and abrupt de-
crease in CD4 lymphocytes count. HIV-associated lymphoma differential
diagnosis involves a wide panel of infectious and oncologic patholo-
gies, therefore extensive investigation and the implication of specialists
from various medical fields are required. A fast and accurate diagnosis
may warrant the future evolution of the patients.
Consent
Written informed consent was obtained from the patient/from the
next of kin for publication of this Case report and any accompanying
images. A copy of the written consent is available for review by the
Editor of this journal.
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Background
Among immunocompetent hosts the enteroviral infections are most
frequently benign and auto-limited illnesses. Exceptionally these sum-
mer viral pathologies can evolve dramatically, presenting under severe
forms of disease, with important associated complications sometimes
leading to death. In the present paper we present the clinical evolution
of an acute Coxsackie virus infection in an immunocompetent child,
complicated by pancytopenia.
Case report
A young baby girl, 11 months of age, without any particular patho-
logic medical history is submitted in the 9th Pediatric Department at
the National Institute for Infectious Diseases “Prof. Dr. Matei Balș” for
fever, poor feeding, sleepiness and diarrhea. The clinical onset, registered
48 hours before her hospital submission was characterized by fever and
poor feeding. The initial clinical evolution found a moderately ill appear-
ing child, with pallor identified, without associated petechiae or bruising
and without any other particular exanthematous elements, with a stable
cardio-circulatory status, with no clinical signs of renal function im-
pairment, diarrheal stools emitted, no nuchal rigidity or neurological
focal signs present. The laboratory investigations isolated a franc pan-
cytopenia (NL = 1.600/cmm, Hb = 8.8 g/dL, PLT = 105.000/cmm), with
no other pathological findings. The serological screening for HIV, HTLV,
adenovirus, EBV, CMV, Parvovirus, Influenza came back negative, with a
normal peripheral smear and bone marrow aspiration. No clinical
relevant result was communicated by the microbiological laboratory
(negative hemocultures, nasal and pharyngeal swabs, uroculture and
stool cultures). A positive IgM serology for Coxsackie virus was ob-
tained. Cortisone, i.v. immunoglobulin, endovenous hydration and
supportive therapy were initiated, with subsequent favorable evolu-
tion, with rapid normalization of the hemogram parameters (a
discrete hypochromic anemia persists at a level previously identi-
fied in the infant) and clinical restoration.
Conclusions
The acute Coxsackie virus infection in the immunocompetent pediatric
population can sometimes evolve severely, complicated by acute
diarrheal manifestations with subsequent dehydration and possible
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 59 of 76hematological involvement. In evolution the presented case main-
tained a residual anemia (Hb = 10.8 g/dL), with no other para-clinical
imbalances.
Consent
Written informed consent was obtained from the patient’s next of
kin for publication of this Case report and any accompanying images.
A copy of the written consent is available for review by the Editor of
this journal.
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Background
Viral respiratory infections are the leading cause of morbidity in children
and improving their management is a priority of our clinic. Etiological
diagnosis of respiratory viral infections provides the necessary conditions
for the proper management and improves clinical outcomes. Objectives:
Identification of viral etiology of respiratory infections and establishing
correlations between pathogens and clinical manifestations of infections
produced in children.
Methods
We tested patients aged 0–14 years diagnosed with viral respiratory
infections in our clinic between December 1, 2015 - May 31, 2016.
Identification of respiratory viruses was achieved by rapid tests
(MARI-POC) and by molecular methods - PCR performed in nasal se-
cretions. We recorded changes in biological constants and clinical
manifestations caused by respiratory viruses.
Results
Identification of etiologic agents allowed appropriate epidemiological
measures necessary to isolate the patients and the study of the inci-
dence of seasonal viruses. The season 2015–2016 was dominated by
the AH1N1 influenza virus. In much smaller proportions we diagnosed
infections with respiratory syncytial virus, influenza B virus, adenovirus
and human metapneumovirus. Influenza infection has evolved this
season with high severity index. The severe complications of influenza
in children were severe neurological diseases represented by febrile
seizures, encephalitis and encephalitis reactions. Two cases of enceph-
alitis have progressed to death.
Conclusions
The etiological diagnosis of respiratory viral infections has epidemio-
logical and therapeutic implications. Infection with influenza viruses can
cause severe complications and deaths, so we need prophylactic
measures, early diagnosis and timely treatment administered.
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Background
Hepatocellular carcinoma (HCC) is the most common malignant
tumor of the liver, the overall incidence of approximately 626,000
cases annually, with predominance in males. HCC is considered the
third leading cause of death from malignancy and the second leading
cause of death respectively in the field of digestive cancers. These
patients are 80 % previously diagnosed with hepatitis B or C. The
incidence of HCC in patients diagnosed with cirrhosis of viral B andC etiology is increasing, overall survival at 5 years continues to remain
below 10 % due on the one hand to the discovery of tumors in ad-
vanced stages, ineffective screening in patients with risk factors for
HCC and on the other hand to the lack of curative therapies applicable
to this category of patients. Curative or palliative treatment of HCC de-
pends mainly on local tumor extension and preexisting liver disease.
Angiogenic agents of the type Sorafenib may cause an increase in over-
all survival by 44 % compared to placebo in patients with advanced
HCC.
Case report
We present the case of a of 47 years old male, known with cirrhosis
of viral etiology B from 2003, consumer of ethanol, who refused anti-
viral therapy with entecavir in 2009 and was diagnosed in February
2016 with HCC with extrahepatic extension. The patient was admit-
ted in January 2016 at the Suceava Emergency Hospital with jaun-
dice, fever, right upper quadrant pain, loss of appetite, weight loss.
Clinical exam: patient with intense jaundice, emaciated, superficial
lymph impalpable, ascites fluid quantity average, slightly sensitive
right upper quadrant. Laboratory findings: significant hepatic cytoly-
sis, cholestasis, elevated amylase, alpha-fetoprotein slightly elevated,
thrombocytopenia, moderate inflammatory syndrome. CT and MRI
exam revealed a nodular lesion in segment VI/VII with extra capsular
extension and diaphragm and chest wall invasion. Histopathology
and immunohistochemistry outlined trabecular hepatocellular car-
cinoma developed on a background of chronic active hepatitis
advanced fibrosis. The patient has no indication for liver trans-
plantation and liver resection, but could benefit from treatment
with Sorafenib. The patient devloped important ascites, right
massive pleurisy, hepatic encephalopathy phenomena and died
6 months after the diagnosis of HCC and one month after starting
treatment with Sorafenib.
Conclusions
Current medical treatments are less effective in advanced HCC, and
their role after liver transplantation, liver resection, should be explored
further. Current hopes are turning to new molecular “target” therapies
that explore the biological pathways involved in carcinogenesis signal-
ing in the liver.
Consent
Written informed consent was obtained from the next of kin for
publication of this Case report and any accompanying images. A
copy of the written consent is available for review by the Editor
of this journal.
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Background
Influenza seasons represent a major strain on the health care system
and they can vary in their severity, timing and duration from one
season to another. Most of patients the infected with A H1N1 influ-
enza virus exhibit no symptoms or very mild respiratory symptoms
and high fever. In some cases, regardless of age or comorbidities,
severe disease and complications due to infection, including
death, may occur. Our case series study is meant to analyze the
epidemiological, clinical and paraclinical characteristics of patients
infected with type A H1N1 Influenza virus, admitted in the Inten-
sive Care Department of INBI “Prof. Dr. Matei Balș” in the 2015-
2016 influenza season.
Methods
A retrospective, observational case series study was conducted over
a 6-month period, on 21 adult patients admitted in the Intensive
Care Department, that have been confirmed with severe influenza in-
fection through nasopharyngeal swab and tracheal secretion PCR
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comorbidities. Clinical data, microbiological samples and imagistics
were extracted from patients’ medical charts through thorough ana-
lysis. Eventually, therapeutic measures were statistically correlated
with the outcome.
Results
There were 21 subjects enrolled with median age of 50.6 years old.
57.14 % were male, 100 % Caucasian. High-risk conditions were
present in 34 %. The majority of influenza viruses of the patients in
the case study matched the strains present in the seasonal vaccine,
but none of the patients had been vaccinated. The demographical
spectrum impressed through diversity. The mortality rate was 31.8 %
taking into account that influenza might have triggered latent disor-
ders or exacerbated chronic afflictions and put the patients at risk of
acquiring bacterial superinfections. The data strongly implicate A
H1N1 influenza virus infection combined with bacterial superinfec-
tion as the primary cause of mortality during the A H1N1 influenza
outbreak.
Conclusions
The incidence of severe influenza cases in the Intensive Care Depart-
ment was relatively low, but the severity was high; 28.5 % of the
cases might have been prevented by following the recommendation
for vaccination of risk groups in Romania.
A76
Acute respiratory distress syndrome in a child with measles
Ana Vaduva-Enoiu1, Ramona Georgiana Stanculete1, Adelina Raluca
Marinescu1, Voichita Elena Lazureanu2
1Dr. Victor Babeş Clinical Hospital of Infectious Diseases and
Pneumology, Timişoara, Romania; 2Dr. Victor Babeş University of
Medicine and Pharmacy, Timişoara, Romania
Correspondence: Ana Vaduva-Enoiu (annalupu20@yahoo.com)
BMC Infectious Diseases 2016, 16(Suppl 4):A76
Background
Measles is an acute infectious disease, highly contagious; the death
among infants still remains in very high proportion (about 60 %) due
to bronchopneumonia. Respiratory diseases are the result of measles
virus with associated bacterial infection, which may include any respira-
tory area, secondary lesions, both viral and immune cellular depression.
Case report
We present the case of a child, 11 months old, female, unvaccinated,
with multiple hospitalizations for bronchiolitis in the last 3–4 months,
suppurative otitis, febrile convulsion syndrome, last hospitalization at
“Louis Turcanu” Emergency Hospital for Children Timișoara, 10 days
before presentation in our clinic for: emphysematous acute bronchio-
litis, otitis media with effusion. Affirmative, 2 days after discharge the
patient had fever, nasal obstruction, rhinorrhea, cough and some
eruptive elements. The child was guided to our hospital by the gen-
eral physician. At admission the child presented: influenced general
condition, adynamia, nasal obstruction, cough with expiratory 3–4
secuses, saburral tongue, throat congestion, erythemato-macular ele-
ments eruptive with tendency to confluence on the face and chest,
liver at 2 cm below the lower edge of the costal margin. Biological
tests at admission: anemia, inflammatory syndrome present. A diag-
nosis of measles and bronchial hyperreactivity was suspected (subse-
quent anti measles IgM positive). Treatment was begun with water
and electrolyte rebalancing treatment, bronchodilators, corticoste-
roids. Antibiotics were administrated after 2 days, due to the persist-
ence of fever (isolated febrile hooks) and positive procalcitonin. After
4 days general condition was altered with polypnea, intercostal draft,
oxygen saturation 85 % without oxygen mask, requiring transfer to
intensive care. Endotracheal intubation was necessary, because of de-
saturation episodes, highlighting this radiological image: diffuse fog
of both lung fields. In an attempt to extubate, the patient presents
pulmonary edema and severe bronchospasm, requiring reintubation
after 4 days. After about 2 weeks the child's respiratory status degrades,
evolving to acute respiratory distress syndrome with metabolic acidosis
and severe episodes of bradycardia. She is mechanically ventilated, butbecomes oligoanuric, bradycardia does not respond to atropine then
cardiopulmonary arrest occurs.
Conclusions
Overall measles prognosis is favorable in children with satisfying nu-
tritional status and good living conditions. Prognosis remains poor in
children under 2 years with dystrophic syndromes (anemia, rickets)
and multiple comorbidities.
Consent
Written informed consent was obtained from the next of kin for publi-
cation of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Right-sided infectious endocarditis (IE) is a common condition in IV
drug users (IVDU), Staphylococcus spp. being the most involved patho-
gen. Many IVDU are HIV positive, condition making them extremely
susceptible to infections. Our aim is to present the challenges raised by
the management of IE in an HIV positive IVDU.
Case report
A 27-year-old former IVDU, currently under methadone substitution,
with HCV chronic infection, HIV infection (naive to treatment), was
admitted into the hospital for fever (38.3 °C), dyspnea on minimal ex-
ertion (SaO2 = 87 % spontaneous), cough, generalized arthromyalgia,
temporal-spatial disorientation. Taking into account the HIV status
correlated with the severe general presentation and important lym-
phopenia, the patient had inserted a left jugular central venous line
(CVL) for easier administration of medication, blood cultures were
taken, and he was started on maximal antimicrobial therapy associated
with dexamethasone and mannitol to treat a potential meningitis (later
ruled out by lumbar puncture). The drug abuse history, the continu-
ously deteriorating state urged for a transthoracic echocardiography
(TTE) that revealed 3 vegetations located on the tricuspid valve, evoca-
tive for IE. Therapy was adapted for a possible staphylococcal endocar-
ditis (vancomycin IV 2 g q12h 3 days, and gentamycin IV 200 mg single
dose 2 days), with diuretic and beta-blocker drugs. A few days later
one blood culture came out positive for methicillin-sensitive S. aureus
(MSSA). The diagnosis was IE with MSSA on tricuspid valve (revised
Duke criteria: 1 major criterion - vegetations seen on TTE, 3 minor
criteria: predisposing factors, one positive blood culture and fever),
the antibiotherapy was changed again to oxacillin IV 12 g per day
(7 days). Despite the correct treatment, the patient’s evolution worsened
(low fever, intense dyspnea, increased biologic inflammatory syndrome,
pulmonary rales), the chest radiography was consistent with pneumonia,
bronchoscopy with bronchoalveolar lavage was performed, tuberculosis
was excluded, but MSSA was confirmed (probable septic emboli). Blood
cultures were taken from the CVL, and one was positive for
vancomycin-resistant Enterococcus faecium (the new finding was
interpreted as a nosocomial infection due to the patient’s poor
adherence to the hygienic procedure involving the CVL). Linezolid
was used for 2 weeks, and then oxacillin was resumed, completing a
6 week successful antibiotherapy.
Conclusions
An HIV positive patient, especially an IVDU, is characterized by a great
susceptibility to infections, making him a challenge for the physician to
diagnose and treat. Even with adequate therapy, these patients are
prone to develop life-threatening complications, mainly because of
poor adherence to treatment.
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Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Infection with influenza virus through the many types and subtypes
but also by its airborne spread, remains a public health problem. Lack
of specific therapies, safe, decreased immunity and host aggression by
germs from the external environment, the possible source of super in-
fection lead to the great severity of this condition. This is reflected in
mortality rates: from 21 patients with H1N1 flu (confirmed PCR), 8 pa-
tients died (38.1 % death rate during 2015–2016 season).
Methods
Retrospective analysis of cases hospitalized in the period December
2015 - April 2016, confirmed with influenza AH1N1 virus, with severe
respiratory failure (ARF). We highlight clinical data, biological, viral,
and biological imaging specific to each patient.
Results
Bacterial reinfection with unique or mixed germs, type MDR, PDR,
both cocci (MRSA pneumonia E. faecium) and Gram negative bacilli
(A. baumannii, K. pneumoniae, E. coli) and fungi (C. albicans, C. non
albicans: glabrata, kefir) detected in both carriage and pathological
products or on the surface of catheters or probes, were the targets
of antimicrobial therapy (AB latest dose and multiple association and
supportive therapy ± antifungal therapy appropriate to the stage of
sepsis + antiviral therapy - oseltamivir) initiated early and individual-
ized casework. Advanced support of vital functions and physiopatho-
genic supportive therapy with intensive nursing formed the basis of
therapeutic complex behavior. The death of the 8 patients was carefully
analyzed from a bacteriological standpoint: 5 cases died of severe sep-
sis or septic complications caused by pneumococcus, K. pneumoniae,
P C, A. baumannii+ A. fumigatus, MRSA and 3 cases, admitted in ex-
treme status of serious critical conditions, unstable condition, in septic
shock and MSOF had unidentified etiology and death between 3–9
days after admission.
Conclusions
The data presented above show us great seriousness of respiratory
infections with influenza with quick development of respiratory failure,
requiring advanced support through IOT + VM method, imminent help,
but increasing the risk of superinfection. Extremely severe bacterial in-
fections with multiple resistance, create great difficulties in ensuring
the success of bacteriological control. To optimize this success particu-
lar material resources are needed, to cover the acquisition of highest
technology and the latest equipment, as well as human resources,
highly qualified and experienced practice to be able to make quick de-
cisions, accurate and responsible multidisciplinary working groups.
Interdisciplinary studies in infectious
diseases
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Influenza is an acute infectious disease with increased epidemic potential.
Flu and severe acute respiratory infections (SARI) are an important public
health problem. Objectives: 1. Evaluation of types/subtypes of influenza
in the 2015–2016 season, in patients from the Clinical Hospital of Infec-
tious Diseases (SCBI), Constanța. 2. Epidemiological characterization of
SARI hospitalized in SCBI Constanța, according to the criteria in the
surveillance methodology for influenza, acute respiratory infections
(ARI) severe acute respiratory infection (SARI), during the 2015–2016
season.
Methods
Retrospective analysis of laboratory-confirmed flu cases in the 2015–
2016 season in SCBI Constanța. Retrospective analysis of SARI cases,
according to epidemiological criteria – distribution by gender, age,
area of origin, prior vaccination status, seasonal travel history, contact
with a confirmed case of influenza, associated chronic diseases, signs
of severity (clinical signs of pneumonia, complications such as acute
respiratory failure or secondary bacterial infection, oxygen therapy,
mechanical ventilation, antibiotic therapy).
Results
The total number of laboratory confirmed influenza cases was 359, of
which 334 were Type A subtype H1N1, 13 type A, negative subtype
H1N1, 8 type A, 1 type A subtype H3, 3 type B. Hospitalization was
necessary for 74 patients with SARI (45 females and 29 males), belonging
to different age groups (2–4 years – 1, 15–49 years – 21, 50–64 – 36,
over 65 – 16), backgrounds of different origin (urban 52, rural 22) with
comorbidities (cardiovascular 38, bronchopulmonary 12, diabetes 4
cases, other 44, pregnancy 3, obesity 37), with history of travel abroad
(Bulgaria, Libya) – 2 cases, previous contact with a person with con-
firmed influenza – 1 person, and only 4 persons with a history of in-
fluenza vaccination. Sixty-six patients had clinical signs of pneumonia.
There were medical complications like acute respiratory failure – 15
cases and secondary bacterial infection (pneumonia) – 56 cases. 68
patients received antibiotic therapy, 38 patients received oxygen.
All survived. No patient was mechanically ventilated.
Conclusions
In the Clinical Hospital of Infectious Diseases, Constanța, Romania,
SARI mortality was zero. The receptive population was unprotected by
vaccination and mostly consisted of adults with comorbidities. AH1N1
was the most prevalent subtype in the flu in season 2015–2016.
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Background
Interleukin 6 (IL-6) is involved in the pathogenesis of inflammation, in-
fections, neoplasms and autoimmune diseases. Its biological activity is
exerted through two mechanisms which involve the binding of IL-6 to
a specific membrane receptor, abbreviated as IL-6R (classic signaling
pathway) or the binding of IL-6 to the soluble form of the receptor, ab-
breviated as sIL-6R (trans signaling pathway); this step is followed by
the interaction between the previously formed complex and the trans-
ducer subunit (gp 130). The investigation of the intracellular signaling
pathways, by which IL-6 mediates pro- and anti-inflammatory effects in
viral infections, represents the aim of our prospective study.
Methods
In our study we included 136 subjects divided into 4 groups: group
A – 40 patients with viral infections (HIV, HCV, HBV), group B – 40 pa-
tients with cutaneous malignant melanoma, group C – 16 patients with
malignant melanoma associated with viral infections and group D – 40
healthy subjects. The determination of serum levels of IL-6, sIL-6R and
soluble glycoprotein (sgp) 130 was performed by ELISA technique.
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Serum levels of IL-6 were significantly higher in patients with viral in-
fections (31.2 ± 7.3 pg/mL p < 0.05), malignant melanoma (19.3 ±
6.8 pg/mL, p < 0.05) and malignant melanoma associated with viral
infections (37.9 ± 11.5 pg/mL, p < 0.05) than in the control group
(2.11 ± 0.85 pg/mL). Compared to controls (74.23 ± 2.17 ng/mL),
serum levels of sIL-6R were moderately elevated in patients with viral
infections (114.1 ± 33.6 ng/mL, p <0.05), malignant melanoma (96.3 ±
31.4 ng/mL, p > 0.05), and malignant melanoma associated with
viral infections (127.1 ± 43.1 ng/mL, p < 0.05). Significant variations
were also obtained for sgp 130, as follows: 281.4 ± 19.4 ng/mL in
the control group, 309.8 ± 22.4 ng/mL, p > 0.05 in patients with viral
infections, 363.8 ± 43.8 ng/mL, p < 0.05 in patients with malignant
melanoma, 331.3 ± 29.5 ng/mL, p = 0.05 in patients with malignant
melanoma associated with viral infections.
Conclusions
IL-6 is secreted in response to viral infections and malignant transform-
ation. The sIL-6R subunit is overexpressed in viral infections. Soluble
glycoprotein 130 is synthesized in small amounts in the studied
viral infections. Therefore IL-6 may be involved in the regulation of
inflammatory responses of the human body through many mecha-
nisms. In viral infections IL-6 trans signaling pathway is overexpressed.
Knowledge of intracellular signaling mechanisms of IL-6 has important
consequences on the therapeutic strategies which are aimed at block-
ing the activity of this cytokine.
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Background
We have studied the evolution of clinical, humoral and pathological
parameters in patients with persistent HBsAg for more than 3 months
after the acute phase.
Methods
We followed in this study 50 patients hospitalized in our clinic within
5 years. Patients in the study were diagnosed with acute B type
hepatitis in patients with positive HBsAg. Have observed that our pa-
tients with persistent HBsAg over 3 months in 19 patients presenting
more frequently than unfavorable evolution towards healing.
Results
Subjectively patients described signs such as weakness, fatigue, ef-
fort pain. Objectively we have detected the presence of hepato-
megaly and splenomegaly. After 2 years of persistence of HBsAg
in 3 patients vascular stars were present, which were later shown
as signs of chronic active hepatitis. We have followed the dynam-
ics of viral markers, evolving pursued hepatodepressive syndrome,
syndrome retention cytolysis and inflammatory dysproteinemia.
Humoral changes present in HBsAg persistent hepatitis are gener-
ally encountered in the acute phase (but with different intensity),
plus they develop or intensify the inflammatory syndrome. In
cases with persistent HBsAg the dynamic development of humoral
syndromes is categorically different compared to the evolution of
hepatitis with the same syndromes in cases of acute infection
evolving with HBsAg negativity.
Conclusions
The persistence of HBsAg after the acute phase was detected in
64.4 % of cases. In 15.6 % we observed evolution towards chronicity.
Evolution toward healing (seroconversion) was seen in 20 % of cases,
after 12 months after the acute phase.A82
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Background
Bacterial infection or colonization during pregnancy may be innocu-
ous or may lead to significant consequences for the mother or the
fetus. Early diagnosis and appropriate antimicrobial treatment are es-
sential steps towards the best possible pregnancy outcome.
Methods
We have performed a retrospective study to assess the prevalence
of potentially pathogenic bacteria and fungi identified through
smears and cultures of vaginal and cervical discharge collected
from pregnant patients attending one gynecology/obstetrics ward
of a tertiary care hospital in Bucharest, Romania from July 2015 to
July 2016. The statistical analysis included the Chi-square test for
categorical variables and the Mann–Whitney non-parametric test
for continuous variables, and was performed with IBM SPSS Statistics
v.22 (Armonk, USA).
Results
We have assessed 120 pregnant female patients, with a median
(interquartile range) age of 30 (26.3, 33) years and a median (inter-
quartile range) duration of pregnancy of 30 (26.5, 33) weeks at the
time the smear and culture tests were performed. Roughly half (58,
48.3 %) of the patients presented the normal Gram-positive tinctorial
predominance on vaginal smears while 39 (32.5 %) presented appar-
ently pathogenic Gram-negative flora, although only 2 of the vaginal
discharge cultures (1.7 %) grew Gram-negative bacilli, namely E. coli.
Another 17 (14.2 %) vaginal cultures were positive for yeasts, and all
were negative for S. aureus, Klebsiella spp., and Trichomonas vaginalis.
Among cervical cultures, 11 (9.2 %) grew E. coli (including the two
cases that also had positive vaginal cultures for E. coli), 2 (1.7 %)
grew Klebsiella pneumoniae, 12 (10 %) grew yeasts, 1 (0.8 %) grew
Enterococcus spp. and none were positive for S. aureus or Trichomonas
vaginalis. Of the 11 identified E. coli strains, almost half (n = 5) were re-
sistant to ampicillin, 2 were resistant to ciprofloxacin, and all were sus-
ceptible to cephalosporins, carbapenems, and co-trimoxazole. Klebsiella
strains were positive for extended-spectrum beta-lactamases and
were significantly more frequent at lower gestational ages (p =
0.023, Z = −2.152), while fungal growth from cervical cultures was
significantly associated with younger maternal ages (p = 0.040,
Z = −2.056).
Conclusions
We have identified fairly low prevalences of cervical pathogens in a
population of pregnant female patients closely monitored in a tertiary
care hospital in Bucharest, Romania. Our results suggest that screening
for Klebsiella should be performed earlier in pregnancy and that
younger women have higher incidences of fungal infections.
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Group B streptococci (GBS) are major causes of morbidity and long-
term disability in babies born-to-mothers colonized or infected with
this germ [1]. Neonatal GBS infection is prevented by intra-partum
antibiotics, and all asymptomatic pregnant women should be screened
for GBS through vaginal and intra-rectal cultures at 35–37 weeks of
pregnancy [2].
Methods
We performed a retrospective study to ascertain the prevalence of
GBS colonization/infection during July 2015-July 2016, in pregnant
patients monitored in a tertiary care hospital in Bucharest, Romania.
Results
We studied 120 pregnant women with a median (IQR) gestational
age of 30 (26.5, 33) weeks. The patient sample was representative for
Southern Romania: 82 (68.3 %) from urban areas, 79 (65.8 %) from
the Bucharest-Ilfov area, 32 (26.7 %) Southern, 5 (4.2 %) South-Eastern
and 2 (1.7 %) from the South-Western area of Romania, while two
patients were from Ukraine and Moldova. One-fourth of the patients
(32, 26.7 %) had previous obstetrical medical history: uterine scarring
(n = 24, 75 %), uterine fibroids (n = 2, 6.3 %), history of preeclampsia
(n = 2, 6.3 %), and cervical scarring, septate uterus, history of placenta
praevia, or history of intrauterine death (n = 1, 3.1 % each).
None of the vaginal cultures yielded GBS while 7 (5.8 %) of the cer-
vical cultures grew GBS. The patients did not consent to intra-rectal
cultures, therefore the real prevalence of GBS colonization may be
somewhat underestimated.
The mean age ± SD of patients with positive GBS cultures was 30.03
± 6.4 years; cultures were collected at a median gestational age of
38.5 ± 1.6 weeks. Urine cultures were performed in all but one case
of GBS colonization and only one of them yielded asymptomatic GBS
bacteriuria requiring treatment during pregnancy along with stand-
ard intra-partum antimicrobial prophylaxis for GBS colonization.
The prevalence of GBS colonization was slightly higher in patients
from urban areas (6/82, 7.3 % vs. 1/36, 2.8 %) but the difference
failed to reach statistical significance, probably due to the small num-
ber of overall positive cultures (p = 0.674, χ(1) = 0.924). The prevalence
of GBS was not influenced by obstetrical history (p = 0.187, χ(1) =
2.703), patient age (p = 0.951, Z = 0.062), or gestational age (p = 0.620,
Z = −0.496), and GBS colonization increased the odds of C-section
12-fold (OR: 12.242, CI95 %: 2.420–61.933, p = 0.005, χ(1) = 13.392).
Conclusions
We identified a fairly low prevalence of GBS colonization (5.8 %) and
one case of urinary GBS infection during pregnancy. Our study did
not reveal major risk factors for GBS colonization or infection in this
cohort of pregnant women from Southern Romania.
References
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Background
In the absence of a clinically evident trauma it is difficult to diagnose
a muscle hematoma which can be easily mistaken for a profound
thrombophlebitis.
Case report
A 74 years old patient coming from the rural area, with a history of
penile tumor with lymph nodes expansion (2008), operated on, diabetic
and coronary patient, under treatment with Trombex for one year, is
hospitalized accusing fever, dysuria, cloudy urine. Objective, withoutmodifications on admission, paraclinically only a prostate hypertrophy
is retained on ultrasound. Initially interpreted as urinary infection,
therapy with ciprofloxacin is started after urine culture is collected.
On the day of admission, the patient falls from his own height while
going to the bathroom, without apparent trauma, without loss of con-
sciousness. On the second day from admission, the patient accuses
right lower back and right lower leg pain, without objective cutaneous
modifications. The third day the pain centralizes on the right lower leg,
with gradual evolution towards posterior edema, with positive Hoffman
sign. The situation is interpreted as being deep vein thrombosis and,
therefore, anticoagulant therapy is initiated. After three days of treat-
ment the patient is afebrile, still presenting edema and pain in the calf,
neutrophilic leukocytosis appears, inflammatory evidence increases,
metabolic imbalance is present, urine culture is sterile. The treatment is
changed to ceftriaxone. The ultrasound of the right lower leg section
shows a fluid collection of 15/3.5 cm. Puncture is performed in the area
of the collection but nothing externalizes. A vascular surgery consult-
ation in Timișoara refutes the diagnosis of thrombophlebitis thus main-
taining the suspicion of possibly infectious hematoma. The patient is
transferred to the surgery ward where the suspicion is confirmed surgi-
cally and the collection is evacuated.
Conclusions
A calf muscle hematoma can be easily mistaken, clinically, for a pro-
found thrombophlebitis in the absence of cutaneous modifications.
For a correct diagnosis, extended investigation is needed since ther-
apy is completely different in these two situations.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
More than 15 million individuals are infected by the T-lymphotropic
virus (HTLV) through the world, the first described human oncovirus.
Etiologically linked to the adult T‐cell leukemia/lymphoma (ATLL), the
spread of the virus is endemic in Japan, Africa, Central and South
America but little is known about the infection rates in Romania,
where testing of blood-donors in the only structured epidemiologic
ongoing program regarding the HTLV infection. Starting from the dir-
ect mutagenic effects of the virus, the present paper wants to raise
awareness towards this endemic problem we are facing.
Methods
Under high clinical suspicion, the ATLL diagnosis was established in
the Hematology department of the Clinical Hospital Colentina –
Bucharest, from January 2014 to March 2016, by analyzing the lympho-
cyte morphology, immunophenotype, histology of the tissues affected
in the pure lymphoma forms. The HTLV-1/2-specific antibodies were
detected using an enzyme-linked immunosorbent assay (ELISA) and
were confirmed by real-time PCR assay. For the confirmed cases we
prospectively recorded the age, sex, immune status, the form and the
severity of the disease, the response to the first, and if applied, to the
second line of chemotherapy, in some instances in association with
antiretroviral therapy. The epidemiological link to a possible HTLV infec-
tion source was explored using a standard questionnaire.
Results
During the survey period the department worked on 16 cases of
ATLL, with a mean surviving period of 14 months post-diagnosis.
Hyper-CVAD, or CHOP- regimen based chemotherapy were imple-
mented, in association with antiretroviral therapy in 5 (30 %) of the
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 64 of 76managed cases. Only 3 (18.5 %) patients were known as HTLV posi-
tive patients before the oncologic diagnostic, being followed in
monitoring infectious diseases centers; in one case a vertical trans-
mission was identified after the mother’s diagnosis as a ATLL; 9
(56 %) of the patients presented with a HBV or HCV co-infection
and 4 (25 %) of the patients declared they travelled and practiced
at-risk activities in HTLV endemic areas.
Conclusions
Despite major advances in understanding the pathogenesis of the
disease, management of these patients remains a challenge for clini-
cians as they do not respond or achieve only transient responses.
Easy and constant access to antiretroviral therapy is essential and
stem‐cell transplantation should be considered but prevention pro-
grams, standardized nationally and integrated internationally, need to
become a public health priority.
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Background
In clinical practice, sometimes we meet cases that prove to be a real
professional challenge.
Case report
We present a male patient, 68 years old, retired, hospitalized between
03.05–08.06.2016 in the Adult Infectious Disease Clinic, Victor Babeș
Hospital, Craiova, being transferred from the Intensive Care Unit of
Clinical Regional Hospital, Craiova. The disease had an acute onset,
a week before the presentation in the Infectious Disease Clinic, with
psychomotor agitation, language disorders, and confusion, being
admitted in the Neurology Clinic with the suspicion of a stroke,
infirmed subsequently by the imagistic explorations. The presence
of fever in a confused patient without a stroke determines the solicita-
tion of an infectious disease specialist consult, who then performs a
lumbar puncture. Following the lumbar puncture the diagnosis of men-
ingoencephalitis with clear cerebrospinal fluid (CSF) was formulated,
the patient is then transferred in the Intensive Care Unit for sustaining
vital functions receiving also etiologic target treatment (ceftriaxone,
acyclovir, DOT). Three days later, due to favorable evolution, the patient
is transferred in the Infectious Disease Clinic. From the anamnestic data,
relevant are: the contact with his tuberculosis infected parents,
daily alcohol consumption (75 gr/day) former smoker. Physical
examination at admission reveals average general state, no fever,
aware, cooperating, balanced cardio-respiratory, stiff neck. Stage
diagnosis: meningoencephalitis with clear CSF. Biological examination
reveals: complete blood count (normal leukocytes number and bal-
anced leukocyte formula), moderate biological inflammatory syndrome
(ESR = 27/55 mm), slight hepatocytolysis syndrome (TGP = 133.8 U/L,
TGO = 50.4 U/L), negative HIV serology, the lumbar puncture performed
in dynamics highlights CSF with persistent albumin cytological dissoci-
ation (elements count = 30/cmm, Pandy +++), decrease of chlorides
(684 mg%). Pneumophtiziology consult recommends continuation of
DOT, ENT consult diagnoses oropharyngeal candidosis, the rest of the
exploration being in normal limits. Positive diagnosis: Meningoenceph-
alitis of probable bacillary etiology. Drug-induced toxic hepatitis. He has
received treatment with acyclovir and ceftriaxone (up to 10 days),
DOT (initially H300 R600 E1600 Z2000 7/7 with further shift because
of the hepatocytolysis syndrome to H300R450E1600 7/7), Nistatin,
corticosteroids (dexamethasone 1fx2/day), mannitol, hepatoprotec-
tive and symptomatic drugs. The evolution was slowly favorable,
raising management issues because the hepatocytolysis syndrome.
Conclusions
This bacillary meningoencephalitis raised some diagnosis issues be-
cause of the atypical onset (acute), the presence of a rough meningealsyndrome and therapy problems linked to the appearance of the
hepatocytolysis syndrome.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Ocular impairment in HIV-positive patients appears mostly in severe
immunodeficiency and involves especially opportunistic germs. There
are also cases where HIV virus itself can cause ocular manifestations.
Case report
We present the case of a 26 years old woman known with HIV infec-
tion, admitted to National Institute for Infectious Diseases “Prof. Dr.
Matei Balș” for sudden visual acuity decrease associated with blurred vi-
sion and eye pain exacerbated by motions. At the time of admission
CD4 = 5/cmm, HIV RNA = 1655124 copies/mL patient dropped-off anti-
retroviral therapy several years ago. Investigations have ruled out other
infections (viral, bacterial, fungal, TBC), neoplasia and autoimmune dis-
eases. An ophthalmic examination revealed normal ocular fundus and
a right visual field defect. Cerebrospinal fluid examination obtained at
lumbar puncture was cell free, with proteins, glucose, chlorides on nor-
mal ranges, negative China ink test, negative Cryptococcus antigen test,
negative VDRL, undetectable PCR-BK, undetectable Polyomavirus JC
DNA, HIV RNA = 218468 copies/mL, negative cultures for bacteria, fungi
and BK. Brain MRI recommended by the neurologist revealed swollen
optic nerve without brain demyelinating lesions. A favorable course
was noticed with ful recovery of visual acuity under i.v. treatment with
dexamethasone and resumption of antiretroviral therapy.
Conclusions
HIV induced optic nerve damage may occur in HIV-positive patients
with severe immunodeficiency. HIV related retrobulbar optic neuritis
can be demonstrated by imaging study (MRI) and the exclusion of
other infectious and noninfectious causes. We highlight the favorable
outcome with cortisone and antiretroviral therapy. The effective anti-
retroviral treatment, resulting in increasing CD4 and undetectable
HIV RNA, significantly decreasing up to extinction the incidence of
the ocular manifestations of HIV virus infection.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Q fever is a zoonosis caused by Coxiella burnetii. The clinical presen-
tation is polymorphic and nonspecific, but most often characterized
by: self-limited influenza-like illness, pneumonia or hepatitis. On the
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 65 of 76other hand, there are other clinical forms, which are less frequent
like: cardiovascular, neurologic, obstetric manifestations and derma-
tologic (5–20 %) in the form of erythema nodosum or other non-
specific exanthemas, maculopapular rash or diffuse punctiform
pruritic rash.
Case report
We report the case of a 53 year old Caucasian female, consumer of raw
milk, who presented for clinical and diagnostic reevaluation of a persist-
ent fever. Initially, the case was diagnosed as an acute acalculous chole-
cystitis (cholestatic syndrome associated with hepatic cytolysis and
thick gallbladder wall at CT) and treated with ertapenem and ciproflox-
acin, under which the patient became afebrile, but the fever reap-
peared as soon as she left the hospital. At the time of admission in our
clinic, the case was considered as an angiocholitis and treated initially
with ampicillin/sulbactam, but after 48 h we escalated to piperacillin/
tazobactam and doxycycline and then to meropenem and doxycycline
(9 days of meropenem and 5 days of doxycycline) because the patient
presented relapsing fever under treatment (maximum 39 °C). At day 6
of hospitalization, the patient developed erythematous, indurated
nodules, not sharply marginated, with 2–3 cm in diameter, located
on the anterior lower legs. Investigations were extended for finding
the etiology of this new manifestation, diagnosed after the histopatho-
logic examination as erythema nodosum. We excluded: pulmonary tuber-
culosis, sarcoidosis, streptococcal, Yersinia, Salmonella and Mycoplasma
infections, cholangiocarcinoma, genital cancer. The only positive finding
was positive IgM antibodies for Coxiella burnetii. We reintroduced doxy-
cycline, despite lack of response at the beginning of hospitalization and
soon after that the fever remitted. Repeating the Coxiella serology we still
found high antibodies titer and the favorable evolution of erythema
nodosum under doxycycline pleaded for the diagnosis of Q fever.
Moreover, it is important to mention that the patient forgot to take
her treatment for 1 day, which determined the apparition of new
nodules. The evolution of these new lesions was favorable, a com-
patible aspect of a therapeutic confirmation of the diagnosis, which
confirmed once more the efficacy of our management.
Conclusions
The case is highlighting a rare clinical form of Q fever and its particu-
larities of evolution with a slow response to the usual therapy. At the
same time our case is illustrating the differential diagnosis of persist-
ent fever and associated erythema nodosum.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Tinea incognita is an atypical manifestation of dermatophytoses. Most
often it is due to inappropriate treatment with corticosteroids (steroid-
modified tinea), systemic or topical, prescribed for some pre-existing
pathology or given mistakenly for the treatment of misdiagnosed tinea.
The inflammation and scaly, typical clinical signs of dermatophytoses,
are suppressed making the diagnosis difficult. The usual sites where
this problem occurs are the face, groins, lower legs, and hands. Long-
standing steroid modified cases may require prolonged oral antifungal
therapy.
Case report
We present the case of a 74 year-old female patient who for several
months had an erythemato-squamous eruption located on the face
(distributed especially over the malar region) and on the dorsum of the
hands. Because of the distribution of the eruption on photo-exposed
areas, it was established clinical diagnosis of lupus erythematosus andbegan treatment with topical corticosteroids. After an initial im-
provement of clinical manifestations, rash reappeared and contin-
ued to expand gradually. The patient is referred to our clinic for the
diagnosis and therapeutic management. In addition to clinical man-
ifestations described above, dermatological examination revealed
nail changes, including on the fingers. Usual laboratory investigations
were within normal limits, and HIV serology was negative. Immuno-
logical investigations for lupus erythematosus were inconclusive and
direct mycological examination of the lesions (after a week period of
treatment’s cessation) was negative. A biopsy was carried out on one of
the face’s lesions, and histopathological examination revealed fungal el-
ements. It was initiated topical and systemic antifungal treatment, as
the rash disappeared; after three months of treatment the nail changes
remitted also.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Infections during pregnancy may significantly impact fetal development,
while causing minimal maternal morbidity. This is particularly true for a
subset of pathogens such as Toxoplasma/others/rubella/cytomegalovirus
(CMV)/herpesviruses (TORCH). Among these, the highest risk of con-
genital malformation is associated with early pregnancy acute rubella
infection, but CMV and Toxoplasma also account for significant fetal
developmental issues, while herpesviruses pose the highest threat to
newborns, if infection is transmitted vertically.
Methods
We have studied the incidence of acute Toxoplasma, rubella and CMV
infection (serum IgM screening) and the seroprevalence of serum
IgG antibodies in pregnant females attending a reference center for
obstetrics-gynecology in Romania. The study was implemented through
the Norwegian Financial Mechanism and access to the screening
program was available to pregnant females from all over Romania
in any trimester of pregnancy. To date, 500 patients have been screened
for TORCH in this project. The statistical analysis was performed with
SPSS Statistics for Windows (v22.0, IBM Corp, USA), using Pearson
Chi-squared test for multi-group comparisons and independent-
samples t-test for normally-distributed continuous variables.
Results
We present the preliminary results for the first 200 patients screened,
with a mean ± standard deviation age of 31.2 ± 4.9 years, most of
them (81 %) from urban areas, with wide national coverage: 66.5 %
Bucharest-Ilfov, 26 % South, 3.5 % South-West, 2.5 % South-East and
1.5 % North-East Romania. Screening was performed at a median
(interquartile range-IQR) gestational age of 21.1 (11.8, 21.1) weeks.
The highest seroprevalence was recorded for CMV (95 %, with a me-
dian [IQR] value of 435.2 [317, 500] AU/mL), followed by rubella
(90 %, median [IQR] 88.2 [42.6, 161] IU/mL) and Toxoplasma (27.5 %,
median [IQR] 46.9 [26.2, 107.7] IU/mL). Anti-Toxoplasma IgM (or
IgM + IgG) were positive in 4.5 % (4 %) of patients, 1.5 % (1 %) for
rubella and 4 % for CMV (all 4 % IgM + IgG). Patients with positive
anti-CMV IgM had higher gestational ages at screening: 29.4 ± 9.7
vs. 21.6 ± 10.9 weeks (p = 0.048, t(193) = −1.988, high effect-size, d =
0.8). Patients with positive anti-Toxoplasma IgM were significantly more
likely to cumulate pregnancy-associated adverse-behaviors (e.g.,
smoking, p = 0.008, χ(2) = 9.620), while those with anti-Rubella IgM
were frequently ex-smokers (p = 0.004, χ(2) = 11.102). Rural dwelling
was not a risk factor for acute infections.
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We report high seroprevalence for major pregnancy pathogens, suggest-
ive for protective immunity, but also posing risk of reactivation during
pregnancy. The incidence of acute infections in pregnancy was fairly
low, but patients with such acute infections during pregnancy also
cumulated pregnancy-associated adverse-behaviors, requiring close
monitoring and specialized counselling.
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Background
Acute respiratory infections are the most common cause of hospitalization
in ICU in INBI Matei Balș so from 86 patients with severe sepsis admitted,
34 patients experienced respiratory dysfunction with ARDS, 19 patients ex-
perienced cardiac dysfunction and 17 patients showed dysfunction NSC.
ARDS is defined as an acute inflammatory syndrome characterized with bi-
lateral parenchymal lung infiltrates on chest x ray and PaO2/FiO2 ratio <
200, resulting from causes other than acute left ventricular dysfunction. In-
flammatory lung lesions may be induced by different causes like: viruses,
pathogenic germs, parasites, fungi, etc. The outcome of patients is de-
pending on the comorbidities, age, and status of immunocompromised
pattern and the stage of infection in the moment of admission in ICU.
Methods
Monitoring and analysis of clinical data, biological imaging, microbio-
logical and evolution of gases in the blood, guides us on the effect-
iveness of therapy and management to follow.
Results
Monitoring data presented above have demonstrated that of the 34
patients with acute respiratory failure (ARF), 26 patients developed se-
vere sepsis of bacterial etiology with ARDS with respiratory starting
point (nosocomial pneumonia). Pathogens involved were put out in
pathological products as: sputum - 1 case, tracheal aspiration - 8 cases,
hemoculture- 5 cases; invasive devices: catheters, e.g.: IOT (5 cases),
CVC (4 cases), urinary catheter (4 cases). Cocci pathogens accounted
for: 12 cases (pneumococcus - 8, MRSA - 3, Staphylococcus aureus - 2,
Enterococcu spp. - 2). Gram-negative bacilli: 13 cases (A. baumanii - 3,
Pseudomonas - 5, Klebsiela pneumoniae - 5). Fungi: 3 cases (C. krusei, C.
albicans, C. glabrata). Of the 26 developed nosocomial pneumonia 11
had unfavorable evolution, 42 % death rate. Median age of affected pa-
tients was 62.5 years. Antimicrobial therapy, according to microbiological
evidence included associations of last generation antibiotics in individu-
alized doses, ± antifungals ± antivirals (oseltamivir) in case of flu. ARF re-
quired specific protective measures using noninvasive ventilation or
mechanical ventilation. ARDS in influenza was analyzed separately.
Conclusions
Great progress has been made in the management of ARDS. Nowadays
novel agents and techniques are available, including antimicrobial
drugs, extracorporeal membrane oxygenation, as well as supportive
treatment (advanced mechanical ventilation). It seems that only the
subgroup of patients with relative mild, early ARDS are likely to benefit
from non-invasive ventilation.
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Granulicatella species are nutritionally variant streptococci. They are a
normal component of the oral flora, but have been associated with a
variety of invasive infections in humans, especially bacterial endocardi-
tis or abdominal abscesses. Recently, Granulicatella elegans was isolated
from the central nervous system (CNS) as well. CNS involvement has to
be early recognized since Granulicatella infections have an increased
morbidity and mortality as well as great bacteriologic failure and re-
lapse rates.
Case report
We present a case of a 53 years-old woman with meningitis, first con-
sidered to be tuberculosis (TB). She received antiTB treatment, includ-
ing streptomycin. Seven days after treatment initiation, the general
condition improved, but the patient experienced bilateral deafness as
well as severe disequilibrium, documented by pure tone audiometry
and vestibular investigations (posturography, videonystagmography
and video head impulse test – HIT). These permanent sensorial deficits
have a huge negative impact on quality of life – patient cannot com-
municate anymore, walk alone or perform daily activities. Together with
appropriate new antibiotic treatment for Granulicatella infection, hear-
ing aid and vestibular rehabilitation program were recommended. Very
few cases of Granulicatella meningitis are reported and none with hear-
ing and equilibrium deficit secondary to this infection. We consider this
case as a cochleo-vestibular bilateral deficit secondary to meningitis
more than to ototoxic treatment, since in the majority of adult cases
with ototoxic lesions, aminoglycosides affects only one of the sensorial
structures from the inner ear – hearing sensory epithelium or vestibular
one, but not both.
Conclusions
Granulicatella induce invasive infections. Rapid initiation of adequate
antibiotic therapy minimizes the severity of the disease as well as
long-term sequels. In this case, sudden severe bilateral onset of the
hearing loss limited communication and permanent hearing loss will
be partially compensated by the hearing aids. Regarding bilateral
vestibular deficit, rehabilitation is very difficult and long-lasting, with
dramatically limitations in daily activities.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Seasonal influenza is a public health problem, associated every year
with an important number of hospitalizations especially in elderly
population.
Methods
The aim of our study is to describe the clinical, epidemiological and
virological characteristics of the influenza cases in people aged
65 years or older, admitted in three infectious diseases hospitals from
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 67 of 76Romania (two in Bucharest and one in Iași) in the season 2015–2016.
The study was funded by I-MOVE+ project.
We screened patients admitted for signs and symptoms compatible
with influenza infection in three infectious diseases hospitals, from
week 53/2015 till week 20/2016. We collected information on demo-
graphics, vaccination and underlying conditions using a standardized
questionnaire. No personal data were transmitted with questionnaires
and patients gave a written informed consent to be swabbed. Cases
were patients RT-PCR positive for influenza and controls those negative
for any influenza virus.
Results
The influenza activity started in Romania in the week 4/2016,
reached the peak in week 9 and lasted until week 19/2016 and was
characterized by dominance of influenza A(H1N1)pdm09 viruses. We
enrolled in our study 190 subjects; 168 met the influenza clinical case
definition and the inclusion criteria and were analysed. Sixty-six patients
(39.9 %) were influenza laboratory confirmed. Six of them (9.1 %) were
vaccinated with seasonal influenza vaccine. Median age was 74.5 years
and 51.5 % were female. The most frequent signs and symptoms
presented at admission were: cough (98.5 %), fever (95.5 %), malaise
(87.9 %), shortness of breath and myalgia (69.7 %). 90.9 % had at least
one medical chronic condition. Heart diseases (77.3 %), diabetes
(37.9 %) and lung diseases (21.2 %) were the most frequent. Seven
patients (10.7 %) died, no one vaccinated. Majority of cases received
antiviral treatment. 57 cases (86.4 %) were positive for A/H1N1, 7
(10.6 %) for influenza A/H3N2, 2 (3 %) for B. All strains AH1N1 pdm09
isolated were antigenically related to vaccine strain, A/California/7/09-
like. The influenza viruses AH3N2 detected belonging to the genetic
group 3C, subgroup 3C.2a and the type B detected belonging to
B/Victoria lineage (B/Brisbane/60/2008).
Conclusions
People over 65 years old are at greater risk of complications from in-
fluenza, that might result in hospitalization or death. The most effect-
ive way to prevent influenza remains vaccination. Also, the antiviral
treatment may reduce severe complications and deaths.
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Background
Chickenpox is a common childhood infectious disease, very conta-
gious, usually benign and self-limited, and complications are believed
to be rare.
Methods
The purpose of this study is to describe the epidemiology of varicella
complications in immunologically healthy children admitted to Infec-
tious Disease Hospital of Brașov within the period January 2013 –
July 2016, and to analyze the clinical and evolutive aspects of studied
cases.
Results
Out of 178 cases hospitalized during this period with chickenpox
diagnosis, 165 presented various complications. The majority of compli-
cations occurred in preschool age children, with an impressive number
of cases (40 – 22.4 %) under one year of age. We found a gender
predominance (56.1 % male, 43.9 % female), primarily within the
urban population (74.1 %). The most frequent complication of varicella
was bacterial superinfection of skin lesions (40.6 %) and pneumonia(36.3 %). Cellulitis occurred in 67 cases, 11 cases presented abscess with
various locations (facial, extremities, trunk), requiring multidisciplinary
treatment. Streptococcus pyogenes was the leading cause of bacter-
ial infections (46.2 %), but also Staphylococcus aureus was found in
a few cases. Other cutaneous complications include hemorrhagic
varicella (3 cases) or purpura fulminans (1 case) which is associated
with thrombocytopenia and disseminated intravascular coagulation.
Invasive group A streptococcal disease (GAS) appeared in four cases,
presenting positive blood culture, and multiorgan involvement in two
cases, with favorable evolutions after treatment. Other complications
were neurologic, which were reported in 15 children (6 %); meningitis
was the leading diagnosis, followed by encephalitis and cerebellitis.
One case of decease occurred at a child with purpura fulminans.
Conclusions
Bacterial infections complicating chickenpox cause significant morbidity
and mortality, mainly in patients younger than 5 years of age. Varicella
increases the risk for acquiring GAS disease. Cellulitis is the most com-
mon infection, deep-seated and septic infections can occur in immuno-
logically healthy children with varicella. Chickenpox continues to cause
significant morbidity in the pediatric population.
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Background
Clostridium difficile colitis is currently a public health issue because of
the rising numbers of cases reported both in children and adults. This
condition arises because of excessive antibiotic use but also because of
the immunodepression caused by chemotherapy in oncological treat-
ments. We propose to appraise the clinical forms of Clostridium difficile
colitis in children as well as the evolution under treatment.
Methods
We have carried out a retrospective study on all cases of acute C. difficile
infection in children admitted in the Pediatric Department of the
National Institute of Infectious Diseases “Prof. Dr. Matei Balș” between
2013 and 2016. In all patients we have monitored age, sex, immuno-
logical status, clinical form of disease, and evolution under treatment.
The diagnosis of colitis was established based on clinical criteria
and confirmed through laboratory methods (detection of C. difficile
A/B toxin from stool). All cases received treatment according to
standard protocol except for one case where allergies to all antibi-
otics from the therapeutic schemes prompted us to perform fecal
microbiota transplantation.
Results
In the aforementioned period we have registered 24 cases of Clostridium
difficile colitis in children. The most affected categories were the 4–8
years age group (41.6 %), female patients (75 %), with 25 % of the pa-
tients being immunosuppressed. No deaths were registered, and 50 %
of cases relapsed (3 cases - 1 relapse, 4 cases - 2 relapses, 2 cases -
3 relapses, 3 cases - more than 3 relapses). In cases with more than
3 relapses we have performed fecal microbiota transplantation. In one
case with multiple antibiotic allergies, we performed fecal microbiota
transplantation as the first choice of treatment without any previous
antibiotic treatment. All fecal transplantation procedures were suc-
cessful, without any incidents, and none of the cases registered any
relapses.
Conclusions
Clostridium difficile colitis represents an important cause of morbidity
in children, with high numbers of relapses and sometimes, with a se-
vere life threatening evolution. Fecal microbiota transplantation rep-
resents an efficient alternative therapy to Clostridium difficile colitis
which is unresponsive to standard treatment.
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Background
Community-acquired pneumonia (CAP) is a common disease caused
by a wide variety of pathogens and may be a professional challenge.
In 1901, Sir William Osler noted in the fourth edition of his book,
“The Principles and Practice of Medicine”, that pneumonia is the most
important cause of morbidity and mortality of all acute diseases. More
than a century later, the prominence of pneumonia did not change,
the pneumonia being one of the most important causes of morbidity
and mortality worldwide. Objectives: to establish the demographic and
clinical aspects, evolution and etiology of CAP.
Methods
Retrospective study (July 2015-December 2015) on hospitalized patients
with CAP in Adult Infectious Diseases Clinics of “Victor Babeș” Hospital
Craiova; we analyzed demographic, clinical and laboratory data and the
evolution of cases.
Results
We identified 238 patients with CAP, which constituted the study lot.
General data of the study lot: gender distribution: 52 % male and
48 % female, 57 % (138) of patients were from urban areas, 43 %
(100) patients were from rural areas with the predominance of elderly
patients (50 % of cases aged over 60 years). The duration of
hospitalization in the study group was significantly higher than the
duration of hospitalization in patients with other infectious diseases
(7.06 days vs. 6.11 days, p < 0.0001). Most cases of CAP (69 %) were
typical pneumonia (by Laennec classification). Unfavorable outcome
was recorded in 4 % of cases. Evaluation by criteria of severity (i.e.,
CURB-65 score and sepsis criteria) in the study group showed that
most subjects met severity criteria, as follows: CURB-65 ≥ 3 points -
85 % of cases and sepsis defined by 2016 consensus criteria - 97 %
of the cases. In most cases, patients in the study group, associated
comorbidities, the most common comorbidity was chronic lung dis-
ease (37 % of cases). CAP etiology was identified in 15 % of cases.
The etiology most frequently involved in CAP in the study group
was represented by Streptococcus pneumoniae.
Conclusions
CAP patients were often elderly patients from urban areas. The duration
of hospitalization in subjects with CAP was significantly higher vs
subjects with other infectious diseases. The most common clinical
presentation was a typical pneumonia, meeting criteria of severity
(i.e., score CURB-65 ≥ 3 points and/or presence of sepsis criteria), in
a patient associated comorbidities and having sometimes a fatal
outcome. The most common identified etiology was S. pneumoniae.
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Background
Varicella is an eruptive disease with mild clinical evolution. Adult patients
can develop severe forms due to the complications that might occur.
The cardiac complications caused by varicella zoster virus are rare, but
with potentially high mortality rate, myocarditis being the most frequent
of them.Case report
We present the case of a 19 year old female patient diagnosed prior
to admission to our clinic, with generalized skin blisters and rash,
and fever (38 °C), chills, dyspnea at rest, precordial chest pain with
irradiation to both shoulders. The patient had no personal and
pathological antecedents or family history of cardiovascular disease.
During clinical examination, the patient presented mild fever (37,3 °C),
maculo-papular generalized rash, dyspnea at rest, 96 % SO2, normal
breathing sounds, tachycardia (108 bpm), ventricular gallop, mitral sys-
tolic murmur of Ist/IInd degree. Laboratory tests: troponin I 1.1 ng/mL,
positive IgM VZV serology. Echo, Coxsackie, CMV, Epstein Barr and
Toxoplasma IgM were all negative. VDRL, HIV serology negative. Normal
lung chest x-ray. ECG on admission showed sinus rhythm 100 bpm,
negative T waves in precordial leads V3-V5, in DII, DIII, aVF. Echocardi-
ography showed global hypokinesia, systolic dysfunction LVEF 45 %,
mitral valve prolapse, moderate mitral regurgitation IInd degree. The
diagnosis of intra-infectious myocarditis was established according to:
1) minimum 2 elements objectivized at clinical heart exam (tachycardia,
gallop rhythm, mitral systolic murmur of Ist/IInd degree), 2) etiological
context (maculo-papular generalized rash, Ig M VZV positive), 3) abnor-
mal enzymes values: troponin I 1.1 ng/mL, 4) ECG abnormalities (negative
T waves DII, DIII, aVF, V3-V5 - changes that did not exist on previous
ECG), 5) elements of myocardial dysfunction (echocardiography). After
5 days of treatment with acyclovir 4 grams/day, beta-blocker and bed
rest the evolution was favorable with precordial chest pain and dyspnea
remission and normal troponin I values. Echocardiography performed
after 7 days showed an improved LVEF 66 %, with persistent moderate
mitral regurgitation. ECG normalization was achieved in a few weeks.
Conclusions
Although varicella pneumonia is the most common cause of dyspnea,
myocarditis can be a complication of chickenpox that determines
shortness of breath. Early diagnosis and appropriate treatment of this
rare form of myocarditis can lead to complete recovery of the patient.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Diphtheria has been mostly eliminated, as a result of routine childhood
introduction of anti-diphtheria vaccination worldwide; in Romania the
last case being identified in 1989.
Case report
A 34 year-old female with no medical history presented to an Otorhino-
laryngology (ENT) Department in Bucharest for sore throat, odynopha-
gia, mild fever, malaise and bilateral referred otalgia dating back
3 days, and recently installed shortness of breath. The clinical ENT exam
and the laryngoscopy revealed: swollen palatine and lingual tonsils,
covered by purulent exudates, with edema of the posterior pharyngeal
wall, uvula, epiglottis and interarytenoid mucosa, as well as narrowed
glottis cleft. No throat swabs were performed at that moment. She was
diagnosed with probable epiglottic abscess and received treatment
with ceftriaxone, gentamicin, metronidazole and corticotherapy. Given
the absence of clinical improvement and the result of laryngoscopy:
coalescing, adherent pseudo-membranes spreading from the tonsils
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the suspicion of diphtheria. At admission in our clinic, a detailed
anamnesis revealed that she had developed shortness of breath
30 minutes after she had applied propolis tincture on the left tonsil.
Epidemiological investigation identified that the patient was completely
immunized during childhood and didn’t travel to endemic areas. The
clinical exam showed afebrile patient with a satisfactory general state,
without palpable lymph nodes, with balanced cardiovascular and re-
spiratory functions. The lab reports showed leukocytosis with neutrophi-
lia and acute inflammatory syndrome. Throat cultures were negative for
Corynebacterium diphtheriae, but positive for group F Streptococcus. The
levels of anti-diphtheria toxin IgG antibodies had protective value. In
order to monitor the evolution of the lesions, daily ENT consult and
flexible fiberoptic laryngoscopy were performed. Considering all this
data, we interpreted the case as viral acute tonsillitis followed by
caustic wound generated by the application of propolis tincture,
superinfected with group F streptococcus. The patient received treat-
ment with penicillin G and dexamethasone with full recovery after
9 days.
Conclusions
Although it is exceptionally rare now, diphtheria should not be ex-
cluded as differential diagnosis, especially given the latest Romanian
epidemiological report that shows a decrease to 65 % in childhood
vaccination rate and no immunization booster in adulthood. Natural
therapy may at times have a harmful effect, such as the one described
in the aforementioned case, or it can produce drug-drug interactions
which can increase/decrease the efficacy of medical therapy.
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Background
Diarrhea commonly occurs among HIV-infected patients, with many
possible causes, including infectious agents (especially opportunistic
germs because of immunity loss), cancer or antiretroviral therapy by
itself. Multiple prior hospital admissions, antibiotics use as treatment
or prophylaxis increase the risk of Clostridium difficile infection (CDI)
in these cases.
Methods
We retrospectively analyzed the HIV-infected patients with diarrhea
(defined as at least 3 loose stools in 24 hours) admitted in the Na-
tional Institute for Infectious Diseases “Prof. Dr. Matei Balș”, be-
tween 1 January 2015 and 31 December 2015. Incident cases were
defined as first positive C. difficile toxin A and/or B using enzyme
immunoassay technique, or PCR for toxin A/B gene in stool samples
using GENEXPERT method. The relapses of CDI were excluded from
our study.
Results
18 patients completed the inclusion criteria, representing a total of
24 % of the HIV-positive patients with diarrhea, and 75 % of the
HIV-positive patients with infectious etiology of diarrhea, in whichCDI was the most frequent agent. Male gender prevailed (61,19 %),
with a mean age in our group of 40 years (ranging from 26 to
60 years) and an average hospitalization period of 27 days (ranging
from 2 to 68 days). In 94.5 % of the cases, the diagnosis was estab-
lished by PCR. 94.44 % of cases had previous hospitalizations within
the last 3 months and 72 % had a recent antibiotic treatment, other
than regimens used for opportunistic infection prophylaxis. As for
the biological abnormalities, the mean WBC count was 6300/cmm
(ranging from 1990 to 12690/cmm). The average value of CD4 cell
count was 231 cells/cmm (ranging from 4 to 1044 cells/cmm).
61.11 % of the patients had a CD4 cell count under 200 cells/cmm.
A sustained under-treatment viral suppression was noticed in
61.11 % cases from a total of 84 % of cases being under antiretro-
viral therapy. Remission of the symptoms was obtained by using
oral treatment with vancomycin in 72.22 % of the patients, metro-
nidazole in 22.22 % and intravenous treatment with tigecycline in
5.55 %. No case of fulminant CDI was reported and no death case dir-
ectly attributable to CD infection. 5 patients of all (27.77 %) encoun-
tered relapses.
Conclusions
In our study, conformable to international medical data, Clostridium
difficile proved to be the most frequent cause for infectious diarrhea
in HIV-positive patients.
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Background
Candida superficial mycosis are very common fungal infection, one
of the most frequent being Candida stomatitis. It is usually associated
with immunocompromised status and with certain nutrition habits. A
serious epidemiological evaluation for Romania was not published,
yet.
Methods
The raw data were obtained from the Medical Statistic Direction of the
Romanian Ministry of Health (2008–2012 data from the entire country).
A statistical analysis based on usual methods (mean, standard devi-
ation, Annova, Fisher tests, T Student, and other tests were performed
in order to validate the results.
Results
We identified more that 3963 cases with an annual average of 793
cases. Most were registered in urban areas (2311 cases, 463/year), com-
paring with rural areas (1652 cases, 331/year) affecting mainly men
(232 cases/year). Comparing with the other Candida infections the
stomatitis represents an average of 46.6 %. The incidence of cases
is higher at 0–4 years old group (51.2 %), mainly in male children
between 0–1 years old. Over age 4 the percentage tends to re-
verse. The tests showed a significant correlation with age of the
patients.
Conclusions
Candida stomatitis is more frequent in urban areas (463 cases/year),
more than half being men (232/year) and little children. More stud-
ies are needed in order to evaluate the involvement of different
Candida species in the infections. More laboratory confirmation
data are needed and a very good collaboration between laboratory
doctors, clinicians and epidemiologists is strictly necessary.
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Background
Anthrax is considered a rare disease in the European countries.
Twenty-one cases were reported (14 confirmed) in 2012, in Europe
(last update by ecdc.europa.eu). In Romania, the National Institute of
Public Health confirmed one case in 2013, 2 probable cases in 2014
(among 7 suspicions) and 2 confirmed cases in 2015 (among 6 suspi-
cions): all cutaneous form, one meningo-encephalitis. All were related
to animals and/or animal products exposure. The aim of our study is
to describe the anthrax cases recently diagnosed in south-eastern
Romania.
Methods
We reviewed the data of the patients admitted with anthrax suspicion,
in 3 infectious diseases (ID) hospitals from south-eastern Romania: Na-
tional Institute ID-Bucharest, Pitesti-County Hospital and Constanța-ID
Hospital, between January 2013 and August 2016. Along with ECDC
definitions of “confirmed” and “probable”, we used the category of
“suspected” case from CDC* definitions. (*http://wwwn.cdc.gov/nndss/
conditions/anthrax/case-definition/2010/).
Results
Among 9 suspicions, 4 were “confirmed”, 2 “probable” and 3 remained
“suspected”. All had cutaneous lesions. In one, the main form was
meningo-encephalitis. Median age was 43 year-old (34–67), male:fe-
male ratio 5:4. All live in rural areas and have been in contact with
cows/goats/sheep. Case 1/2013: confirmed, 34 year-old man, butcher:
black eschar and malignant edema on left upper limb; subsequently
developed necrotizing fasciitis, superinfected with MDR Gram-negative
bacilli, requiring adapted salvage antibiotic therapy and surgical de-
compression. Cases 2, 3&4/2014: suspected cases, females (39, 51,
57 year-old), painless red-vesicular lesion and black eschar on fingers,
surrounding edema, after contact with similar lesions on animals. All
had positive B. anthracis in-house serology. Case 5/2015: a 43 year-old
shepherd with meningo-encephalitis: fever, psycho-motor agitation,
hemiparesis, aphasia, neck-stiffness, CSF compatible with acute bacter-
ial meningitis; black eschars on both hands. From CSF and cutaneous
lesions, DNA-Bacillus anthracis was positive PCR-techniques performed
in Victor Babeș Clinical Hospital, Bucharest, where the patient was
transferred in ICU). Cases 6,7,8&9/July 2016: 2 confirmed, 2 probable, all
shepherds with deceased animals, all cutaneous forms: a cluster of 3 (2
men and a woman: 67, 42 and 61 year-old) and a 34 year-old man. All
patients had favorable evolution.
Conclusions
There is an important increase in anthrax cases in south-eastern
Romania, all in animal-breeders, connected with an inappropriate
veterinary surveillance. Not all cutaneous forms had a rapid good
evolution, one developed potential fatal complications. The anthrax
meningo-encephalitis described here had an unexpected favorable
outcome, probable due to the young age, good previous health,
early suspicion and prompt treatment.
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Written informed consent was obtained from the patients for publica-
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Background
The outbreak of Ebola virus disease (EVD) in 2014 has exerted a great
pressure on healthcare systems both inside, but also outside the
African continent, in the attempt to identify and manage imported
cases in order to prevent further transmission. In Romania, the National
Institute for Infectious Diseases “Prof. Dr. Matei Balş” was the desig-
nated medical facility to manage possible cases of EVD. Our study aims
to evaluate the knowledge, attitudes and risk perception of the Insti-
tute’s healthcare workers (HCWs) regarding Ebola virus disease and the
recent epidemic.
Methods
We designed a cross-sectional survey based on a self-administered
printed questionnaire comprised of 26 questions. In June 2016, all
medical doctors and nurses were invited to take part voluntarily and
anonymously in the study. Data were analyzed using Microsoft Excel
(2013) and IBM SPSS Statistics (v. 22).
Results
Questionnaires were filled out by 157 HCWs. Physicians represent
36 % of all respondents. All participants are familiar with Ebola virus
disease, but only 54 % of nurses had learned about it before the
2014 epidemic, as opposed to 75 % of medical doctors. The most fre-
quent symptoms and main routes of Ebola virus transmission were
correctly identified by the majority of respondents, whereas the pos-
sibility of airborne transmission was the most common mispercep-
tion (55 %). During the epidemic, participants were slightly more
worried for the health of their families, mean score 6.25/10, rather
than for personal risk of contracting Ebola, 5.88/10 (p = 0.025). HCWs
who had been involved in the medical care of Ebola suspect cases
are two times more likely to volunteer to care for such patients in
the future (RR = 2.475, 95 % CI 1.283–4.774, p = 0.039). Participants
obtained most of the information on Ebola at their workplace (82 %);
92 % of HCWs attended at least one specific training and 64 % believe
there are adequate personal protection methods available at the Insti-
tute. Donning/removing personal protective equipment was the most
frequented course (85 %). Many participants think they were provided
with sufficient information on EVD (66 %), but wanted to know more
about preventive methods, treatment and the preparedness plan of
Romania.
Conclusions
Most HCWs possess significant knowledge about Ebola virus disease.
During the African epidemic, they experienced a moderate degree of
worry and relied mostly on information provided at the Institute. Our
study reveals the importance of professional education offered to
employees by medical institutions and could help improve training
sessions held during public health emergency situations.
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Extensive masses due to abdominopelvic actinomycosis raise challen-
ging diagnostic and therapeutic problems due to frequent confusions
with malignant tumors. First-line therapy includes high doses of penicil-
lin over a prolonged period up to 6 months. Data concerning other
antibiotics or shorter courses of therapy in actinomycosis are limited.
We present a case of abdominopelvic actinomycosis with a complete
remission after 42 days of penicillin combined with 21 days of tigecyc-
line, in a 42 year-old woman hospitalized in “Matei Balș” National Insti-
tute for Infectious Diseases between 22.02-05.04.2016, who was later
followed for 12 weeks after treatment.
Case report A 43 year-old woman with solitary right kidney and a
12-year history of an intrauterine device presented to the urology
department of “Sf. Ioan” Clinical Emergency Hospital for a 2-month
history of nausea, abdominal pain, 8 kg weight loss and dysuria. Im-
aging and laboratory investigations revealed severe anemia, obstructive
renal failure, right ureterohydronephrosis and a large retroperitoneal
mass of 10 cm× 9 cm× 10.4 cm involving the right ovary and uterus,
invading the sigmoid, rectum, urinary bladder and compressing the
right ureter. A double J stent and a urinary catheter were placed. The
patient was consulted in the surgery ward for what was believed to
be a metastatic ovarian carcinoma. Exploratory laparoscopy revealed
dense but friable adhesions allowing only a left anexectomy with par-
tial omentectomy and impeding a complete resection. Histological
samples showed an inflammatory granulomatous tissue with multiple
abscesses containing colonies of Actinomyces spp. and the patient was
referred to the “Matei Balș” National Institute for Infectious Diseases.
The patient was started on penicillin 12 million units/day for a total of
42 days. After the first 10 days of penicillin, tigecycline (100 mg/day)
was added for 21 days for the treatment of concurrent urinary infection
with MDR Klebsiella pneumoniae resistant to colistin and sensitive only
to tigecycline and fosfomycin. The patient had a favorable clinical and
biologic outcome. A CT assessment after 4 and 12 weeks revealed
complete remission of the abdominopelvic mass with right ureterohy-
dronephrosis and a few small abdominal adenopathies (<11 mm).
Conclusions
The case highlights the favorable effect of tigecycline for 21 days
associated with the standard therapy of penicillin in a case of abdo-
minopelvic actinomycosis with a remission at 6 weeks of therapy.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Raoultella planticola is a gram-negative bacillus that was primarily
considered as environmental bacteria, belonging to family Enterobacte-
riaceae and related to Klebsiella spp. R. planticola is sensitive to cephalo-
sporins, aminoglycosides, fluoroquinolones; strains of R. planticola with
resistance to almost all clinically available antibiotics except tigecycline
and colistin have been reported. The reports of R. planticola infections
are limited; this bacterium has been reported in cholecystitis, urin-
ary tract infections, skin and soft tissue infections, pancreatitis and
pneumonia.
Case report
We present a case of a 70 years old male from rural areas hospital-
ized in the Adult Infectious Diseases Clinics of “Victor Babeș” Hospital
Craiova. The onset of illness was 7 days before admission with fever,
chills and productive cough with purulent sputum. Medical history:
hypertension and congestive heart failure class III NYHA. Admissionexam: afebrile, right basal crackles at chest exam. Biological examination
reveals: complete blood count - leukocytes number 7760 cells/mL with
granulocytes percentage of 72.4 %; the rest of the biological exam in
normal limits. Chest X-ray: right infrahilar internal alveolar opacity and
cardiomegaly. Sputum culture reveals bacteria initially considered as
Klebsiella spp. and further identified as R. planticola sensitive to amoxicil-
lin/clavulanate, ceftriaxone, cefuroxime, trimethoprim/sulfamethoxazole,
tetracycline, moxifloxacin and resistant to ampicillin. The patient re-
ceived moxifloxacin with favorable evolution after 7 days of treatment.
Conclusions
R. planticola infections are recently reported in human pathology
and there are very few published cases of pneumonia. The bacteria
can be confused with Klebsiella spp. and this could be an explanation
of the scarcity of cases recorded in literature. Our case is not a health
care associated infection; the patient comes from rural areas. In general,
sensitivity to common antibiotics does not raise special problems (as
was the presented case), but there are clearly aggressive, multiresistant
strains, that could problematize treatment in the future.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Vitamin D, a secosteroid, has different immunomodulatory properties.
Several recent studies have demonstrated the relationship between
vitamin D deficiency and the severity of illness and mortality. The
purpose of this study was to assess the vitamin D (25(OH)D) status
in pediatric patients with sepsis and the association with severity
score and biochemical characteristics.
Methods
The study was conducted at the pediatric department of Teaching
Hospital of Infectious Diseases, Cluj-Napoca, between February and
March 2016. We performed a prospective clinical observational study
among children 1–18 years of age, admitted to our department. All
consecutive patients with infection were screened for sepsis criteria
at admission and were stratified in two groups with and without sepsis.
Serum vitamin D measurement was performed in all patients within
2 days of admission and deficiency was defined as concentration of
25(OH)D <20 ng/mL. Electronic database included age, gender,
diagnosis, identified microorganisms, Pediatric Risk of Mortality III score
(PRISM-III), hematological and biochemical characteristics. Statistical
analysis was performed by using GraphPad-Prism5. Mann–Whitney test
was used to compare nonparametric variables. The relationship be-
tween vitamin D deficiency and clinical or biochemical variables was
determined by relative risk and Spearman’s rank correlation.
Results
Twenty-eight children with sepsis and 21 without sepsis were enrolled.
In all children enrolled, we found a negative correlation of 25(OH)D
levels with PRISM-III score (R =−0.333, p = 0.01) and a positive correlation
with iron, total and ionized calcium levels (R = 0.312, p = 0.03, R = 0.394,
p = 0.007, respectively R = 0.515, p = 0.001). Patients with sepsis had a
significantly lower median levels of 25(OH)D compared to cases without
sepsis (21.35 ng/mL versus 34.8 ng/mL, p = 0.0004). The relative risk for
sepsis was 2.22 (p = 0.03, specificity 0.79) and for PRISM-III >5 was 3 (p =
0.03, specificity 0.729) at vitamin D concentration <20 ng/mL. Compared
to the group without sepsis, the sepsis group had significantly lower
levels of HDL-cholesterol (22 mg/dL vs. 38.4 mg/dL, p = 0.015), albumine
(3.6 g/dL vs. 4.08 g/dL, p = 0.005), total and ionized calcium (9.4 mg/dL
vs. 9.8 mg/dL, p = 0.01, respectively 4.3 mg/dL vs. 4.8 mg/dL, p = 0.02).
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 72 of 76Conclusions
In pediatric population vitamin D deficiency was associated with
sepsis and higher PRISM-III score.
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Background
There were seen 45 patients who presented to the Infectious Disease
Hospital, “Toma Ciorbă” with complains of insects bites during May
and June 2016. Thirty of them were bitten by Ixodes ticks.
Methods
We studied the clinical and epidemiological aspects and prophylaxis of
Lyme disease among patients who presented with tick bites to the Clinical
Infectious Disease Hospital “Toma Ciorbă”, Chișinău, Republic of Moldova.
Results
Among 30 patients with tick bites 21 were women with the average age
of 40.8 years and 9 men, aged 58.1. 25 persons were from urban and 5
from rural areas. Seventeen patients (1st group) did not show symptoms
of Lyme borreliosis while 13 (2nd group) were diagnosed with Lyme dis-
ease (LD). The mean span, while ticks were attached to the host was in
average 1.7 days among persons in the first group while in second one -
2.5 days. The incubation period in LD patients varied from 7 to 32 days,
and lasted in average 13 days. The diagnosis was established based on
clinical presentations, erythema migrans (EM) and was confirmed by
ELISA IgM and IgG anti Borrelia burgdorferi (Bb) antibodies. The most fre-
quently revealed were complains on EM, pain and local burning sensa-
tions. Patients from the first group were given prophylactic treatment
with doxycycline 200 mg as a single dose or amoxicillin in case of contra-
indications. None of them developed LD during a 45 days follow up
period. Treatment for LD patients was successful in most of the cases; 4
patients were given doxycycline 100 mg twice daily (BD) for 14 days, 2 -
for 10 days and 1 had doxycycline 100 mg BD for 21 days. Amoxicillin
500 mg orally TID for 14 days was prescribed to 3 patients and for 10 days
in the same dosage to 2 patients. One person was given ceftriaxone 1 g
BD for 21 days. Most of the patients had treatment as outpatients and
just in 1 case the patient needed hospital treatment. During 45 days fol-
low up period 1 patient was still complaining of anxiety, headaches and
insomnia. Another one complained of general weakness. In one case skin
lesions persisted despite of long lasting courses of antibiotics.
Conclusions
During a 60 days period LD was diagnosed in 13 patients who pre-
sented to the hospital with a history of tick bite. Fourteen patients
were given doxycycline or amoxicillin as a prophylactic treatment
which proved to be effective in all cases. Patients with LD were
treated successfully with doxycycline or amoxicillin for a course last-
ing from 10 to 14 days as outpatients. In most of the acute LD cases
outcomes were favorable.
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Drug-resistant (DR) tuberculosis (TB) is a growing problem in HIV-
infected patients, being associated with high rates of treatment failure
and mortality. According to WHO, in 2014, 312 (2.1 %) patients di-
agnosed with TB were HIV-infected. The rate of multidrug resistant
TB (MDR-TB) was 2.8 % (1.8–4.2) in the newly diagnosed TB cases
and 11 % (8–15) in the retreatment group. Objective: Our aim was to
describe clinical and laboratory characteristics of DR-TB in HIV infected
patients.
Methods
We retrospectively analyzed HIV-infected patients diagnosed between
January and December 2015 with TB in six tertiary care facilities in
Romania. We included patients with diagnosis of DR-TB based on
genotypic (MTB/RIF Xpert) and/or Löwenstein-Jensen culture plus
drug susceptibility testing.
Results
We identified 150 HIV-infected patients with TB, of which 102 (68 %)
had microbiological confirmation. Nineteen (19 %) patients had DR-TB:
six (6 %) patients had resistance to isoniazid, 7 (7 %) to rifampicin and
6 (6 %) had MDR-TB. HIV diagnosis was established before TB diagnosis
in 14 (74 %) patients with DR-TB, respectively 59 (58 %) patients with
drug susceptible (DS) TB (p = 1, OR[95 % CI] 1.1[0.3–3.5]). The median
age was 28 years both in the DR-TB group (IQR 26–40) and in the DS-
TB group (IQR 26–37) (p = 0.648). Males represented 68 % in DR-TB
group vs 67 % in DS-TB group (p = 1, OR[95 % CI] 0.9[0.3–2.7]). In the
DR-TB group, 14 (74 %) patients had pulmonary TB, 2(10 %) extrapul-
monary TB and 3 (16 %) patients had concomitant pulmonary and
extrapulmonary TB. In the DS-TB group, 47 (57 %) patients had pulmon-
ary TB, 15 (18 %) extrapulmonary TB and 21(25 %) patients had con-
comitant pulmonary and extrapulmonary TB. At TB diagnosis 9 (64 %)
patients with DR-TB were on antiretroviral therapy vs 43 (52 %) patients
with DS-TB (p = 0.8, OR[95 % CI] 0.8[0.3–2.2]). Seven (50 %) patients in
the DR-TB group vs 33 (40 %) in the DS-TB group were on co-
trimoxazole preventive therapy (p = 1, OR[95 % CI] 0.8[0.3–2.4]). Six
(32 %) patients with DR-TB had previous treatment vs 10 (12 %) pa-
tients with DS-TB (p < 0.005, OR[95 % CI] 5.5[1.7–17.8]). The rate of MDR
was 4.6 % in the newly diagnosed TB cases and 12.5 % in the retreat-
ment group. In-hospital mortality rate was higher in patients with DR-
TB (37 %) vs patients with DS-TB (14 %) (p = 0.016, OR[95 % CI] 3.6[1.2–
10.5]). The median CD4 cell count in patients with DR-TB vs those with
DS-TB was 18 (10–96) cells/cmm vs 84 (21–189) cells/cmm (p = 0.032).
Conclusions
In HIV-infected patients DR-TB caused was associated with previous
treatment, lower median CD4 cell-count and increased in-hospital
mortality. There were no statistically significant differences between
the two groups regarding the TB site. The rate of MDR was greater
than in HIV non-infected patients.
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Background
Some urinary infections are considered to be triggers for interstitial
nephropathies. The most frequent urinary infections are determined
by bacteria, rarely by viruses or yeasts. The authors aimed to evaluate
if kidney injury molecule-1 (KIM-1) could represent a specific serological
marker in patients with urinary tract infections susceptible to develop
kidney dysfunction.
Methods
The authors developed a prospective study on 55 patients with urinary
tract infections caused by Escherichia coli and 30 control cases. All the
subjects were adults, with normal serum lipids, normal weight and a
balanced diet. Serum profile of KIM-1 (ELISA method) was analyzed by
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 73 of 76correlation with markers of renal dysfunction. The renal function
was evaluated by serum urea, serum creatinine, estimated glomerular
filtration rate (eGFR), albumin/creatinine ratio and uric acid/creatinine
ratio.
Results
Compared to the control group (158 ± 39 pg/mL), the serum
levels of KIM-1 were higher in patients with urinary infections
(246 ± 82 pg/mL, p = 0.002). A negative correlation between KIM-
1 levels and eGFR was observed in patients with urinary tract
infections (r = −0.542, p = 0.001), and a positive association between
KIM-1 and serum creatinine (r = 0.329, p = 0.015). No significant
correlation between KIM-1 and other analyzed parameters were
determined.
Conclusions
These results sustain the idea that KIM-1 could be a prediction factor
for renal dysfunction in patients with urinary infections.
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Background
Benign prostate hyperplasia (BPH) is a multifactorial pathology that
affects life quality in elderly men. Recurrent urinary tract infections,
frequently present in patients with obstructive benign prostate
hyperplasia (BPH), could determine molecular disorders. The aim of
the study was to investigate the effects of urinary tract infections
on serum gangliosides.
Methods
The study included 60 subjects with benign prostate hyperplasia
grouped, as follow: group A – 30 cases of benign prostate hyperpla-
sia with urinary tract infections, group B - 30 cases of benign pros-
tate hyperplasia without urinary tract infections. Gangliosides status
by prostate specific antigen (PSA), C-reactive-protein (CRP), prostate
volume and IPSS were determined. Serum levels of gangliosides
were determined by spectrophotmoteric method using resorcinol-
clorhidre, evaluated at 580 nm. PSA was determined by ELISA, CRP
by immunoturbidimetry.
Results
Serum levels of gangliosides were significantly higher in patients
with BPH and urinary tract infections compared with those without
infection (28.4 ± 4.1 mg/dL in group A versus 22.7 ± 6.3 mg/dL in
group B, p = 0.022). The statistical analysis showed the following
correlations: between serum levels of gangliosides and PSA: r =
0.339, p = 0.053 in group A, r = 0.128, p = 0.042 in group B; between
serum gangliosides and CRP: r = 0.301, p = 0.027 in group A, r =
0.326, p = 0.054 in group B, between serum gangliosides and IPSS:
r = 0.367, p = 0.047 in group A, r = 0.209, p = 0.058 in group B. No
relation between serum gangliosides and prostatic volume was
observed.
Conclusions
Increased levels of serum gangliosides in patients with BPH could be
considered a defense mechanism against infections, important in main-
taining a vital biological balance. Serum gangliosides could represent a
useful monitoring parameter in patients with obstructive prostate
benign hyperplasia and urinary infections.A110
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Background
Toxocariasis is caused by a series of related nematode species that
routinely infect dogs and cats throughout the world. This study is a
warning on geographical regions underestimated. In the region of
Moldova (Iași) toxocariasis is frequent in dogs, cats and foxes.
Methods
In the studied period (2013–2015), 180 cases of toxocariasis were
admitted to the Iași Infectious Diseases Hospital.
Results
Toxocariasis prevalence in our geographic region is 51.7 %, with no
significant gender differences. We can say that the majority of cases
(66.5 %) were in the age group of 30–39 years and 40–49 years,
while the minimum number of cases was found in the age group
60–69 years – (4 cases). The gender distribution of cases shows that
91 % of cases were women, 122 cases (67.77 %) being owners of
pets (dogs). General clinical manifestations were represented by latch
edema (44.44 %), headache (43.33 %), paresthesia (36.66 %), sweating
(35.55 %), hoarseness (27.77 %), exanthemas (21.11 %) and abdominal
pains (11.11 %). Locating ocular larvae of T. canis occurred more often
in older children (10–16 years) and in adults. In the studied cases we
met decreased visual acuity in 9 cases, 6 cases of uveitis, 2 cases with
retinal granuloma, and 4 cases of endophthalmitis, all cases being hos-
pitalized in Ophthalmology Clinics for appropriate therapy. Biochemical
tests useful for diagnosis were represented by: major hypereosiniphilia,
hyperleukocytosis, increasing ESR and gammaglobulin. In our study,
leukocytosis was found in 62 % of cases and hypereosiniphilia in 88 %.
For the certain diagnosis of toxocariasis we used serological methods
which consisted in determination of specific Toxocara antibodies.
Toxocara antibodies were present in all studied patients. The result was
positive in 96 (69.56 %) cases and negative in 42 (30.43 %) cases. An
IgG antibody titer of 1/100 was found in 40.5 % cases. The described
complications and sequelae were met in 42 cases: respiratory disor-
ders, ocular larva migrans, splenomegaly, uveitis, chorioretinitis and
hepatomegaly.
Conclusions
Toxocariasis is characterized by expression of polymorphic clinical
manifestations, from asymptomatic to various clinical forms with severe
expression. What is needed in terms of future control programs is the
radically development of new approaches, such as the effectiveness of
molecular vaccines or based on DNA, offering the possibility of lifelong
protection.
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Background
The most pyogenic infections in the oro-maxillo-facial region are of
odontogenic origin and are mixed infections, involving aerobic and
anaerobic bacteria. The microbiological investigation is not commonly
performed in such infections. The aim of the present study was to
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 74 of 76identify at species level a collection of 31 isolates of anaerobic
Gram-positive cocci, stored in ultra-freezer at the laboratory of the
Microbiology Department, Faculty of Dentistry, University of Medicine
and Pharmacy (U.M.F.) “Carol Davila” - Bucharest. The strains had been
previously isolated from pus samples collected by needle aspiration
from 31 patients among those treated for different types of odonto-
genic abscesses (vestibular abscess, submandibular abscess, etc.) at the
Department of Oro-Maxillo-Facial Surgery, U.M.F. “Carol Davila” -
Bucharest, during March 2012 - March 2014.
Methods
The isolates of anaerobic Gram-positive cocci were identified at spe-
cies level using the Rapid ID 32 A system (BioMérieux, Marcy-l’Etoile,
France).
Results
All isolates except one belonged to Parvimonas micra (formerly
Peptostreptococcus micros and Micromonas micros). The remaining strain
was identified as Finegoldia magna (formerly Peptostreptococcus
magnus).
Conclusions
Parvimonas micra is by far the predominant species of anaerobic
Gram-positive cocci involved in odontogenic abscesses. Species iden-
tification must not be neglected in oro-maxillo-facial infections due
to its contribution to a better understanding of the etiopathogenesis
of such infections.
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Background
One of the most challenging aspects of Clostridium difficile infection
(CDI) is its propensity to recur. First-line therapies were associated
with high rates of recurrences. Objective: To assess the factors associ-
ated with recurrences in patients hospitalized with CDI.
Methods
Retrospective cohort study of adults admitted between September
2014 and August 2015 for CDI. We included patients diagnosed on
clinical symptoms and detection of CD toxin in stool using polymerase
chain reaction, which were treated with metronidazole, vancomycin
and vancomycin plus at least 7 days of tigecycline. We excluded epi-
sodes in whom data to calculate Atlas severity score were not available.
Recurrence was defined as another episode of diarrhoea, with positive
toxin test within 8 weeks after the onset of the previous episode.
Results
From a total of 660 episodes of CDI we included 437 episodes (in 359
patients), of which 40 (9 %) were treated with metronidazole, 328
(75 %) with vancomycin and 69 (16 %) with tigecycline associated with
vancomycin. Eighty-eight (20 %) episodes were CDI recurrences after
the included episode. Forty-four (50 %) episodes from the recurrences
group versus 156 (45 %) episodes from the group without recurrences
were men (p = 0.22). The median age was similar for both groups:
71 years for patients with recurrences versus 70 years for patients
without recurrences. There was no difference regarding the median
Charlson score (4 for both groups) and the median Atlas severity
score (3 for both groups). A neoplastic disease was diagnosed in 14
(16 %) CDI recurrence episodes versus 49 (14 %) CDI non-recurrence
episodes (p = 0.423). The CDI recurrence episodes included in our
analysis were treated with metronidazole in 9 (10 %) cases, vancomycin
in 68 (77 %) cases and vancomycin plus tigecycline in 11(13 %) cases(p = 0.617). Thirty-three (38 %) episodes with recurrence as outcome of
the included episode were preceded by recurrences versus 108 (31 %)
episodes without recurrences after the current episode (p = 0.148).
We did not find any significant association between CDI recur-
rences and age over 70 years (p = 0.283), albumin value less than
3 g/dL (p = 0.201), leukocytes number greater than 15000/cmm (p =
0.552), presence of acute renal insufficiency (p = 0.236) or concomitant
systemic antibiotic therapy (p = 0.371).
Conclusions
CDI recurrences were not correlated with older age, presence of a neo-
plastic disease, administration of concomitant systemic antimicrobial
therapy, history of another CDI recurrence, severity of CDI, expressed
by lower albumin, high number of leukocytes or presence of acute
renal insufficiency. Associating tigecycline did not reduce the re-
currences compared to conventional therapy (metronidazole or
vancomycin).
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Background
With the incidence of tuberculous osteodiscitis on the rise, Mycobac-
terium tuberculosis is currently considered the second etiological
agent of osteodiscitis.
Case report
A 65 year-old female presented to our clinic for low-grade fever with
intense back pain that progressed to the medial side of both lower
limbs, with paresthesia in the left leg and pain in the right iliac fossa
dating back 14 days. Medical history revealed stage 2 hypertension,
right sylvian hemorrhagic stroke (2010) with left sequel hemiparesis
and bilateral pulmonary thromboembolism (2010). The clinical exam
showed left sequel hemiparesis, slightly diminished deep tendon re-
flexes on the left side and intensely impaired mobility. The lab reports
showed acute inflammatory syndrome, coagulation disorders and ele-
vated serum creatinine. A lumbosacral spine MRI scan conducted one
day prior to admission described L4-L5 spondylodiscitis with massive
anterior epidural abscesses and right paravertebral abscess. It was ini-
tially labeled as probably staphylococcal osteodiscitis and therapy was
initiated with rifampin and levofloxacin with no clinical improvement
and persistence of low-grade fever after 5 days, when rifampin was
changed to linezolid. The evolution was apparently favorable (afebrile
with decrease in biological inflammation markers), but the MRI con-
ducted after one month of treatment revealed lesion progression. She
was transferred to neurosurgery where a L4-L5 laminectomy was per-
formed and during surgery a gray-yellow mass suggestive for Mycobac-
terium tuberculosis (TB) etiology was found. Wound and blood cultures
were negative, Gram stain showed no bacteria and Ziehl-Neelsen stain
failed to show acid-fast bacilli. Still, the histopathologic examination
was highly suggestive for Mycobacterium tuberculosis etiology and anti-
TB therapy was initiated with the 4-drug-regimen: isoniazid, rifampin,
pyrazinamide, ethambutol, with clinical and biological improvement. So
far, the patient has undergone anti-TB therapy for 3 months with
neurological improvement and a repeat MRI scan is scheduled when
the patient completes 5 months of therapy.
Conclusions
In the presented case, the clinical and radiological findings were insuffi-
cient to allow the differentiation between tuberculous and staphylococcal
etiology. Additionally, the activity of anti-staphylococcal agents such as ri-
fampin and linezolid on Mycobacterium tuberculosis masked the clinical
progression of the disease and further prolonged the time to etiological
BMC Infectious Diseases 2016, 16(Suppl 4):602 Page 75 of 76diagnosis. Bacteriological tests failed to identify the etiologic agent, and
the definite diagnosis was eventually based on histopathologic examin-
ation, highlighting the importance of obtaining a tissue specimen to
allow accurate diagnosis and correct interdisciplinary management.
Consent
Written informed consent was obtained from the patient for publica-
tion of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor of this journal.
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Background
Respiratory syncytial virus (RSV) is an important pathogen that causes re-
spiratory infections often severe and even death especially in children
younger than 6 months. There are certain population groups that may
be vulnerable to severe RSV infections, as pregnant women, immuno-
compromised patients and persons with chronic diseases. Usually the
clinical aspect does not differ from those determined by other respiratory
viruses and RSV often causes co-infections with other respiratory viruses.
Methods
We examined nasopharyngeal swabs taken from 646 patients diag-
nosed with SARI (severe acute respiratory infection) and admitted to
20 hospitals from six counties and Bucharest. Laboratory techniques:
(1) real-time RT-PCR (reverse transcription-polymerase chain reaction)
for the detection of influenza viruses type A and type B; (2) multiplex
RT-PCR commercial kit RT-PCR One-Step ACE Seeplex (Seegene) for
the detection of other respiratory viruses, and (3) sequencing of a
fragment of 212 base pairs of the gene SH RSV B for identification
and confirmation of RSV.
Results
Of the 646 samples, 339 were positive: 309 for Influenza Virus-IV and 30
for other respiratory viruses; 19 RSV, 1 hMPV (human MetaPneumoVirus),
2 Coronavirus 229E, 1 Adenovirus, 2 Rhinovirus, 5 Bocavirus. Three of the
patients positive for RSV died (one death occurred in a woman of
82 years, one in a woman aged 59 years and one in a child 5 months).
The three deceased patients had associated diseases. We mentioned
that in February 2015 we reported a death from a child aged 2.9 years
with type B of RSV disease and who didn’t present associated diseases.
Lung samples were sequenced from this patient to confirm the pre-
sumptive diagnosis of RSV infection caused by type B. Sequencing
showed 100 % identity between the two pieces of lung and 97–98 %
identity with sequences from GenBank.
Conclusions
Although type B of RSV didn’t give severe clinical forms, in the case
of the child aged 2.9 years, RSV type B induced a severe clinical
form which resulted in death. In patients with associated chronic
diseases, RSV can cause either death or serious infections. Infections
like flu and infections due to RSV can spread easily in the commu-
nity. Pathogenicity mechanisms for understanding this infection are
needed along with more studies for genotyping and gene sequen-
cing of RSV.
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Postoperative sepsis occurring in immunocompromised elderly pa-
tients, imposes complex clinical-therapeutic monitoring, and is known
as an important cause of mortality in this population. The purpose of
the paper is to present a clinical case with Acinetobacter baumannii
sepsis associated with Clostridium difficile enterocolitis in an elderly
immune suppressed patient.
Case report
The authors present the case of a patient of 83 years from urban envir-
onment with Acinetobacter baumanii sepsis associated with C. difficile
enterocolitis. The patient was discharged from the Vascular Surgery
Clinic, where he had undergone a right femoral-popliteal bypass. He is
transferred to the Clinic of Nephrology with massive edema. After a
day from hospitalization in the Clinic of Nephrology, he presents mul-
tiple diarrheal stool with positive Toxin A/B of C. difficile and he is sent
to the Clinic of Infectious Diseases for specialized treatment. After five
days of hospitalization, he presents a febrile episode (T = 38 °C), associ-
ated with chills and sweating. The blood culture which is harvested
after 24 hours, was positive for Acinetobacter baumannii and other
blood tests results include: RBC = 2.09*106/μL, WBC = 6.86*103/μL,
PLT = 86*103/μL, NEUT = 87.5 %, LYMPH = 8 %, MONO = 3.4 %, EO =
0.7 %, BASO = 0.4 %, HGB = 6.8 g/dL, HCT = 23.9 %, ESR = 20 mm/1 h, fi-
brinogen = 1.37 g/L, serum uric acid = 2.43 mg/dL, AF = 23.7 U/L, serum
C-reactive protein = 59.38 mg/L, chol = 45 mg/dL, trigly = 22 mg/dL,
procalcitonin = 3.75 ng/mL. During hospitalization he received therapy
with metronidazole (3x500 mg/day orally), vancomycin (4x250 mg/day
orally for C. difficile enterocolitis) and colistin (3x1 MUI/day), amikacin
(4x250 mg/day), Sinerdol (3x300 mg/day) according to antibiogram re-
sults, and hydro-electrolyte rebalancing solutions. Intrainfectious severe
anemia (HGB = 6.8 g/dL) imposed the erythrocyte mass administration.
Evolution is favorable with remission of the diarrheal stools and the
fever, together with correcting anemia (HGB = 13 g/dL at discharge).
Conclusions
Early detection of postoperative sepsis associated with infection
with C. difficile, alongside effective therapeutic clinical monitoring
can help increase life expectancy in elderly immunocompromised
patients.
Consent
Written informed consent was obtained from the patient for publi-
cation of this Case report and any accompanying images. A copy of
the written consent is available for review by the Editor of this
journal.
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Background
The aim of this study was to identify the risk factors and their im-
pact on psychopathology and quality of life among people living
with HIV/AIDS in Romania, in order of obtaining a risk psychological
profile.
Methods
For this purpose, 85 HIV-positive patients (18–57 years, 45 men
and 40 women) under antiretroviral therapy, were evaluated using
psychometric clinical instruments: 5 scales, 3 questionnaires and 2
inventories for measuring depression, anxiety, psychosis, mania,
posttraumatic stress, substance use disorders, personality dimen-
sions of the big five model and the quality of life with the main
domains: physical health, psychological health, level of independ-
ence, social relationships, environment, spirituality/religion/personal be-
liefs. We analyzed the following probable risk factors: age, sex, urban/
rural location, level of education attained, marital status, serostatus
(asymptomatic/symptomatic/AIDS converted), modes of HIV transmis-
sion and perception of health state.
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For every studied variable (psychopatological or quality of life indica-
tors) a generalized linear model (GLM) was elaborated where we in-
cluded the probable risk factors. Level of education attained, sex and
marital status are important factors of risk for the state of health
(both psysical and psychological) and quality of life among people liv-
ing with HIV/AIDS. Level of education is significantly associated with de-
pressive disorder (<0.001), anxiety disorders (0.019; 0.002; <0.001), post
traumatic stress disorder (0.004), obsessive-compulsive disorder (0.011),
substance use abuse (0.01), neuro-cognitive function (<0.001) and
with quality of life indicators: health (0.04), psychological (<0.001),
social relationships (0.001), environment (<0.001), and overall quality of
life perception (0.007). Sex is strongly associated with global cognitive
function (0.030), depressive disorder (0.011), substance use abuse
(0.017), somatic symptom disorder (0.026), physical (0.009) and spiritual-
ity domain (0.01). Marital status is associated with global cognitive
function (0.016), depressive disorder (0.005), anxiety disorders (0.012;
0.039; <0.001), obsessive-compulsive disorder (0.006), emotional
stability (0.041) and psysical domain (0.036), social relationships
(0.009) and overall quality of life perception (0.003). Age is a risk
factor regarding cognitive decline (0.021; 0.042; 0.049), while the
serostatus (asymptomatic/symptomatic/AIDS converted) is associated
with depression (0.022), social phobia (0.003), substance use disorders
(0.007), perceived stress (0.041) and general health condition (0.004).
Subjects who perceived themselves as sick have a higher risk of sub-
stance abuse (0.004), isolation (0.024) and antisocial behaviour (0.048).
Conclusions
Our study identified a psychological risk profile of people living with
HIV/AIDS in Romania and we concluded that every single risk factor
should be addressed properly by a specialist multidisciplinary team.
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Background
The WHO Experts on Influenza Antiviral Susceptibility work closely
to promote understanding of the means of prevention, treatment
and control of influenza virus diseases, including the emergence of
antiviral resistance. Due to the high prevalence of resistance to the
adamantane class of drugs among influenza A(H3N2) and A(H1N1)
2009 pandemic strain, neuraminidase inhibitors (NAIs) are currently
the only antivirals used in treatment of respiratory infections caused by
influenza viruses and less in their prevention - in Romania. Because
current pharmaceutical options for treating influenza infection and the
opportunity of their use in prophylaxis therapy are limited, there re-
mains a critical need for surveillance on NAI susceptibility of influenza
viruses circulating worldwide and also in Romania. The National Influ-
enza Center of the Cantacuzino Institute performs laboratory diagnosis
and virological surveillance of influenza viruses, including antiviral sus-
ceptibility testing.
Methods
In the Cantacuzino Institute, antiviral susceptibility testing is
performed mainly by phenotypic methods, only able to detect the
degree of reduction of neuraminidase inhibition, respectively
highly reduced inhibition (HRI) indicating a resistant influenza
virus strain. The concentrations of the antiviral substance required
to inhibit 50 % of the neuraminidase enzymatic activity (IC50)
generated in this assay are used to evaluate the NAI-susceptibility. In
the last epidemic season the use of fluorescent instead of chemilu-
minescent substrate was introduced in phenotypic assay, the
method which led to a more reliable analysis, functional and in-
creasing the number of samples tested. The viruses strains with
significantly elevated IC50s are further analyzed by conventional
sequencing to identify known markers of NAI resistance or novel
changes in the NA.Results
During the epidemic seasons of years 2013–2016 164 strains of influ-
enza virus were tested phenotypically (type A subtype H1N1 or H3N2
and type B). With the exception of two strains which exhibited IC50
values at the upper limit of normal inhibitions, all were within the
sensitive criteria to oseltamivir and zanamivir.
Conclusions
Due to the implementation of sensitive and functional testing for anti-
viral susceptibility of influenza viruses circulating during the last 3 epi-
demic seasons, the number of samples tested in Romania has been
increasing. Recorded values are in the baseline of the characteristic
strains, still being sensitive to antivirals. Continuous monitoring of anti-
viral susceptibility is needed to allow early detection of resistant strains.
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Background
Sepsis remains a major problem of modern medicine despite considerable
medical advances in recent decades. The undeniable relevance of this con-
dition is explained by the increasing incidence, high mortality, and high
economic costs related to treatment. More than 750,000 cases of sepsis
occur annually in the United States and this number has been increasing
over the years, and the cost of treatment is estimated to be 17 billion USD
per year. In Europe the number of sepsis cases annually recorded is ap-
proximately 500,000 cases, and according to the data reported by several
authors the number of fatalities would vary between 30 % and 90 %.
Methods
We conducted a retrospective study of hospital records of 15 patients
admitted to the Infectious Diseases Hospital “T. Ciorbă” with the diag-
nosis of sepsis. Data elements assessed included demographic informa-
tion, physiological variables, comorbidities, laboratory measurements,
suspected source of infection, and administered treatment.
Results
A total of 15 patients were admitted. The most affected age range
was 55–64 years and males were more commonly affected than
women. The diagnosis of referral was as follows: 4 patients have been
directed with sepsis, 2 patients came with acute or chronic hepatitis, 1
with acute respiratory infection, 1 with salmonellosis, and 7 patients
had no diagnosis of reference. At admission the diagnosis of sepsis was
established in 5 patients, fever of unknown origin in 4 patients, entero-
viral infection in 2 patients, and in other cases the diagnosis of acute
hepatitis, influenza, food poisoning and yersiniosis was established.
The identification of the primary source of infection was possible in
8 patients: infectious endocarditis 2 cases, urogenital sepsis 2 cases,
HIV + tuberculosis 1 case, generalized form of salmonellosis 1 case,
1 case of lung infection (medial-lobe pneumonia), and 1 case of skin in-
fection. Identification of etiologic agent was possible in 10 patients by
bacteriological examinations. The causative agents most frequently
found were the species of Staphylococcus: Staphylococcus aureus - 1
case, Staphylococcus epidermidis - 3 cases, Staphylococcus hemolyticus -
4 cases, 1 case of Salmonella enteritidis, Mycobacterium tuberculosis - 1
case. The most commonly used antibiotics were generation III and IV
cephalosporins, alone or associated with other antibiotics: metronida-
zole, fluoroquinolones, aminoglycosides, and in 2 cases vancomycin ± 1
aminoglycoside was administered.
Conclusions
The most common pathogens identified in the etiology of sepsis were
the species of Staphylococcus, which corresponds to some literature data.
